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Summary 
 
 
Traumatic spinal cord injury (SCI) leads to severe functional deficits for 
which there are currently no effective treatments. About 50% of SCIs 
are incomplete leaving varying numbers of spared axons intact whilst 
damaging the cells which ensheathe them. These spared fibres provide 
targets for therapeutic interventions which aim to maximise their 
potential for supporting residual functions. In preclinical studies, 
functional outcomes are most commonly assessed using behavioural 
approaches. However they are unable to provide information on the 
mechanisms of recovery or differentiate between mechanisms 
occurring in the spinal cord and compensatory mechanisms occurring in 
the brain. This study had two main aims: Firstly to develop an 
electrophysiological protocol for assessing transmission in the 
ascending dorsal column pathway, to use this protocol to characterise 
the effects of contusion injuries of different severities and to 
investigate the time course of changes to long tract function following 
SCI. The second aim of this project was to use this protocol combined 
with behavioural testing to investigate the use of human lamina-propria 
mesenchymal stem cells (hLP-MSCs) as a potential therapy for spinal 
cord injury. 
 
An electrophysiological approach was used to investigate function in 
rats subjected to T9 contusion injuries of the dorsal columns. Changes 
in the function of this pathway were assessed by recording sensory 
evoked potentials (SEPs) from the surface of the exposed 
somatosensory cortex, following stimulation of the contralateral sciatic 
nerve.  
 
Functional effects of increasing injury severities were investigated in 
normal animals and animals 6 weeks after receiving contusion injuries 
of increasing severity. Maximum SEP amplitudes and isopotential plot 
areas were reduced with injury severity, and latency to sciatic SEP 
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onset was seen to increase in a graded fashion with increasing injury 
severity. SEP mapping revealed that the region of cortex from which 
SEPs could be recorded at or greater than certain amplitudes remained 
focused in the same location with increasing injury severity. 
 
Animals were investigated at different time points from acute up to 6 
months post injury. Acute investigation revealed that sciatic SEPs are 
ablated immediately following injury and after incomplete recovery 
stabilise within hours of injury. Maximum sciatic SEP amplitudes and 
cortical areas both show 2 phases of recovery: One at 2 weeks post 
injury and one at 6 months. Onset latencies are seen to increase 
initially before gradually returning nearer to normal levels by 6 
months. SEP mapping revealed that the region of cortex from which 
SEPs could be recorded at or greater than certain amplitudes remained 
focused in the same location with increasing post injury survival time. 
Histological observations confirmed that the injury causes substantial 
damage to the dorsal columns. 
 
To assess the effects of potential therapeutic hLP-MSC transplants, the 
functional effects of T9 150 Kdyn contusion injuries were investigated 
in medium injected controls and 3 week delayed hLP-MSC transplanted 
Sprague Dawley rats, at 10 weeks post injury. Behavioural testing was 
performed throughout, with terminal electrophysiological and 
immunohistological investigations performed at the end of the study.  
 
Animals were behaviourally tested at pre- and post-operative time 
points for the duration of the experiment. Electrophysiological 
recordings suggest some recovery of function with time after injury. 
Two phases of recovery are seen, one at about 2 weeks after injury and 
the other at about 6 months after injury; however other measurements 
suggest hLP-MSC transplants had little or no effect on the functional 
integrity of the dorsal column pathway. Open field locomotor testing 
using the Basso, Beattie and Bresnahan (BBB) locomotor scale revealed 
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no differences between the recoveries of cell transplanted and control 
groups. Gait analysis was performed using the Digigait™ Imaging System 
revealing a trend for earlier recovery of co-ordination between 
forelimbs and hindlimbs in hLP-MSC transplanted animals compared to 
control animals. Moreover the step sequence data also suggested a 
better recovery of co-ordinated stepping in transplanted compared to 
medium injected animals. Dynamic weight bearing apparatus (BIOSEB) 
was used to measure the percentage of body weight borne on the 
forepaws and hindpaws, this demonstrated no effect of transplanted 
cells on postural changes. hLP-MSC transplants did not increase 
indicators of neuropathic pain in our model suggesting they are unlikely 
to exacerbate neuropathic pain following spinal cord injury. At present 
there are no immunohistochemical (IHC) markers that can be used to 
differentiate axons which have been remyelinated with central-type 
myelination from those which survived the injury. Thus, the degree of 
peripheral-type myelination was investigated as a simple way of 
assessing remyelination. This suggested that there was a greater 
degree of remyelination in transplanted animals, and that this was 
specifically in areas where transplanted cells were located. 
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Chapter 1                              
Introduction 
 
 
 
 
1 
 
1.1 Spinal cord injury  
 
1.2 Epidemiology and aetiology 
 
The spinal cord is a columnar projection of neuronal and support cells which 
extends caudally from the medulla oblongata in the brainstem and projects 
down the spinal canal of the vertebral column. It receives and processes 
sensory and autonomic information from the muscles, joints, skin and viscera, 
and carries motor signals to the musculature. 
 
Injury to the spinal cord can disrupt the ascending and descending long white 
matter tracts which carry sensory and motor signals, respectively, to and from 
the brain. Injury can also damage the spinal grey matter in the dorsal, ventral 
and lateral horns which can result in the loss of local interneurones and 
motorneurones. SCI therefore has the capacity to produce deficits in motor, 
sensory and autonomic function, and due to the limited reparative capacity of 
the central nervous system these deficits are often permanent. 
 
The number of people worldwide currently living with a SCI is unquantifiable 
due to inconsistencies in data reporting, however, reported annual incidences 
range from 10.4-83 per million population (Wyndaele and Wyndaele, 2006). 
Estimated annual incidence is reportedly 15 per million population in Western 
Europe, and 40 per million population in North America (Ackery et al., 2004; 
Cripps et al., 2011; National Spinal Cord Injuries Association Statistical Centre, 
2013 - http://www.nscisc.uab.edu). In the UK an estimated 15-20 people per 
million population suffer a traumatic spinal cord injury (TSI) each year and a 
total of 40,000 people currently live with spinal cord injury (Bellack and 
Hersen, 1998).  
 
The aetiologies of spinal cord injuries vary from country to country as well as 
between demographic groups. In the USA an estimated 36.5% of traumatic 
spinal cord injuries occur as a result of road traffic accidents, 28.5% as a result 
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of falls and 9.2% due to sports-related injuries (National Spinal Cord Injuries 
Association Statistical Centre, 2013 - http://www.nscisc.uab.edu). More 
developed countries tend to have lower rates of work-related injuries and a 
higher incidence of sports-related injuries when compared to developing 
countries; this is due to more developed nations having higher levels of worker 
safety as well as workers having more free time and greater disposable income 
(Sekhon and Fehlings, 2001). 
 
 
1.3 General anatomy of the Spinal cord 
 
The brain and spinal cord make up the central nervous system (CNS) and are 
protected from damage by physical and chemical barriers. The main defence 
against mechanical damage to the CNS is provided by the skull and vertebral 
column which encase the CNS and provide support and protection from blunt 
force and penetrating injuries. Physical protection is also provided by a tough 
three layered membranous barrier known as the meninges: the innermost pia 
mater, arachnoid mater and outermost dura mater surround the CNS and 
provide physical support (Kimmell, 2011 – see Figure 1.1). The subarachnoid 
space contains cerebrospinal fluid (CSF) which is involved in protecting the 
CNS by acting as a cushion against mechanical damage. The CNS is also 
protected by a selectively permeable membrane between the circulating blood 
and the extracellular fluid in the CNS known as the blood brain barrier (BBB). 
Protection is achieved through the selectivity of the tight junctions between 
endothelial cells that line the blood vessels of the CNS; this allows for 
chemical isolation of the CNS, safeguarding it from potentially damaging 
agents and microbes which circulate in the periphery, whilst allowing 
beneficial substances through via diffusion or active transport mechanisms. 
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Figure 1.1 - Structure of the spinal cord - In transverse section the spinal 
column can be seen to consist of a centrally located butterfly-shaped region 
of grey matter surrounded by white matter. The grey matter is largely 
composed of neuronal and glial cell bodies, whereas the white matter is 
composed largely of axonal fibre tracts. The spinal cord is protected from 
physical damage by the vertebral column and three tough meninges called the 
dura mater, the arachnoid mater and the pia mater. Each spinal segment 
contains two anterior/ventral roots which carry motor signals to the 
periphery and two posterior/dorsal roots which carry sensory signals to the 
CNS. The two roots on each side join to form paired spinal nerves. (Adapted 
from information available online at www.mmi.mcgill.ca, 2008). 
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The human spinal cord contains millions of neuronal and glial cells which 
together act as the main pathways for the transmission of information to and 
from the peripheral nervous system. The spinal column consists of a central 
butterfly shaped column of grey matter surrounded by white matter fibre 
tracts (Figure 1.1). The spinal cord is divided into 31 segments: 8 cervical, 12 
thoracic, 5 lumbar, 5 sacral and one coccygeal. Each spinal segment receives 
sensory input from the periphery via a pair of nerves known as the dorsal roots 
and transmits motor signals to the periphery via a pair of nerves known as the 
ventral roots. The dorsal roots enter the spinal column via the left and right 
dorsolateral sulci and ventral roots exit the spinal column via the left and right 
ventrolateral sulci. Ganglia known as the dorsal root ganglia are located on 
each dorsal root, and contain the cell bodies of afferent spinal nerves, whilst 
the cell bodies of efferent neurones are located in the ventral horn. The dorsal 
and ventral roots of each spinal segment meet to form paired spinal nerves 
before leaving the vertebral canal via the intervertebral foramina. The spinal 
cord contains two enlargements along its length: the cervical enlargement 
which extends from spinal segments C3-T2, and the lumbosacral enlargement 
which extends from spinal segments L1-S3. These enlargements exist due to 
the large numbers of nerves responsible for the innervation of the upper and 
lower limbs, respectively. 
 
The adult spinal cord is shorter than the vertebral column and only occupies 
the upper part of the spinal canal, terminating at around the L1-2 vertebral 
region. Therefore the spinal cord segmental levels do not have a direct 
correlation with the spinal vertebral levels at all levels; this discrepancy 
increases as we travel down the cord from cervical to sacral levels (Figure 
1.2).   
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Figure 1.2 The relative locations of the spinal segmental levels, spinal 
nerve roots and vertebrae - At birth the spinal cord segmental levels are 
located directly below the vertebral levels but the vertebral column grows 
faster than the spinal cord, thus as we grow the spinal cord ceases to occupy 
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the lower third of the vertebral canal. This discrepancy increases until the 
time we stop growing, by which time the terminal portion of the cord, known 
as the conus medullaris, is located within the L1-2 vertebral region. The 
spinal roots of each segment continue to exit the intervertebral foramina of 
their correspondingly named vertebrae, thus at increasingly caudal spinal 
levels, the roots get longer such that the lumbar, sacral and coccygeal nerves 
extend below the level of the conus medullaris before exiting the spinal 
canal, and are collectively known as the cauda equina (From Drake et al., 
2008, pg. 44). 
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1.4 Injury level and type 
 
The specific effects of a SCI depend on the type of injury sustained and the 
level at which it occurs. SCIs can be classified as either complete or 
incomplete injuries, depending on the available neurological evidence for 
sparing of sensory and/or motor functions. Injuries are classified as incomplete 
when some degree of sensory and/or motor function remains below the injury 
level, which is defined as the lowest level that has normal neurological 
function. In complete injuries, no sensation or voluntary motor functions can 
be observed below the injury level. 
 
Clinically, SCI severities are classified using the ASIA scale (American Spinal 
Cord Injury Association’s International Standards for Neurological Functional 
Classification of Spinal Cord Injury - http://www.asia-spinalinjury.org), which 
allows clinicians to assign patients to one of 5 categories from A-E based on 
the observed level of injury, which is defined by touch and pinprick tests of 
sensory function and the strength of key muscles on both sides of the body 
following injury. A = complete: no motor or sensory function is preserved 
below the injury level. Patients that are assigned an ASIA A classification are 
least likely to recover any function. B = incomplete: sensory but not motor 
function is preserved below the neurological level and includes the sacral 
segments S4-S5. C = incomplete: motor function is preserved below the 
neurological level, and more than half the key muscles below the neurological 
level have a muscle grade less than 3. D = incomplete: motor function is 
preserved below the neurological level, and at least half the key muscles 
below the neurological level of injury have a muscle grade of 3 or more. E = 
normal: motor and sensory functions are normal and the patient may have had 
prior deficits or may have sustained an injury with no neurological damage. 
 
Based on the ASIA scale, there has been a substantial reduction in the 
proportion of SCIs that are classified as complete in the last 40 years, from 
approximately two thirds to the current rate of less than a half. Many factors 
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have played a role in these statistics, including the increased awareness of SCI 
and the importance of immediate immobilisation and well planned post-injury 
care, better health and safety regulations as well as the use of drugs, such as 
anti-inflammatory drugs which appear to limit the effects of the secondary 
injury (Strauss et al., 2006), although this is still debated (Pinzon et al., 2008). 
 
The level at which a SCI occurs determines the parts of the body in which 
function may be impaired or lost. Cervical level SCIs are the most commonly 
seen, accounting for approximately 45% of all SCIs, with thoracic level injuries 
accounting for approximately 29% and lumbar level injuries accounting for 
approximately 23% of all SCIs (Hasler et al., 2011). As shown in Figure 1.3, SCIs 
at the cervical level usually result in tetraplagia whereas SCIs at the thoracic 
(or lower) levels usually result in paraplegia. Tetraplegia, also known as 
quadriplegia, is characterised by paralysis in all limbs, although this does not 
have to be complete paralysis or loss of function. Injuries of this type will also 
affect the chest and abdominal muscles, often affecting respiratory and 
digestive functions. Paraplegia occurs when the injury level is at or below the 
level of the first thoracic spinal nerve and is characterised by complete or 
incomplete loss of function in the lower limbs and the abdomen up to the 
nipple line, with full function remaining in the upper limbs (Figure 1.3). 
 
Lumbar and sacral SCIs (L1-S5) are characterised by decreased function in the 
legs, urinary tract and bowel. Lower thoracic SCIs (T9-T12) are capable of 
producing partial paralysis of the lower body and limbs; at higher thoracic 
levels (T1-T8) SCIs begin to also affect trunk control due to the decrease in 
abdominal muscle control, as well as beginning to adversely affect the 
sympathetic nervous system. Injuries at levels above the T1 spinal level start 
to affect arm and hand function, with C7-T1 injuries frequently causing 
deficits in hand and finger function whilst control of the arms remains. SCIs at 
the C7 spinal level are generally the highest level injuries with which patients 
can still live relatively independently. At the C6 level all function in the wrists 
and fingers is lost whilst wrist function remains, whereas at the C5 level 
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patients are only able to control the upper arms and shoulders with no control 
over their wrists. Individuals with injuries at the C4 level might retain some 
control over the upper arms and shoulders but this will be weaker than that 
seen with injuries at the C5 level. High cervical injuries (above the C3 level) 
typically result in deficits on head and neck movements as well as loss of 
diaphragm function, which if the patient survives the initial trauma, requires 
the use of an artificial ventilator to enable to patient to breath. Other 
common problems associated with SCI include neuropathic pain and/or 
spasticity (Burchiel & Hsu, 2001).   
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Figure 1.3 SCI level and associated functional deficits. 
The severity of spinal cord injury and the level it occurs at both affect the 
type and degree of resultant functional deficits. SCIs at the cervical level 
usually result in tetraplegia, a symptom in which the individual experiences 
paralysis in all four limbs - though not necessarily complete paralysis or loss 
of function. SCIs at the thoracic level or below usually result in paraplegia, a 
symptom where the individual experiences paralysis of the lower limbs whilst 
retaining full function in the upper limbs. The area of paralysis is indicated in 
red (taken from Thuret et al., 2006). 
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1.5 Pathology following SCI 
 
Due to the paucity of information from clinical injuries in the literature, much 
of our understanding of the events that follow the initial trauma of SCI come 
from studies that utilise animal models. Following SCI it is known that a 
complex sequelae of pathophysiological events occurs, which are summarised 
in Figure 1.4. 
 
SCI is characterised by two stages of injury processes known as the primary 
and secondary injury response. During the primary injury response the 
mechanical force of the injury results in local axotomy as well as disruption of 
the spinal vasculature and cellular membranes. The secondary injury response 
rapidly follows this initial trauma and is characterised by a complex and time 
dependent series of pathophysiological events at and adjacent to the injury 
site; these ongoing sequelae include vascular disruptions, inflammation, 
oedema, excitotoxicity, demyelination, axonal degeneration, apoptosis and 
scar formation (Tator, 1995) (Figure 1.4). Whilst most of the cells that 
participate in the secondary injury response already reside in the spinal cord, 
others infiltrate the injured cord after being recruited from the circulatory 
system (Schwabb & Bartholdi, 1996). 
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Figure 1.4 Pathogenesis of SCI - Spinal cord injury occurs in two stages, 
referred to as the primary and secondary injury processes: The primary injury 
refers to the physical damage resulting from the initial mechanical impact on 
the cord whereas the secondary injury refers to a complex series of time-
dependant pathophysiological processes that succeeds the primary injury, 
including disruption of the vasculature, excitotoxicity, inflammation, 
apoptosis, demyelination and axonal degeneration and dieback (taken from 
Bareyre and Schwab 2003). 
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1.5.1 Necrosis, apoptosis and excitotoxicity 
 
Mechanical injury to the spinal cord causes many cells to undergo immediate 
cell death, via a process called necrosis. This is often associated with 
inflammation and the severe depletion of cellular energy stores caused by 
disruption of the vasculature, and is characterised by cells swelling until their 
membranes rupture. 
 
Later on, cells undergo another kind of cell death called apoptosis 
(programmed cell death), characterised by cells condensing before a highly 
controlled cascade of enzymatic reactions breaks the cell down into its 
constituent parts (reviewed by Beattie et al., 2000). Ionic disruption leading to 
a rapid influx of calcium has been shown to play a critical role in apoptosis 
(Mattson & Chan 2003). Calcium influx is induced by enzymatic modifications 
to Na+ channels in cellular membranes, leading to rapid influx of Na+ ions by 
causing reversal of the Na+–Ca2+ exchangers, which in turn causes the rapid 
influx of Ca2+ through voltage-gated Ca2+ channels, leading to apoptosis 
(Nashmi and Fehlings et al., 2001; Mattson & Chan 2003; Iwata et al., 2004). 
Apoptosis has been shown to be ongoing for around three weeks to a month 
following injury in animal models (Crowe et al., 1997; Beattie et al., 2000) and 
around 2 months in humans (Emery et al., 1998). 
 
Necrosis, apoptosis and excitotoxicity afflict many cell types following SCI, 
including neurones, oligodendrocytes, astrocytes and microglia (Beattie et al., 
2000). Oligodendrocytes in particular are highly susceptible to degradation and 
have been shown to undergo apoptotic cell death in the proximity of the injury 
site as well as several segments rostral and caudal to the injury site in the 
degenerating white matter tracts, both in rats (Li et al., 1999) and in humans 
(Emery et al., 1998). As discussed earlier, microglia have been associated with 
oligodendrocyte apoptosis, though other factors have been implicated, 
including alterations to the level of trophic factor expression following injury 
(Krenz and Weaver, 2000). 
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Following injury, all types of glial and neural cells are at risk of excitotoxic 
cell death due to accumulation of the excitatory amino acids aspartate, 
glutamine, asparagine and glutamate. It has been shown that such molecules 
build up in the injured cord to levels capable of over activating AMPA (α-
amino-3-hydroxy-5-methylisoxazole-4-propionic acid) and NMDA (N-methyl-D-
aspartate) receptors, leading to an influx of extracellular calcium which causes 
the release of cyctochrome c from mitochondria. Cytochrome c then binds to 
receptors on the endoplasmic reticulum and causes further calcium release, 
initiating a positive feedback loop whereby more cytochrome c is released 
from the mitochondria, leading to further release of calcium from the 
endoplasmic reticulum. This ultimately results in a massive increase in 
cytoplasmic calcium and cytochrome c concentrations, leading to the 
formation of the apoptosome which leads to the activation of a full caspase 
cascade and subsequent cell death (Mattson and Chan, 2003). 
 
 
1.5.2 Disruption of spinal vasculature  
 
Following SCI blood flow alterations are observable at and around the injury 
site. These alterations are required for the development of the destructive 
processes that take place in the secondary injury response (Mautes et al., 
2000; Popa et al., 2010; Ng et al., 2011).  
 
SCI invariably results in damage to the blood vessels at the site of injury, 
usually manifesting as intraparenchymal haemorrhage with a propensity for 
damaging highly vascularised regions and the central grey matter (Mautes et 
al., 2000). Bleeding is usually from the capillaries, arterioles and venules and 
very rarely from arteries such as the anterior spinal arteries (Tator et al., 
1995). Over time haemorrhagic damage is seen to extend from the grey matter 
into the white matter (Mautes et al., 2000). More substantial bleeding rarely 
occurs within the cord; when it does occur, these larger bleeds, termed 
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hematomyelia, are occasionally accompanied by distension of the cord (Tator 
et al., 1995). 
 
It has been shown that various proteinases including matrix metalloproteinases 
cysteine proteases, and serine proteases are upregulated following SCI in mice 
rats and human (Noble et al., 2002; Wells et al., 2003; Buss et al., 2007; 
Veeravalli et al., 2012). This upregulation causes excessive proteolytic activity 
in the injured cord, which causes further damage to the capillary endothelial 
cells that make up the blood brain barrier. As a result macrophages and 
neutrophils from the periphery are able to cross into the CNS, thus enhancing 
phagocytosis and protein breakdown (Noble et al., 2002; Wells et al., 2003; 
Buss et al., 2007). 
 
Mechanical damage to the microvasculature has been shown to cause 
vasospasm, resulting in a reduction in arteriolar luminal area by up to 80% 
(Anthes et al., 1996). Thrombosis of small blood vessels has also been 
documented (Koyanagi et al., 1993). It has been shown that in brain injuries 
which result in subarachnoid haemorrhage, vasospasm can be induced by the 
breakdown products of red blood cells and endothelial cells, such as 
endothelin and oxyhemoglobin (Roux et al., 1995; Macdonald and Weir, 1991), 
similar mechanisms could feasibly act to induce or enhance the degree of 
vasospasm following damage to spinal vasculature caused by spinal cord 
trauma (Anthes et al., 1996). Combined, these processes are capable of 
causing ischemic injury in spinal cells by preventing spinal cells at and 
adjacent to the disruption from accessing the oxygen and nutritional support 
required to survive (Tanaka et al., 2005). In turn, inadequate nutrient and 
oxygen supply to the spinal tissue is capable of resulting in the spinal cord’s 
failure to function properly in the first few weeks following injury (Krassioukov 
and Claydon, 2006). During the ischemic period, most cell types release 
numerous kinds of free radicals including reactive oxygen species and reactive 
nitrogen species which are known to play a significant role in progressive cell 
death during the secondary injury response (Liu et al., 2000; Jia et al., 2012).  
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Disrupting central control of the cardiovascular system occurs following 
complete cervical injuries and frequently results in hypotension and 
bradycardia, which can in turn lead to further damage to the cord (Weaver et 
al., 2012). 
 
1.5.3 Oedema 
It has been shown that following SCI extensive bleeding into the extracellular 
spaces of the spinal parenchyma plays a major contributing factor in the 
development of local oedema, which is maximal during the first hour after 
injury and then rapidly decreases (Griffiths and Miller, 1974). Oedema is 
known to start in the central part of the cord and to spread centrifugally into 
the white matter (Noble and Wrathall 1989), as well as extending considerable 
distances rostrally and caudally from the injury site (Wang et al., 1993). The 
degree and rate of spread is known to be highly dependant on injury severity 
(Griffiths and Miller, 1974). 
Injury is known to cause blood vessels near the injury site to increase 
permeability, whilst the BBB remains intact. This process, known as vasogenic 
oedema, serves to exacerbate the oedema caused by bleeding from ruptured 
vessels, ultimately enhancing the deleterious effects that oedema exerts on 
the local tissue. These effects are believed to result mainly from localised 
tissue compression which further disrupts the vasculature and ultimately 
enhances necrosis (Griffiths and Miller, 1974). 
 
1.5.4 Inflammatory response 
 
SCI leads to a strong inflammatory response in an attempt to restore tissue 
homeostasis, with the recruitment of peripherally derived leukocytes 
(monocytes/macrophages, neutrophils and T-lymphocytes) and activation of 
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glial cells (astrocytes and microglia). This is accompanied by the up-regulation 
of soluble factors including cytokines and chemokines by activated glia. The 
release of cytokines and chemokines initiates intracellular signalling cascades 
which result in epithelial damage, alterations to vascular permeability and 
oedema (Schnell et al., 1999; Bareyre and Schwab 2003; Hagg and Oudega 
2006). Using animal models of SCI, many such factors, including IL-1 and TNFα 
have been shown to be up-regulated as quickly as an hour following injury and 
are down-regulated again within 6-24 hours (Bartholdi and Schwab, 1997). 
 
Inflammation is known to have strongly dichotomous effects on recovery 
following SCI; complex concomitantly occurring destructive and constructive 
processes occur during the post-injury inflammatory episode (Bethea, 2000). 
Reducing the inflammatory response has been shown to facilitate functional 
recovery (Sterling et al., 2004), despite this, the inflammatory response has 
also been shown to be advantageous to recovery through the elimination of 
cellular breakdown products from the injury site (Fleming et al., 2006; Rice et 
al., 2007). 
 
Following SCI, the first group of cells to participate in the immune response 
are the local microglia. Using mouse models, it has been suggested that 
microglia may be activated within minutes following injury (Rice et al., 2007). 
Once activated, local microglia produce numerous pro-inflammatory molecules 
such as cytokines and chemokines as well as numerous mediators of cellular 
injury including various reactive oxygen species, reactive nitrogen species and 
proteases (Banati et al., 1993) all of which are capable of inducing apoptosis. 
Moreover, two of the reactive oxygen species up-regulated in activated 
microglia, nitric oxide and superoxide anion, have been shown to indirectly 
cause oligodendrocyte death (Li et al., 2005b). Despite this, several cytokines 
released by activated microglia are believed to have both direct and indirect 
neuroprotective and neuroregenerative actions (reviewed by David and Kroner, 
2011). 
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Haematogenous macrophages arrive in the spinal cord within 2-3 days and 
remain there for weeks where they play one of the most active roles in the 
post-injury inflammatory period (Popovich et al., 1999). They are widely 
believed to have both beneficial and detrimental effects on recovery following 
SCI (Bethea 2000; David and Kroner 2011). Macrophages act to phagocytose 
cellular debris in and around the injury site as well as secreting factors that 
promote axonal growth and Schwann cell proliferation, which may lead to an 
increase in functional recovery. Concomitantly, it has been shown that a 
different subset of macrophages also synthesise and release numerous 
cytokines and reactive oxygen species which facilitate the inflammatory 
episode, cause severe membrane damage and contribute to further cell death 
(reviewed by David and Kroner, 2011 and Kigerl et al., 2012). 
 
 
1.5.5 Demyelination  
 
Like neurones, oligodendrocytes are extremely sensitive to the effects of SCI. 
When oligodendrocytes are injured or destroyed they cease to provide the 
insulating myelin sheath that axons require to function normally. This process, 
known as demyelination, impairs the axon’s ability to conduct action 
potentials due to there being insufficient sodium channels distributed along 
the internodal axonal membrane regions (Black et al., 1991). Demyelination 
severely slows or blocks signal conduction through spared axons (Bostock and 
Sears, 1976; Bostock et al., 1978). As a result, a compensatory mechanism 
known as “channel spreading” occurs whereby the membrane channels which 
were tightly grouped around the nodes of Ranvier spread out along the 
axolemma to aid in signal transduction (Balentine, 1978; Griffiths and 
McCulloch, 1983; Nashmi et al., 2000; Karimi-Abdolrezaee et al., 2004). 
 
Using animal models of SCI it has been possible to document the first phase of 
demyelination, called primary demyelination which is initiated by the primary 
injury response and involves the destruction or partial destruction of the 
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myelin sheath with axons remaining relatively structurally intact (Griffiths and 
Mcculloch, 1983). The initial loss of oligodendrocytes is complex and poorly 
understood. In animal models of SCI, primary demyelination has been 
attributed to the initial mechanical insult and resultant necrotic ischemia 
around the injury site (Salgado-Ceballos et al., 1998; Waxman 1989); whilst in 
humans it does not appear to be as common, with only sparse demyelination 
seen (Norenburg et al., 2004). However, in compression injuries in humans 
there has been shown to be a much more robust degree of demyelination 
(Bunge et al., 1993) observable at acute time points. As yet it remains 
unknown to what extent early demyelination might occur in humans following 
moderate SCI, as moderately injured human spinal tissue is normally only 
available at acute time points. 
 
In animal models of SCI it has been reported that around 3 weeks after injury a 
second phase of demyelination begins, which results in further damage to 
myelin sheaths (Griffiths and Mcculloch, 1983). Totoiu and Keirstead reported 
chronic progressive demyelination following thoracic contusion injury in rats, 
which began between 2-4 weeks post injury and continued for up to 450 days 
(Totoiu and Keirstead, 2005). Where seen experimentally, later phases of 
oligodendrocyte loss have been linked with numerous factors involved in the 
secondary injury response, including reductions in the levels of trophic support 
molecules caused by axonal degeneration (Barres et al., 1993) as well as the 
delayed recruitment of macrophages to the injury site as part of the 
inflammatory response (Blight 1985). Despite these observations, several 
studies have been unable to corroborate the findings of Totoiu and Keirstead, 
2005 (Lasiene et al., 2008; Powers et al., 2012). If however, as Totoiu and 
Keirstead have reported, chronic progressive demyelination occurs following 
contusive SCI, then this would present a potential therapeutic target for the 
treatment of SCI. 
 
 
1.5.6 Axonal degeneration  
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Axons may be disrupted by the initial trauma or they may undergo anterograde 
neurodegeneration following apoptosis of the oligodendrocytes which ensheath 
their axons. This process is called Wallerian degeneration and may help 
explain the ongoing sensory-motor dysfunction following injury (Griffiths and 
Mcculloch, 1983). Wallerian degeneration is associated with disruption to the 
spinal vasculature (Sinescu et al., 2010), as well as ionic imbalances caused by 
the reversal of the Na+–Ca2+ exchangers (Fehlings and Nashmi et al., 1996; 
Imaizumi et al., 1999; Iwata et al., 2004), resulting in an influx of calcium 
which induces cellular apoptosis (Mattson & Chan 2003), as discussed above. 
SCI also results in reduced expression of myelin-associated proteins, including 
myelin basic protein and myelin-associated glycoprotein, which results in 
abnormal myelination (Wrathall et al., 1998). Wallerian degeneration, also 
results in the loss of collateral projections, which accounts for the reduction in 
residual functions seen following the primary injury response. Axonal dieback 
also leads to a reduction in the degree of functional recovery that the later 
plastic changes are capable of inducing (see section 1.6.3.2). 
 
 
1.5.7 The lesion scar  
 
Various cytokines released by invading macrophages, leukocytes and 
lymphocytes in the inflammatory period lead to the recruitment of activated 
astrocytes, microglia, meningeal cells, oligodendrocytes and oligodendrocyte 
precursor cells around the injury site, resulting in the formation of a glial scar. 
Astrocytes are the most common and most important cell type associated with 
the glial scar, whilst fibroblasts of meningeal and perivascular origin also 
invade the injury site and form a fibrotic scar. The glial and fibrotic scars form 
a dense, highly organised, solid network, collectively known as the lesion scar, 
which acts as a barrier to axonal regeneration (Fawcett and Asher 1999; 
Faulkner et al., 2004; Fitch and Silver, 2008; Kawano et al., 2012). 
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Together the glial and fibrotic scars act as a physical and chemical barrier to 
regenerating axons. Many of the cell types involved, including 
oligodendrocytes, oligodendrocyte precursor cells, astrocytes, meningeal cells 
and activated microglia, are known to release factors which are inhibitory to 
axonal outgrowth (Fawcett and Asher 1999), as well as producing extracellular 
matrix molecules which have been shown to have potent growth inhibitory 
properties (Davies et al., 1999). Together these features combine to produce 
an environment which is highly non-permissive to axonal regeneration; 
however, some investigators have reported robust long distance axonal growth 
through lesion scars and into the sites of chronic SCI (Lu et al., 2007) 
 
Despite the negative effects the lesion scar has on regenerating axons, it also 
plays a protective role in the recovery process by repairing the damaged blood 
brain barrier, preventing further degeneration and limiting the spread of 
damage to the surrounding, healthy tissue (Faulkner et al., 2004). 
 
 
1.5.8 The lesion cavity  
 
Following SCI the destruction of the grey matter at the injury epicentre 
sometimes leads to the formation of a cavity with a rim of preserved subpial 
myelinated axons (Beattie et al., 1997; Hayes and Kakulas, 1997). At the 
boundary between the cavity and the preserved axons, some studies have 
shown the presence of partially demyelinated axons (Blight and Decrescito, 
1986; Salgado-Ceballos et al., 1998). It is believed that the myelinating cells 
are relatively more susceptible to injury than axons as unlike axons, their cell 
bodies are local to the injury site (Crowe et al., 1997; Emery et al., 1998; Frei 
et al., 2000; Yamaura et al., 2002). 
 
The lesion cavity usually begins to form in the grey matter; this may be the 
case for numerous reasons, including simply that damage to the central canal 
causes leakage of CSF into the expanding extracellular space. Other 
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possibilities include the grey matter is inherently more rigid and thus fragile 
than the white matter, as revealed by studies in bovine cords (Ichihara et al., 
2001), or that the comparatively denser vascular network of the grey matter 
makes it more susceptible to mechanical injury than the white matter (Tator, 
1995). Irrespective of aeiteology, ongoing degeneration leads to the cavity 
extending outwards to include parts of the white matter whilst concomitantly 
spreading in the rostro-caudal plane, mostly in the grey matter, such that it 
can be seen extending several millimetres above and below the injury within a 
few weeks in animal models (Ek et al., 2010; James et al., 2011). Cavity size 
and the amount of uninjured or partially demyelinated tissue surrounding the 
cavity varies depending on the type, severity and location of the injury. 
 
Single cavities are most commonly seen, though multiloculated cavities are 
also observed separated by fine trabeculae of connective tissue, blood vessels 
and a small number of axons. They are filled with extracellular fluid and 
frequently contain residual macrophages, connective tissue and blood vessels. 
Whilst fluid filled cavities provide a bad substrate for regenerating axons and 
therefore act as a physical barrier to regeneration, filled cavities provide a 
comparatively good substrate for regenerating axons (Norenberg et al, 2004). 
As the cavities expand over time, if multiloculated, individual cavities may 
coalesce. This condition, known as syringomyelia, only affects 4% of SCI 
patients but has been documented occurring from as little as 2 months up to 
30 years following injury (Schurch et al., 1996). 
 
 
1.6 Spontaneous recovery of function  
 
As mentioned previously, spontaneous improvements in function are frequently 
reported following SCI, as reviewed by Fawcett et al., 2007. Spontaneous 
regeneration in the adult CNS is extremely limited, although some degree is 
observed in almost all cases in the days, weeks and years following injury; this 
may play a role in functional recovery. Synaptic plasticity in spared pathways 
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and the formation of new circuits by collateral sprouting may also contribute 
to the recovery of function (Raineteau and Schwab 2001). 
 
 
1.6.1 Spontaneous recovery of function in humans 
 
Following spinal cord injury in humans, highly predictable but limited degrees 
of functional recovery are known to occur (Brown et al., 1991; Fisher et al., 
2005). However, functional recovery following incomplete SCIs is known to be 
much faster and extensive, yet highly variable. For example, following 
incomplete injuries some patients recover almost complete motor function, 
whereas in others it can be highly limited (Burns et al., 1997; Ditunno et al., 
2000). It is known that spontaneous recovery of motor function in humans is 
rapid in the first few months following injury, but has usually reached a 
plateau between 12–18 months, at which point the injury is considered stable, 
although in some cases limited ongoing regeneration has been recorded up to 
several years following injury. Limited sensory recovery is also seen to follow 
the case time course as that seen for motor recovery (McDonald and Sadowsky, 
2002; Fawcett et al., 2007). 
 
The degree of spontaneous recovery of function observed is highly dependant 
on injury severity, with less severely injured patients more likely to 
experience greater degrees of functional recovery. Data from the US Model 
Systems, EMSCI and Sygen databases were reviewed by Fawcett et al., 2007 to 
reveal that approximately 10% of ASIA A patients are ultimately downgraded to 
ASIA B, and 10% to ASIA C due to the limited recovery of some sensory and 
motor function below the level of injury, respectively, in the first 12 months 
following injury. Between 15-40% of ASIA B patients were reassigned to ASIA C, 
and 40% to ASIA D. As discussed earlier, the majority of ASIA C patients are 
intimately reclassified as ASIA D; Fawcett et al., 2007 recorded this figure to 
be between 60-80%. Despite this, very few ASIA D patients ever recover fully 
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enough to be assigned an ASIA E score, indicating normal motor and sensory 
function (Fawcett et al., 2007). 
 
 
1.6.2 Spontaneous recovery of function in animals 
 
Several studies utilizing animal models of SCI have demonstrated spontaneous 
recovery of function (McKenna and Whishaw, 1999; Weidner et al., 2001; 
Bareyre et al,. 2004; Courtine et al., 2005; Ballermann and Fouad, 2006; 
Gulino et al., 2007), though the time course, extent and variability of 
functional recovery are seen to vary greatly between models utilising different 
injury types, severities, levels and species of animal (Noble and Wrathall, 
1989). 
 
Most animal models in which spontaneous recovery is seen show a much 
greater degree of functional recovery than we would expect to see in humans 
afflicted with comparable injuries. As discussed below, the most widely 
utilised functional assessments are behavioural tests, most of which have 
shown that varying levels of spontaneous recovery occur following injuries of 
different type, severity, level and in every species investigated. Behavioural 
assessments of locomotive abilities in animal models of SCI have shown that 
the prognosis for experimental animals is better than for humans. It is thought 
that this observation can be explained, in part, by the fact that quadrupeds 
have a wide range of compensatory modifications to gait which they can 
employ to compensate for the locomotor deficits caused by the injury 
(Rossignol et al., 2004; Ballermann et al., 2006).  
 
 
1.6.3 Processes underlying spontaneous recovery of function  
 
The physiological processes that underlie spontaneous functional recovery are 
complex and poorly understood. It is widely accepted that spontaneous 
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improvements in function cannot be attributed to axonal regeneration alone, 
and that other mechanisms such as remyelination and plasticity must also play 
critical roles, as discussed below.  
 
 
1.6.3.1 Remyelination 
 
Following injury in animal models, it is believed that a proportion of 
demyelinated and regenerating axons are remyelinated by resident 
oligodendrocyte precursor cells or by invading peripheral Schwann cells. 
Oligodendrocyte precursor cells (OPCs) have been shown to be recruited to the 
injury site where they can form myelin sheaths around denuded axons (Gensert 
and Goldman 1997; Keirstead and Blakemore, 1999). Schwann cells, which 
normally myelinate axons in the peripheral nervous system, have been shown 
to be capable of invading the injured spinal cord and remyelinating 
demyelinated and regenerating axons (Salgado-Ceballos et al., 1998), leading 
to improvements in function (Murray et al., 2001). 
 
There has been debate as to the longevity of the spontaneous remyelination 
process, with some authors observing robust long term remyelination (Salgado-
Ceballos et al., 1998; Powers et al., 2012). It has been reported that following 
thoracic contusion injury in the rat, the majority of spared axons were seen to 
be spontaneously remyelinated, as evidenced by at least one abnormally short 
internodal distance (<100 μm). These shortened internodes were significantly 
concentrated around the lesion epicentre where the axonal diameters were 
seen to be thinned by approximately 23% compared to their rostral and caudal 
zones. Using these observations it was predicted that the conduction velocity 
at the lesion epicentre would be reduced by 25% (Powers et al., 2012). Despite 
this, there still remains debate as to the longevity of the spontaneous 
remyelination process, with others reporting the process to be incomplete or 
abortive (Totoiu and Keirstead 2005). In recent years it has been reported that 
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OPCs can differentiate into Schwann cells as well as oligodendrocytes during 
the post-injury period (Zawadzka et al., 2010). 
 
Endogenous remyelination has been demonstrated in primate models of SCI, 
where 7 months post-injury 15% of the newly divided cells were shown to 
display markers for mature oligodendrocytes, they were located at sites of 
injury induced demyelination where they ensheathed host axons (Yang et al., 
2006). 
 
Tissue from humans is only available from chronic time points, by which point 
most or all of the remyelinating processes might have been completed, after 
which point many of the remyelinated axons might have died back. Thus there 
is a paucity of evidence for remyelination in humans following SCI, especially 
at the acute stages of injury, though some studies looking at the effects of 
injury at chronic time points have reported Schwann cell remyelination of 
putatively demyelinated axons in the spinal cords of SCI patients (Guest et al., 
2005). Methods of imaging the demylelination and remyelination that may 
occur in the acute stages of injury in primates (including man) are being 
developed by several laboratories using magnetic resonnance imaging (MRI), 
magnetization transfer imaging (MTI) and diffusion tensor imaging (DTI), as 
discussed by Dubois-Dalcq et al., 2008.  
 
 
1.6.3.2 Plastic changes following injury 
 
Changes in neural pathways and synapses due to changes in environment, 
behaviour, neural processes or changes resulting from injury are referred to as 
plastic changes, or plasticity. Once considered as static organs, the brain and 
spinal column are now known to undergo plastic changes throughout adult life. 
Neural contacts can be strengthened or weakened by the formation or pruning 
of synapses or simply through the strengthening or weakening of existing 
synaptic contacts. This process is termed ‘synaptic plasticity’ and was at one 
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point thought to be mainly limited to facilitating changes associated with 
learning and memory formation in the hippocampus (Gulino et al. 2007). It is 
now known that synaptic plasticity occurs throughout the CNS and plays an 
important role following injury, (Bareyre et al., 2004; Gulino et al., 2007). The 
term ‘anatomical plasticity’ refers to the formation of new circuits through 
sprouting and anatomical reorganisation (Bareyre et al. 2004). It is becoming 
increasingly apparent that anatomical plasticity plays an important role in the 
recovery of function following injury. As reviewed by Raineteau and Schwab, 
2001, spontaneous sprouting of damaged axons has been documented following 
numerous kinds of experimental models of SCI, including contusion (Hill et al., 
2001), partial transection (Fouad et al., 2001) and ischemic injury (von Euler 
et al., 2002). Cortical plasticity has also been shown to occur following SCI 
(Jain et al., 1997; Bazley et al., 2011; Aguilar et al., 2010). Importantly, 
plasticity has been linked with improvements in functional outcomes following 
injury in both experimental animals and humans (Raineteau and Schwab 2001; 
Edgerton and Roy 2002; Oudega and Perez, 2012).  
 
Plasticity is known to occur at the spinal level in experimental models in 
response to SCI. Following peripheral nerve transection in the rat, Basbaum 
and Wall 1976 documented that the dorsal horn somatotopy undergoes 
reorganisation, whereby intact spared afferent fibres establish connections 
with deafferented cells, either through sprouting or unmasking of existing 
connections (Basbaum and Wall, 1976). It has been shown in mice and rats that 
sprouting in uninjured tracts in response to lesion injuries can result in the 
reestablishment of functional spinal circuitry leading to quantifiable 
improvements in functional outcomes (Weidner et al., 2001; Bareyre et al., 
2005). Some studies have provided evidence for unlesioned tracts sprouting to 
form functional connections which ultimately take over the functions of 
lesioned tracts (Lawrence and Kuypers, 1968). In primate models, newly 
formed synapses have been observed in the spinal cord ipsilateral to 
hemisection injury (Aoki et al., 1986; Rosenweig et al., 2010). Other 
hemisection studies have shown that spontaneous plasticity so extensive that 
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the number of sprouting midline-crossing axons is enough to reconstitute an 
estimated 60% of pre-lesion axon density, leading to greatly improved 
behavioural outcomes (Rosenzweig et al., 2010).  
 
After injury, cortical reorganisation is known to occur, with cortical areas 
receiving input from intact peripheral systems enlarging and invading the 
regions that have lost their peripheral inputs. Such cortical reorganisation 
involves both physiological and anatomical change, and has been observed in 
the somatosensory cortices of both experimental animals (Jain et al., 1997; 
Ghosh et al., 2009; Aguilar et al., 2010) and humans (Bruehlmeier et al., 
1998). These changes have been detected immediately following injury in rats, 
accompanied by slower and more silent cortical spontaneous activity, 
representing a switch to a state of slow wave activity in the somatosensory 
network similar to that seen during slow-wave sleep; this is believed to play a 
crucial role in the early stages of cortical reorganisation following SCI (Aguilar 
et al., 2010). Substantial cortical reorganisation has also been shown to occur 
in the motor cortices of both experimental animals (Bareyre et al., 2004; 
Fouad et al., 2001) and humans (Levy et al., 1990; Raineteau and Schwab, 
2001). Human studies have utilised fMRI to investigate cortical plasticity 
following SCI (Jurkiewicz et al. 2007). Individual sub-regions of the primary 
motor cortex are connected by a dense network of horizontal connections 
which are believed to facilitate such rapid changes (Raineteau and Schwab 
2001). It has also been reported that cortical reorganisation occurs in the brain 
at the subcortical level following injury (Kaas et al., 1999; Bruehlmeier et al., 
1998; McKenna and Whishaw 1999). 
 
The spontaneous regenerative processes that occur following SCI, including 
remyelination, axonal sprouting and revascularisation make the differentiation 
and assessment of individual degenerative and regenerative processes all the 
harder (Blight and Young, 1989, Blight, 1993; Jeffery and Blakemore, 1997). 
Concomitantly, this also complicates the assessment of novel experimental 
therapies, especially as plasticity is known to exert negative and well as 
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positive effects. Plasticity in uninjured sensory tracts has been shown to be 
particularly prone to producing deleterious effects such as pain (Finnerup and 
Jensen, 2004; Kalous et al., 2009) and autonomic dysreflexia (Weaver et al., 
2001 and 2006), although these findings were discredited in a more recent 
investigation (Kalous et al., 2007). 
 
 
1.7 Injury type  
 
In order to understand SCI mechanisms and to allow for the assessment of 
potential therapies, several animal models have been developed over the 
years, mostly focused on transection, compression and contusion injuries 
(reviewed by Rosenzweig and McDonald, 2004). As yet there is no one animal 
model that accurately replicates every aspect of traumatic SCI in humans; 
therefore several models are used to replicate different types and aspects of 
traumatic SCI using different species and injury methods (Anderson and Stokes, 
1992). Caution should be exercised when interpreting the results as it has been 
shown that different strains of animal exhibit different behavioural outcomes 
following SCIs of different types (Mills et al., 2001). 
 
Rodent models have been the most popular for the development of SCI models. 
This is largely due to their availability, cost, ease of care, relatively low 
susceptibility to infection and the existence of widely utilised functional 
assessment methodologies (Onifer et al., 2007; Toft et al., 2007; Sedy et al., 
2008). Despite less being known about the recovery of function in mice, the 
transgenic potential of mouse models has led to an upsurge in their popularity 
in recent years (Pajoohesh-Ganji et al., 2010). Higher animal models, including 
cats, dogs and pigs have also been used on occasion (Blight and Young 1989; 
Jeffery et al., 2005; Navarro et al., 2012). It is known that there are 
significant neuroanatomical and functional differences between species; this 
complicates the development of models that can be used to assess human 
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therapies. Modelling SCI in non-human primates is therefore used in order to 
prove efficacy and safety before commencing clinical trials (Nout et al., 2012). 
 
Transection  
Transection injuries, whilst rarely seen in the clinical setting (eg. stab 
wounds), can be advantageous to model in animals. Partial or complete 
transections of the spinal cord are relatively simple to perform and allow 
investigators to examine regeneration across the lesion site (Schrimsher and 
Reier, 1993, Webb and Muir, 2002; Martinez et al., 2009) as such they provide 
excellent models for assessing neuroregeneration in long white matter tracts, 
and allow investigators to selectively injure designated fibre tracts in a highly 
reproducible manner. As such, transection injuries provide a useful and easy 
way of assessing the degree of axonal regeneration and functional recovery, 
spontaneous or induced (Takeoka et al., 2011; Ziegler et al., 2011). Many 
studies have utilised transection injuries, making them an attractive candidate 
for researchers wishing to make comparisons between studies.  
 
Compression / Crush Injuries  
Compression and crush injuries are capable of more accurately simulating the 
type of injury most frequently observed clinically. Compression SCI in rats 
results in severe ischemia and energy perturbations (Zhang et al., 1993), 
substantial neuronal loss at the injury epicentre and the development of a 
cystic cavity (Huang et al., 2007). They can be created by squeezing the cord 
using modified aneurysm clips (Rivlin and Tator 1978; Fehlings and Nashmi, 
1995; Joshie and Fehlings 2002a and 2002b), subdural inflatable balloons 
(Martin et al., 1992; Vanicky et al., 2001) or placing a weight on the exposed 
cord (Black et al., 1986; Nystrom et al., 1988; Huang et al., 2007). By varying 
the degree and or duration of displacement, injury severity can be controlled 
(Joshi and Fehlings 2002b).  
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Contusion  
Following contusion SCI in vivo, the primary injury response is known to closely 
reflect the sequelae observable in the majority of clinical cases and is 
characterised by axotomy and disruption of the vasculature and cell 
membranes. This initial mechanical injury is followed by a secondary response 
which continues for months to years following the initial injury and is 
characterised by continued disruption of the vasculature, excitotoxicity, 
oedema, inflammation, demyelination, Wallerian degeneration, glial and 
neuronal apoptosis, cystic cavity formation, micro-glial and (if the injury 
penetrated the meningese or damaged the BBB) macrophage infiltration 
(Blight, 1988; Bunge et al., 1993; Siegenthaler et al., 2007). 
 
Histological examination of experimental contusion injury sites has shown that 
grey matter is more easily disrupted than white matter (Gensel et al., 2006; Ek 
et al., 2010; James et al., 2011). This is consistent with clinical observations 
which frequently show the creation of large cystic cavities in the grey matter, 
which expand further into the white matter with increasing injury severity and 
proximity to the injury epicentre (Edgar and Quail, 1994; Squier and Lehr, 
1994).  
 
Several observations could help explain why the injury affects the grey matter 
more severely than the white. It has long been known that the gray matter is 
more vascular than the white matter and is thus more vulnerable to the 
mechanical damage and vascular disturbances associated with the primary 
injury response (Craigie, 1920). Biomechanical analysis of bovine spinal cords 
in vitro has revealed that grey matter is more rigid, and thus more fragile than 
white matter (Ichihara et al., 2001). Also, experimental modelling of contusive 
SCI using gelatine filled tubes has shown that the longitudinal forces generated 
by compression are greatest in the centre of tube, in the region of the gray 
matter (Blight and Decrescito, 1986). 
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1.8 Assessments of Function  
 
Functional assessments are required to enable correlation between the 
pathological and functional consequences of different injuries and intervention 
strategies. This allows inferences to be made about the integrity of damaged 
and spared tracts and grey matter circuitry and how these might change 
following injuries of differing severities, locations and types. Once a model is 
fully characterised, therapeutic interventions can be made and assessments of 
function compared to that seen without intervention. 
 
Rodent behaviours have been assessed using numerous different types of tests, 
which can be broadly divided into behavioural tests in which an animal’s 
movements are scored qualitatively and electrophysiological testing which 
quantitatively measures function in the neuronal circuitry, as discussed in 
detail below. 
 
 
1.8.1 Behavioural testing 
 
End point measures  
End point measures are made by scoring the ability to achieve a 
predetermined goal. They are varied and specific to the test in question; 
examples of such tests include the time taken to successfully cross a horizontal 
ladder beam (Soblosky et al., 1997; Metz & Whishaw 2002), the grade of slope 
at which an animal can maintain a fixed position on a tilting surface (Rivlin and 
Tator, 1977) and number of foot-faults whilst walking on a grid (Metz et al., 
2000). End point tests have also been devised to assess an individual limbs 
ability to achieve a set goal, such as the ability to reach for and grasp food 
(Ballermann et al., 2001; Montoya et al., 1991; Schrimsher and Reier, 1992) or 
to remove a sticker from their forehead or paw (Schrimsher and Reier, 1992, 
Onifer et al., 2005). Despite the advantages of using end point measures of 
behavioural function, they also have several caveats. For example, 
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compensatory behaviours are not differentiated from recovery behaviours, 
thus animals that learn to deal with deficits, which may lead to higher scores 
on end-point behavioural tests, are recorded the same as if recovering 
function (Whishaw et al., 1998; Mckenna & Wishaw 1999; Webb and Muir, 
2002). Another caveat is the degree of variability observed in each animal’s 
ability to achieve end point goals (Biesiadecki et al., 1999). It is thus a 
necessity to ensure that each animal’s pre-injury score is recorded for use as 
an internal control when comparing with the scores it achieves post-injury; for 
this same reason it is important to exercise caution when comparing studies to 
ensure that the animals used in each study are of a similar age, sex and strain. 
It is also important to ensure that injury and control groups are capable of 
achieving similar scores prior to injury, which allows for more accurate 
comparisons to be made between the groups. Most behavioural tests that rely 
on end-point measures produce quantitative data; however in some instances 
the use of an ordinal scale has been applied (Basso et al., 1995). As discussed 
below in greater detail, caution should be exercised when interpreting or 
performing statistical analyses to the results of any behavioural test which 
utilises an ordinal scale. 
 
Kinematic measures  
“Kinematic measures” include anything from a qualitative description of an 
animal’s movements to a continuous, quantitative record of an animal’s 
movements; they are made by taking measurements of the whole body, limbs 
or body segments and how they move relative to each other and/or external 
reference points and are thus capable of producing either qualitative or 
quantitative data depending on the actual scoring system employed. Like all 
behavioural tests, different types of kinematic assessments have their 
advantages and disadvantages; the main advantages are that some types of 
kinematic test can be relatively easy and cheap to perform and are capable of 
detecting discrete differences in fine movements which would not be 
detectable using end-point measures alone (Sedy et al., 2008; Couto et al., 
2008). The main disadvantages are that data acquisition in some types of test 
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can be highly labour and or time intensive, usually producing qualitative data 
(Whishaw & Pellis 1990; Whishaw et al., 1992; McKenna & Wishaw 1999; Alluin 
et al., 2011). Some kinematic tests make use of ordinal scales (Basso et al., 
1995) which, as discussed in greater detail below, should be treated with 
caution when interpreting.  
 
In some cases, through the use of sophisticated software and hardware, 
greater degrees of automation are possible, which can aid in the generation of 
quantitative data. Whilst the ability to analyse greater volumes of kinematic 
data and detect minor variances between conditions is highly advantageous, 
such systems are usually highly expensive (Alaverdashvili et al., 2008; Springer 
et al., 2010; Gravel et al., 2010). 
 
- Locomotor assessment scales  
Many kinematic tests have been developed to analyse functional abilities 
following spinal cord injury, mostly in the form of locomotor assessment scales 
which utilise ordinal scoring systems. The most widely used of these is the 
Basso, Beattie and Bresnahan locomotor rating scale (BBB scale), which scores 
an animal’s hind-limb kinematic abilities on an ordinal scale from 0-21, with a 
score of 21 representative of uninjured animals and a score of 0 indicating no 
hind-limb motor function (Basso et al., 1995). This scoring system has been 
shown to be easily learned, highly reliable and capable of producing similar 
results from one lab to the next (Basso et al., 1995), and as a result has been 
widely apopted as the standard for locomotor assessment following SCI. 
Unfortunately, the BBB scoring system has been shown to have several 
limitations, mainly due to its reliance on an ordinal, non-linear scale in which 
the distinctions between each of the categories are defined arbitrarily, this 
has been shown to produce complications when interpreting the results, eg. an 
improvement of +1 at the lower end of the scale (<13) equates to the re-
appearance of a gross motor ability, yet an improvement of +1 at the upper 
end of the scale (>13) equates to the re-appearance of a relatively discrete 
characteristic of normal locomotion (Metz et al., 2000); thus the 
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interpretation and analysis of data is complicated greatly. Whilst it could be 
argued that the only real option for statistical analyses is the use of non-
parametric tests, there are currently no non-parametric tests available for use 
with repeated measures. The BBB scale is known to be less sensitive at the 
lower end of the scale, and had been shown to be more sensitive once animals 
start to achieve scores above 14 (Ferguson et al., 2004); this is likely due to 
the confounding effects of the injury, including inflammation and pain. 
Another limitation of the BBB score is that it relies heavily on the ability to 
accurately assess forelimb-hindlimb coordination, however, in injuries that 
affect the forelimbs the animal may exhibit severe functional deficits but 
remain coordinated. 
 
In order to address the limitations of the BBB scale, several groups have made 
additions and modifications to the scoring system which improve its ability to 
differentiate between animals of different injury levels, severities and types 
(Lankhorst et al., 1999; Ferguson et al., 2004; Koopmans, 2005; Wong et al., 
2009). Despite these scales still relying on ordinal scales of functional 
recovery, they do allow that recovery to occur in any order, which is their 
main advantage over the BBB scale. Despite this, the BBB is still a sensitive 
and reliable tool for assessing function following thoracic contusion injured 
rats and for serving as an effective method of making comparisons of results 
from different laboratories. 
 
 - Continuous Kinematic Tests  
Continuous kinematic tests are a type of kinematic test capable of obtaining 
quantitative data from an animal’s movements, usually through the use of 
cameras and sophisticated computer software. Such tests are capable of 
measuring a vast range of movement parameters, including the distances, 
speeds, and angles of each joints, limbs, and in some cases digits movements. 
Continuous kinematic tests lend themselves particularly to the detailed 
analysis of gait. Data were originally acquired by videoing the movement under 
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investigation and analysing the video frame by frame in a highly time- and 
labour-intensive process (Clarke, 1991; Cheng et al., 1997).  
 
Since then, several systems have been designed which enable the semi-
autonomous collection of numerous gait parameters, including systems which 
allow for the analysis of an animals gait, recorded from below, (Hamers et al., 
2006) including several in which animals are made to walk at pre-determined 
speeds through the use of specially designed treadmills (Li et al., 2005b; Couto 
et al., 2008; Beare et al., 2009). Some authors have even elected to use 
systems that allow recording from several angles to enable analysis of 
movement in 3D (Couto et al., 2008). Several laboratories are currently 
experimenting with the use of Digital Motion X-ray (DMX) technology which 
allows for real-time x-ray scanning of animals performing behavioural tests, by 
using bones as points of reference (Alaverdashvili et al., 2008; Gravel et al., 
2010). 
 
Sensory testing                                                                                            
To measure and detect changes in the degree of cutaneous tactile sensitivity, 
testing known as aesthesiometry testing can be performed. By far the most 
commonly utilised aesthesiometry test is called the von Frey test; this involves 
using nylon filaments in a linear scale of physical force, applied to the skin one 
at a time with enough force to make the filament bend which may or may not 
elicit a response from the animal. If no response is observed then the filament 
is withdrawn after 2 seconds and the next strongest filament is applied; this is 
repeated until an avoidance response is elicited, as discussed in greater detail 
in Chapter 3.  
The von Frey test is quick, easy and inexpensive to perform, and provides a 
highly sensitive, quantitative measure of cutaneous tactile sensitivity with 
limited inter-and intra-rater variability (Chaplan et al., 1994; Dixon et al., 
1980). Such tests are usually performed on the plantar surfaces of the paws to 
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investigate changes in sensation and the development of tactile allodynia 
(Chaplan et al., 1994), though increasingly researchers are also using von Frey 
tests across the animals torso to investigate the response to mechanical 
stimulation nearer the injury level (Lindsey et al., 2000). 
 
 
1.8.2 Electrophysiological testing 
 
Electrophysiology is the study of the electrical properties of biological cells 
and tissues. Direct measurements of electric current or voltage change can be 
made from whole organs to single ion channels. Using animal models of SCI, 
electrophysiological recordings can provide a direct measure of the functional 
abilities of neurological systems and therefore avoids many of the 
complications that exist with behavioural testing, such as distinguishing 
functional recovery from adaptive mechanisms. 
 
 
Cord dorsum potentials 
A cord dorsum potential (CDP) is a series of waves that can be recorded from 
the skin overlying the vertebral column, or directly from the surface of the 
exposed spinal column. The characteristics of CDPs reflect the level of 
electrical activity in the ascending somatosensory white matter in the dorsal 
columns, as well as the activation in local circuits following electrical 
stimulation of peripheral nerves (Sedgwick et al., 1980). 
CDPs can be recorded following stimulation of sensory tracts and are widely 
used to assess the functional abilities of pathways in the spinal column 
following injury as well as providing a way to monitor the health of the spinal 
column during spinal surgery (Sedgwick et al., 1980; Ahn and Fehlings, 2008). 
CDPs provide a sensitive and reliable method of monitoring the effects of 
experimental SCIs and the effects of potential therapeutic interventions, and 
are thus widely used in SCI research (Bradbury et al., 2002; Toft et al., 2007).  
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Somatosensory evoked potentials 
A somatosensory evoked potential (SEP) is a series of waves that can be 
recorded from the somatosensory cortex. The characteristics of SEPs reflect 
the sequential activation of neural structures along the somatosensory 
pathways following electrical stimulation of peripheral nerves (Sedgwick et 
al., 1980). 
When action potentials arrive in the somatosensory cortex they are capable of 
causing a population of cells, primarily located in cortical layer V to become 
depolarized, as ionic currents are leaked from the neurons. A collection of 
such depolarisation events generated by large groups of neurons firing 
simultaneously results in a field potential which can be recorded from a 
distance. 
Recordings of SEPs are used to provide direct quantitative measures of the 
functional abilities of the ascending somatosensory pathways. SEPs are 
frequently used for the diagnosis and characterisation of neurological 
abnormalities in humans (Small et al., 1978; Dietz and Curt, 2006) and are 
capable of measuring dysfunction in the peripheral nerve, the spinal roots, the 
ascending somatosensory pathways of the spinal cord, the dorsal column nuclei 
in the medulla, the medial lemniscus pathways, the ventral posteriolateral 
nucleus of the thalamus, the posterior limbs of the internal capsules or the 
somatosensory cortices. SEPs are also widely used for intraoperatively 
monitoring the condition of the spinal cord in real time (Grundy, 1983). Such 
direct feedback on the condition of the neural networks and pathways allows 
surgeons to safely perform more aggressive surgeries, such as spinal tumor 
resection and the correction of deformities (Malhotra et al., 2010).  
Using a clip compression model of SCI in rats it has been shown that a 
correlation exists between the amplitudes and latencies of SEPs and the 
severity of the injury; thus it was shown that SEPs can be used to assess the 
physiological integrity of the cord following injury (Fehlings et al., 1989). 
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These findings have been confirmed by other studies that also found 
correlations between injury severities, SEP amplitudes/latencies and the 
scores obtained in several behavioural tests, where lower amplitude, longer 
latency SEPs correlate with reduced behavioural scores (Nashmi et al., 1997). 
Thus it would appear that the electrical activity in the somatosensory 
pathways is linked to the functional abilities of the animal. 
By comparing SEPs generated in normal animals with those generated in SCI 
animals with and without potential therapeutic interventions we can 
accurately and quantitatively measure the affects of both the injury and 
potential therapeutic interventions. 
 
1.9 Repair strategies  
 
As mentioned previously, the degree of spontaneous recovery following SCI is 
usually too limited to reinstate functional deficits completely. Consequently, 
many of the functional deficits caused by SCI are permanent. There are 
currently no therapeutic interventions which are capable of repairing the 
damage caused by SCI.  
 
The complex sequelae that occur following SCI seriously hampers the recovery 
process, as discussed above. Several processes are required to occur in order 
to repair damaged tissue and restore functional deficits. Injured cells must 
first survive, only then might a damaged axon extend its cut processes to make 
connections with its original targets. In order for these connections to be 
functional, the axons must be remyelinated and the synaptic contacts must be 
functional. Repair strategies are thus designed to address one or more of these 
problems, and can be classified as one of four different approaches: the 
neuroprotective approach which attempts to reduce the damage caused by the 
secondary injury process and to preserve residual functions, the regenerative 
approach which attempts to create a environment that is permissive to axonal 
regeneration, the plasticity approach which attempts to create an 
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environment that promotes axonal sprouting and the remyelination approach 
which attempts to restore conduction deficits by attempting to create an 
environment which is conducive to remyelinating demyelinated and 
regenerating axons. Several different repair strategies have been employed to 
target each of these approaches in order to induce and support the reparative 
potential of each (Fawcett, 2002). 
 
 
1.10 Therapeutic interventions  
 
Numerous different therapeutic interventions are currently being used in phase 
I and phase II clinical trials, or are about to enter clinical trials (Kwon et al., 
2010). No therapy with substantial beneficial effects has yet made it to phase 
III clinical trials or reached the clinic, although several treatment strategies 
which offer limited beneficial potential are currently available clinically. The 
only pharmacological therapy currently available involves the administration of 
high dose anti-inflammatory steroids such as methylprednisolone (reviewed by 
Breslin and Agrawal, 2012). If required, strategically timed surgical procedures 
designed to prevent further tissue damage have also been employed (reviewed 
by Fehlings and Perrin, 2006). The only other therapeutic interventions 
available following human SCI involve rehabilitative training designed to 
maintain and optimise residual functions and to reduce the effects of 
secondary problems such as muscle wastage, urinary tract infections and poor 
ventilation (McDonald et al., 2002; Behrman et al., 2006). 
 
Whilst single therapies may prove sufficient to overcome individual injury-
induced deficits associated with SCI, it is highly likely that multiple, 
simultaneously administered therapeutic interventions will be required to 
provide a solution for SCI treatment. Efficacious treatment strategies may 
involve treatments that provide a growth-permissive substrate in the lesion 
cavity, preserve residual neurons, reduce or prevent the secondary injury 
response, overcome the inhibitory effects of myelin debris, reduce or prevent 
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the inhibitory effects of the lesion scar, utilize neurotrophic factors to prevent 
axonal atrophy and promote axonal regeneration, promote spontaneous and/or 
exogenously enhanced remyelination and plasticity (Lu et al., 2004; Pearse et 
al., 2004; Houle et al., 2006). In the chronic stages, it is likely that rigorous 
rehabilitative training protocols will further aid functional recovery (McDonald 
et al., 2002). 
 
 
1.10.1 Neuroprotection  
 
Neuroprotection is the term used to describe all the different processes which 
act to reduce the effects of the secondary injury response and to reduce 
further tissue damage, thus preserving surviving spinal pathways and residual 
functions. Many neuroprotective therapies are currently being investigated to 
target the numerous different, concomitantly occurring, injury mechanisms 
that occur following traumatic SCI. 
 
Methylprednisolone sodium succinate is a synthetic corticosteroid with potent 
anti-inflammatory properties. It is believed that methylprednisolone exerts its 
neuroprotective actions by scavenging free-radicals from the injury site (Hall, 
1992) and down-regulating pro-inflammatory gene expression (Almon et al., 
2002; Fu and Saporta, 2005). It is the most widely studied neuroprotective 
therapy for SCI and the standard clinical practice for acute SCI in the USA 
(reviewed by Bracken, 2012). When administered acutely, methylprednisolone 
has been shown to have beneficial effects on functional recovery in 
randomized, double-blind, placebo-controlled clinical trials (NASCIS II and III) 
(Bracken et al., 1990 and 1997). However, these studies have been criticized 
for problems with study design and statistic analysis (Coleman et al., 2000). 
Others have claimed that there is a lack of evidence for efficacy and a greater 
degree of clinical problems associated with methylprednisolone (Sayer et al., 
2006; Suberviola et al., 2008). 
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Another promising neuroprotective agent is the cytokine erythropoietin, which 
has been shown to have potent anti-inflammatory and anti-apoptotic 
properties (Arishima et al., 2006). Erythropoietin has also been shown to 
restore vascular integrity, induce neural regeneration and act as a mediator of 
hypoxic preconditioning; erythropoietin thus has potential as a beneficial 
therapy for SCI (reviewed by Brines and Cerami, 2008). Despite this, 
erythropoietin has the disadvantage of being responsible for increasing the 
aggregation of thrombocytes and augmenting haematocrit (Brines and Cerami 
2008). To combat these problems, mutant erythropoietin analogues, such as 
carbamylated erythropoietin (Kirkeby et al., 2008) and asialo-erythropoietin 
(Erbayraktar et al., 2003) have been created which do not evoke the same 
rheological complications. 
 
Several other pharmacological interventions have been shown to be beneficial 
following SCI. Reducing the action of tumor necrosis factor (TNF) by inhibiting 
the CD95 receptor has been shown to decrease the degree of glial and 
neuronal apoptosis following SCI in mice (Demjen et al., 2004; Casha et al., 
2005). Minocycline application has been shown to lessen the degree of 
apoptosis observed in oligodendrocytes as well as reducing the glial reaction. 
It is uncertain as to whether the surviving cells are functional, and it is not 
known how long they survive for; despite this, improvements in neurological 
function have been documented following minocycline application (Beattie, 
2004; Stirling et al., 2004).  
 
Despite the promising pre-clinical trials achieved with the application of 
neuroprotective pharmacological interventions, the vast majority of phase 
II/III clinical trials with such agents have failed to show significant efficacy 
(Dumont et al., 2001; Hawryluk et al., 2008). 
 
Certain acutely implemented surgical interventions, designed to decompress 
the swollen cord as soon as possible following injury have also been shown to 
be beneficial in animal models (Mirza et al., 1999; Fehlings et al., 1999; 
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Papadopoulos et al., 2002). When performed within 24hrs of injury, 
decompression surgery has also been shown to result in improved outcomes in 
humans (Fehlings et al., 2012). 
 
 
1.10.2 Neurotrophins  
 
Neurotrophins are a class of small molecules capable of signaling to cells to 
differentiate or extend their neurites. In the injured spinal cord, the lack of 
neurotrophic molecules is a major contributing factor in the failure of neurons 
to regenerate.  
 
There are numerous types of neurotrophins, including nerve growth factor 
(NGF), brain-derived neurotrophic factor (BDNF), neurotrophins 3, 4 and 5 (NT-
3/NT-4/NT-5), glia derived neurotrophic factor (GDNF) and fibroblast growth 
factor (FGF). Following injury, neurotrophins act by signaling to their target 
cells to upregulate the genes associated with regenerative processes, thereby 
enhancing cell survival (Bradbury et al., 1999; Ramer et al., 2000; Blesch and 
Tuszynski, 2003; Geremia et al., 2010). Neurotrophins also play an important 
role in targeting and regulating neuron-target interactions (Kobayashi et al., 
1997; Kwon et al., 2002; Novikova et al., 2002). 
 
NT-3 is perhaps one of the most promising neurotrophins studied, and as such 
it has received a lot of attention from different groups. It has previously been 
shown following SCI in the rat that a single injection of NT-3 at the lesion site 
was sufficient to promote sprouting of corticospinal axons (Schnell et al., 
1994). It has also been shown that NT-3 is capable of partially ameliorating 
functional deficits, including when applied via acute cellular delivery into a 
hemisection injury (Grill et al., 1997) and also when injected alongside fetal 
spinal cord transplants 2-4 week following injury (Coumans et al., 2001). 
Whilst some studies have found other neurotrophins to be less able to promote 
axonal growth and sprouting (Bradbury et al., 1999) others have reported BDNF 
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to have neuroprotective and neuroregenerative effects (Namiki et al., 2000). 
The spinal cord contains different densities of receptors that correspond to 
each different neurotrophin, this may account for the different performance 
among those neurotrophins. 
 
Despite their beneficial role following SCI, several complications exist with 
regards the application of neurotrophins for the treatment of SCI. For 
example, as well as their ability to ameliorate the effects of the secondary 
injury response, neurotrophins have been associated with the development of 
neuropathic pain (Pezet and McMahon 2006; Siniscalco et al., 2011). Other 
factors further complicate the use of neurotrophins for the treatment of SCI 
including the various degrees of permeation across the blood brain barrier seen 
with different neurotrophins (Pan et al., 1998), as well as the fact that 
different neurotrophins are known to play active roles at different time points 
following injury (Novikova et al., 2002). Thus the choice of neurotrophins, 
timing of applications and delivery methods require further investigation 
before viable clinical therapies can be developed.  
 
 
1.10.3 Myelin inhibitors  
 
Following injury several well characterized myelin-associated inhibitors of 
neurite growth are released in regions where oligodendrocyte death occurs. 
This plays a significant role in enhancing the growth-inhibitory characteristics 
of the injured cord and presents a substantial obstacle to regenerating axons. 
 
The major CNS myelin-associated inhibitors of neurite growth include Nogo-A 
protein (GrandPré et al., 2000; Chen et al. 2000), myelin-associated 
glycoprotein (MAG) (McKerracher et al. 1994; Schachner and Bartsch 2000) and 
oligodendrocyte-myelin glycoprotein (OMgp) (Mikol and Stefansson, 1988; 
Wang et al., 2002); though several other molecules, including Semaphorin 4D 
and ephrin B3, are known to exert growth inhibitory effects on neurites 
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following SCI by acting as repulsive axon guidance cues as well as stimulating 
growth cone collapse (Moreau-Fauvarque et al., 2003; Benson et al., 2005). 
 
 
1.10.3.1 Nogo  
 
Nogo is the name given to a gene which gives rise to three different protein 
isoforms created by different splicing and promoter usage, these proteins are 
called Nogo-A, Nogo-B and Nogo-C and are found mainly in the endoplasmic 
reticulum. Nogo-A is a high molecular weight trans-membrane protein which is 
heavily expressed by oligodendrocytes (Schwab, 2004) and is the most 
intensively studied of all myelin inhibitors (Schweigreiter and Bandtlow, 2006). 
 
Nogo-A contains 3 regions that are exposed to the extracellular space and 
which are inhibitors of CNS regeneration: A region of the C-terminus containing 
a 66 amino acid loop called Nogo-66, a central inhibitory domain known as NiG 
and a region on the N-terminus (reviewed by Wang et al., 2012). The Nogo-66 
and NiG regions are both inhibitory to neurite outgrowth and are known to 
induce growth cone collapse (GrandPré et al., 2000; Oertle et al. 2003), whilst 
the N-terminus region is known to inhibit fibroblast spreading. 
 
Several studies have utilized Nogo knockout mice to investigate the effects of 
the different Nogo isoforms on regeneration in the injured spinal cord 
(Simonen et al. 2003; Kim et al. 2003; Zheng et al. 2003; Lee et al., 2009). 
Whilst some saw modest improvements in axonal regeneration and function 
(Simonen et al. 2003; Kim et al. 2003), others did not (Zheng et al., 2003; Lee 
et al., 2009). This suggests that Nogo alone does not account for the lack of 
regeneration in the CNS, although other variables might account for these 
differences, such as the types of injuries used (Cafferty and Strittmatter, 
2006), differences in the genetic backgrounds of the strains used (Dimou et 
al., 2006) and the compensatory up-regulation of alternate Nogo isoforms 
(Simonen et al., 2003). 
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The inactivation of Nogo-A has been achieved through the use of function-
blocking antibodies as well as by interfering with its receptors and signalling 
pathways; this has been shown to result in substantial axonal regeneration 
below the injury level in both rats (Schnell and Schwab, 1990; Li et al., 2004; 
Liebscher et al., 2005) and non-human primates (Fouad et al., 2004; Freund et 
al., 2006; 2007). In rat and mouse models of SCI, blocking Nogo-A is known to 
result in substantial axonal regeneration and an impressive level of functional 
recovery (Schnell and Schwab, 1990; Schwab, 2004; Leibscher et al., 2005). 
Blockade of the Nogo-A receptor has also been shown to promote recovery of 
manual dexterity in non-human primate models of SCI (Freund et al., 2006). 
 
 
1.10.3.2 Myelin-associated glycoprotein 
 
MAG is a type I trans-membrane glycoprotein which is part of the 
immunoglobulin superfamily, which are known to important roles in cell 
adhesion, as such it contains five extracellular immunoglobulin Ig-like 
domains. In the rodent, alternate splicing of MAG mRNA yields two different 
isoforms, called simply, large (L) and small (S), which activate different signal 
transduction pathways in myelin forming cells (Lai et al., 1987; Salzer et al., 
1987).  
 
MAG is found in high quantities in both the oligodendrocytes of the CNS and to 
a lesser extent the Schwann cells of the PNS, localized in the periaxonal 
myelin sheaths, where it plays an important role in interactions between glial 
and neuronal cells (Sternberger et al. 1979; Poltorak et al., 1987; Schachner 
and Bartsch, 2000). Whilst MAG is not required for myelination, it plays crucial 
roles in enhancing long term axon-myelin stability as well as regulating the 
axonal cytoskeleton and helping to structure the nodes of Ranvier (reviewed 
by Schnaar and Lopez, 2009). MAG also appears to play an important role in 
axon-myelin stability through mediation of communications between neuronal 
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and glial cells, though these roles may differ between the CNS and the PNS 
(Schachner and Bartsch, 2000; Quarles, 2007). Combined, these properties 
contribute to MAG’s role in preventing axonal degeneration (Nguyen et al., 
2009). In addition to its axon-myelin stabilizing role, following injury MAG also 
acts as a potent inhibitor of axonal regeneration. Both the axon-stabilizing and 
growth-inhibiting roles played by MAG are mediated via 2 families of receptors 
in the axonal membrane, namely members of the sialoglycan family 
(gangliosides GD1a and GT1b) (Yang et al., 1996) and the aforementioned Nogo 
receptors (Liu et al., 2002).  
 
In the injured spinal cord MAG is usually present in large quantities, bound to 
residual myelin debris. Its presence contributes to the potently growth 
inhibitory environment of the injured cord (McKerracher et al. 1994; 
Mukhopadhyay et al. 1994).  
 
 
1.10.3.3 Oligodendrocyte-myelin glycoprotein  
 
OMgp is a myelin associated inhibitory protein that is mainly expressed in long 
projection neurons and white matter in the spinal column (Mikol Stefansson 
1988; Habib et al., 1998). Whilst OMgp is less well characterized than Nogo-A 
or MAG, it is known to also be a potently inhibitory molecule present in the 
injured spinal cord, and has been shown to be capable of causing growth cone 
collapse and inhibiting neurite growth (Wang et al. 2002a). When compared to 
Nogo-A or MAG, OMgp makes up a much smaller component of the myelin 
sheaths found in the CNS or PNS; however it may be present to a much greater 
degree in other non-myelinating cells (Huang et al, 2005). 
 
All of the aforementioned myelin inhibitors are known to exert their effects, 
at least in part, through common receptors and co-receptors, including the 
NgR1-p75 receptor complex (Wang et al., 2002b) and PirB (Atwal et al., 2008). 
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Thus, antagonizing these receptors can impede the actions of all three myelin 
inhibitors and has been shown to induce a significant reduction in the degree 
of myelin inhibition (Atwal et al., 2008). 
 
 
1.10.4 Lesion scar inhibitors  
 
Following SCI, the formation of a lesion scar occurs as part of the endogenous 
local immune regulation and repair process. Whilst this leads to the creation of 
an environment which is inhibitory to regenerating axons, the lesion scar also 
has beneficial effects on recovery.  
 
The injury site is characterized by features which are toxic to regenerating 
axons, such as the inflammatory response, an imbalance in the levels of ions 
and excitatory amino acids, free radicals, reactive oxygen. The formation of a 
lesion scar which encapsulates the injury site and isolates it from the rest of 
the spinal cord thus plays a beneficial role in the injury process (Rolls et al., 
1999). Dichotomously, the lesion scar is also known to have potent growth 
inhibitory properties. The lesion scar consists mainly of reactive astrocytes and 
microglia/macrophages, all of which, though especially reactive astrocytes, 
release various chondroitin sulphate proteoglycans (CSPGs) with their 
glycosaminoglycan side chains (GAGs) into the extracellular space, where they 
act as potent growth-inhibitors (Morgenstern et al., 2002). CSPGs expression 
increases rapidly following injury, peaks within 2 weeks and persists for 
several months (Tang et al., 2003). 
 
It is known that CSPGs are inhibitory to neurite growth across the injury site 
(Silver and Miller, 2004) and negatively affect axonal conduction through the 
injury site (Hunanyan et al., 2010). Injections of the bacterial enzyme 
chondroitinase-ABC (ChABC), which is know to digest the GAG sidechains of 
CSPGs, have been shown to reverse or prevent axonal conduction deficits 
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whilst simultaneously stimulating axonal growth and promoting locomotor 
recovery (Bradbury et al., 2002; Hunanyan et al., 2010). Functional recovery 
may be due to the stimulation of plastic changes around the injury site, as it 
has been observed as quickly as one week following injury (Bradbury et al., 
2002); though axonal regeneration may also play a role, with some 
investigators not observing significant functional recovery until 42 days 
following injury (Hunanyan et al., 2010). Electrophysiological investigations 
have shown that ChABC induced reorganization of primary afferent terminals 
plays a role in improved functional outcomes (Cafferty et al., 2008). ChABC 
has also been shown to potently induce axonal sprouting in uninjured tracts 
contralateral to the injury, resulting in sprouting fibers crossing to the 
denervated side of the cord (Barritt et al., 2006). ChABC treatment has been 
shown to improve functional outcomes when applied up to 7 days following 
injury, which suggests it may have significant clinical potential (Garcia-Alias et 
al., 2008). 
 
Several other growth inhibitory molecules have been shown to be upregulated 
in cells participating in the secondary injury response which are present in the 
lesion scar, including semaphorin 3, slit proteins and ephrin-B2, all of which 
further complicate our understanding of the causes of regenerative failure 
following SCI (reviewed by Silver and Miller, 2004), whilst also providing 
additional targets for potential therapeutic interventions. 
 
 
1.10.5 Immunomodulatory treatments  
 
As mentioned previously, the inflammatory response that occurs following SCI 
is known to have both beneficial and detrimental effects on outcome. Many 
studies have shown that modulating the immune response can affect functional 
outcomes following SCI. 
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Activated macrophages which participate in the inflammatory response are 
known to secrete a cytokine called tumor necrosis factor alpha (TNFα) as part 
of the immune response. Blocking TNFα has been shown to result in reductions 
in lesion size and significant functional improvements (Bethea et al., 1999). As 
discussed above, the immune response is also known to up-regulate the 
expression of numerous interleukins, such as IL-6 and IL-1. Blocking IL-6 
receptors has been shown to reduce astrogliosis and the development of scar 
tissue, leading to improved functional outcomes (Okada et al., 2004), and 
administering IL-1 receptor antagonists has been shown to decrease the degree 
of injury-induced apoptosis (Nesic et al., 2001). 
 
Macrophage recruitment and activation has been shown to have both 
detrimental (Blight, 1985; Blight, 1992) and beneficial (Rapalino et al., 1998; 
Popovich et al. 2002; Vallieres et al. 2006; Schwartz and Yoles 2005) effects on 
outcome following traumatic SCI; however, reduction of the macrophage 
response has also been shown to have beneficial effects on functional 
outcomes (Popovich et al., 1999).  
 
 
1.10.6 Cell transplantation  
 
Following most types of spinal cord injury, especially contusion injury, a large 
fluid filled cystic cavity develops centered around the injury site, as discussed 
in greater detail earlier. In order for regenerating axons to transverse the 
cystic cavity a growth permissive substrate is required; this could be achieved 
through the use of therapeutic cellular transplantations into the cavity. There 
are several advantages to using cellular transplants other than simply providing 
a supportive structure through which regenerating axons could grow. These 
include the possibility that transplanted cells might limit the amount of 
neuronal and glial cell death, reduce demyelination of surviving axons, 
promote the regeneration of surviving axons and supporting glia, induce 
remyelination, replace the damaged neural tissue and promote plasticity. 
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Many different cell types have already been investigated as potential therapies 
for treating the effects of SCI, including foetal tissue (Coumans et al., 2001), 
embryonic stem cells (McDonald et al., 1999), neural stem cells (Akiyama et 
al., 2001), olfactory ensheathing cells (OECs) (Franklin et al., 1996; Li et al., 
1997; Ramón-Cueto et al., 1998; Riddell et al., 2004; Toft et al., 2007), 
oligodendrocyte precursor cells (Groves et al., 1993; Bambakidis and Miller 
2004), Schwann cells (Duncan et al., 1981; Tuszynski et al., 1998) and 
mesenchymal stem cells extracted from bone marrow (Nandoe Tewarie et al., 
2006; Vaquero and Zurita, 2009). 
 
 
1.10.6.1 Stem cells  
 
Stem cells are characterized by their capacity for self-renewal and 
differentiation into different cell types. Stem cells in the early embryonic 
phase are capable of differentiating into cells of any lineage and are therefore 
described as being totipotent. After a few divisions they becomes programmed 
to differentiate into cells from one of the three germ layers: the endodermal 
layer gives rise to the epithelium of the gastrointestinal, urinary and 
respiratory tracts, as well as the outer layers covering most of the internal 
organs; the mesodermal layer gives rise to bone, muscle, blood cells and 
mesenchyma (connective tissues); the ectoderm layer gives rise to nervous 
system and the epidermis (skin cells). Stem cells at this stage are still capable 
of further differentiation into the numerous cell types that each germ-layer 
gives rise to, and are therefore described as being multipotent. 
 
It was believed that the process of differentiation from totipotent to 
multipotent stem cells was irreversible; however researchers have now proven 
the capability of multipotent stem cells to revert back and differentiate into 
cells from any germ-line in a process called transdifferentiation (reviewed by 
Tsonis, 2000). This capability, along with the capability of stem cells to be 
expanded in the quantities required for cellular transplantation therapies has 
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prompted a great deal of research into the use of stem cells for the treatment 
of several conditions that would benefit from cellular replacement and or 
repair, including treatments for SCI.  
 
Stem cell therapies could be used to replace cells lost by SCI and prevent 
further loss by releasing or stimulating the release of neuroprotective factors 
as well as to stimulate axonal regeneration and remyelination. Numerous types 
of stem cells have been investigated as potential therapies for different types 
of SCI, with many appearing to show beneficial effects (reviewed by Coutts 
and Keirstead, 2008; Barnabé-Heider and Frisén 2008). Stem cells have been 
shown to play a role in several different processes which are believed to 
contribute to the restoration of functional deficits following SCI. These include 
the provision of trophic molecules which act to ameliorate damage and rescue 
neurons and oligodendrocytes, the creation of a substrate which is permissive 
to axonal growth and the remyelination of spared but demyelinated axons 
(Parr et al., 2007). Several groups have reported improved locomotor and/or 
sensory performances following stem cell transplantation into mouse 
(Cummings et al., 2005, 2006) and rat models of SCI (McDonald et al., 1999; 
Gu et al., 2012; He et al., 2013). Pre-differentiated OPCs have been shown to 
be a viable and promising candidate for cell transplantation therapies designed 
to promote remyelination and functional improvements (Keirstead et al., 2005) 
 
It is difficult to accurately ascertain the mechanisms by which these functional 
improvements occur, be they through neuroprotective, neuroregenerative or 
other mechanisms, but it is likely that several mechanism are contributing to 
the improved functional outcomes which are seen. Despite this several human 
trials have been approved and are currently underway (Vogel et al., 2005, Illes 
et al., 2011), with some preliminary results suggesting modest functional 
improvements (Illes et al., 2011). 
 
 
1.10.6.2 Schwann cells  
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Schwann cells are responsible for myelinating and stimulating the regeneration 
of axons in the PNS. They have become one of the most intensively studied 
types of cell for the treatment of SCI since the seminal work of Ramon Cajal, 
who in 1928 discovered their axonal growth promoting properties after grafting 
peripheral nerve grafts into the CNS (Ramon Cajal, 1928).  
 
Schwann cells play an important role in spontaneous repair mechanisms 
following PNS injury, thanks largely to their innate ability to dedifferentiate, 
proliferate, migrate, express growth promoting factors, promote axonal 
regeneration and remyelinate demyelinated and regenerating axons (reviewed 
by Bunge and Wood, 2012); all of these properties are also highly advantageous 
for CNS repair. Schwann cells also offer the possibility of simple autologous 
cell transplantions; they can be quickly harvested from the peripheral nerves, 
easily purified and cultured in large enough numbers for transplantation.  
 
Upon transplantation of cultured Schwann cells into spinal injury sites, 
researchers have documented their ability to promote regeneration of 
damaged axons and remyelinate demyelinated axons (Blight and Young, 1989; 
Li and Raisman 1994; Tuszynski et al. 1998; Kohama et al. 2001). However, the 
beneficial role that Schwann cells play is largely restricted to astrocytes-
deficient areas due to the inhibitory interactions that have been shown to 
exist between the two cell types, thus limiting their potential as treatments 
for CNS repair (Baron-Van Evercooren et al. 1992; Shields et al. 2000; Lakatos 
et al. 2000). Despite this, several groups have reported remyelination leading 
to improved electrophysiological function following Schwann cell 
transplantation into animal models of SCI (Blight and Young, 1989; Kohama et 
al., 2001). Other studies have revealed that Schwann cell transplants can lead 
to improved locomotor function (Takami et al., 2002; Biernaskie et al., 2007; 
Ban et al., 2009). 
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It is clear that Schwann cells are promising candidates for repair of the injured 
spinal cord; however it has been shown that their reparative potential can be 
enhanced when applied in conjunction with other therapeutic interventions 
(Ban et al., 2011; Hu et al., 2013). Recently, clinical trials focusing on co-
transplantation of Schwann and mesenchymal stem cells have been performed, 
revealing modest improvements in the ASIA sensory scale and proving the 
safety of the protocol (Yazdani et al., 2013). 
 
 
1.10.6.3 Foetal cells  
 
The ability of foetal cells to differentiate into different cell types has made 
them attractive candidates for treating a variety of neurodegenerative 
disorders. Whilst many studies have made use of foetal cell transplantations, 
the work done in Parkinson’s disease is potentially their most successful 
application to date (Freed et al. 1992; Spencer et al. 1992).  
 
Foetal cell transplants have been shown to reduce functional deficits following 
many types of SCI (reviewed by Reier et al., 1992). It has been shown that 
transplanted foetal cells release trophic factors which act to reduce cell death 
following injury, and may play a role in the observed axonal regeneration. 
Importantly, regenerating axons have been observed not only within, but also 
extending out of the transplanted region, which raises the possibility that 
functional connections might be reestablished (Reier et al., 1992). It has been 
shown that foetal stem cells are capable of significantly improving locomotor 
function when administered acutely following spinal cord contusion (Bottai et 
al., 2010). 
 
Whilst the results from foetal transplant studies are highly promising, their 
potential for clinical application is restricted by their limited availability as 
well as the ethical issues the use of human foetal tissue raises, especially as 
the embryo is destroyed in order to obtain the required cells. However, 
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refining cell culturing methodologies may reduce the impact of these 
restrictions.     
 
 
1.10.6.4 Olfactory ensheathing cells  
 
The olfactory system occupies a unique position at the interface between the 
PNS and the CNS. Throughout adult life the axons of olfactory receptor cells 
are uniquely capable of regenerating, reentering the CNS and forming 
functional synaptic connections with their target neurons. The ensheathing 
cells of the olfactory neurons are called olfactory ensheathing cells (OECs) and 
have been shown to confer this ability by providing structural, functional and 
metabolic support to the regenerating axons (Doucette 1984 and 1991). OECs 
have been shown to support axonal growth and ensheathment in a similar 
fashion to Schwann cells, though are able to survive in the CNS (Farbman and 
Squinto, 1985; Chuah and Au, 1994). These properties make OECs highly 
promising candidates for transplantation therapies designed to treat 
neurodegenerative diseases of the CNS, with notable potential for the 
treatment of spinal injuries. 
 
Over the last few decades, OECs have been used as experimental therapeutic 
interventions in numerous animal models of SCI, which have for the most part 
focused on axonal regeneration, remyelination and functional recovery. Of the 
injury models tested, most have utilized lesion, compression, contusion or 
chemical injuries, using mainly mice or rats. Numerous functional assessments 
and histological investigations have been used to evaluate the effects of OEC 
transplantation after SCI; these include a diverse range of behavioural tests, 
electrophysiological and immunohistological assessments.  
 
A great deal of evidence has been collected that suggests OECs exert a positive 
influence on recovery after SCI, however findings have been mixed – for 
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example: Several studies have reported that OEC transplants promote long 
distance axonal regeneration (Ramón-Cueto et al., 2000; Li et al., 1998; Nash 
et al., 2002; Imaizumi et al., 2000; Ramer et al., 2004a) which may explain 
the observed improvements in function (see below), whilst others have failed 
to observe this (Ruitenberg et al., 2003, 2005; Lu et al. 2006; Ramer et al. 
2004b; Andrews and Stelzner 2004; Deumens et al., 2013). It has recently been 
shown that differences in the source of OECs and the culture methods could 
account for differences in their ability to promote axonal survival and 
regeneration (Richter et al., 2005; Novikova et al., 2011). Differences have 
also been seen in the reported efficacy of OECs to improve behavioural 
assessment scores. Some researchers have observed that OEC transplants 
promote improvements in behavioural assessment scores (Ramón-Cueto et al., 
2000; Plant et al., 2003; López-Vales et al., 2006), whilst others have failed to 
see any significant improvements in behavioural assessment scores (Takami et 
al., 2002; Riddell et al., 2004; Ruitenberg et al. 2005). 
 
Electrophysiological testing around the injury site has revealed OEC-induced 
improvements in local circuitry with no observable long-distance axonal 
regeneration (Toft et al., 2007). This is indicative of OECs influencing 
mechanisms other than the promotion of axonal regeneration, such as 
neuroprotective and plastic processes, leading to improved local circuitry, 
which may account for the observed improvements in behavioural scores. This 
is backed up by previous studies which report enhanced levels of 
neuroprotection (Takami et al. 2002; Ramer et al. 2004a; López-Vales 2004; 
Sasaki et al., 2006) and local plasticity (Chuah et al., 2004) following OEC 
transplantation. 
 
It has been proven that human OECs can be extracted and cultured from the 
human olfactory system (Barnett et al. 2000; Bianco et al. 2004; Féron et al., 
2005; Mackay-Sim et al., 2008). Whilst 2-3 biopsies can be taken from the 
olfactory mucosa without affecting the patient sense of smell (Lanza et al. 
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1994; Féron et al. 1998), it is still hard to culture enough pure OECs to fill a 
human SCI cavity (Choi et al., 2008). Despite this and several other factors, 
such as cost, which may delay the development of OEC-based intervention 
strategies, several human trials are currently in progress worldwide (reviewed 
by Mackay-Sim and St. John 2011). 
 
 
1.10.6.5 Mesenchymal stem cells  
 
Mesenchymal stem cells are stromal cells that have the ability to self-renew 
and also exhibit multilineage differentiation; they can be derived from 
virtually all post-natal organs and tissues (da Silva Meirelles et al., 2006). As 
these cells types are derived from mature, differentiated tissues they have a 
more restricted potential for differentiation than embryonic stem cells. Whilst 
MSCs from several sources have been utilized for the treatment of numerous 
degenerative conditions, those derived from bone marrow are the most widely 
utilized and highly characterised subset of MSCs.  
 
 
1.10.6.5.1 Bone marrow stromal cells  
 
The stroma of the bone marrow contains a subset of heterogeneous, 
multipotent MSCs capable of differentiating into lineages of blood cell, 
skeletal tissue and stromal tissue. It has been claimed by some groups that 
these cells can then transdifferentiate into numerous cell types, including 
neuronal and glial cells (Woodbury et al., 2000; Qi et al., 2010), skeletal 
myocytes (Wakitani et al., 1995; Ferrari et al., 1998), cardiomyocytes (Martin-
Rendon et al., 2008) and liver cells (Petersen et al., 1999), although some 
debate still remains (Castro et al., 2002; Mezey et al., 2003; Walczak et al., 
2004), especially concerning their reported abilities for neuronal 
differentiation (Lu et al., 2004), as discussed in greater detail below. 
Extracting bone marrow, whilst comparatively invasive, avoids the ethical 
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concerns that exist about the use of cells of embryonic origin, thus making 
bone marrow derived cells attractive candidates for autologous stem cell 
transplantation strategies. As a result, there has been considerable interest in 
recent years in several cell types cultured from bone marrow for the 
treatment of numerous disorders (reviewed by Momin et al., 2010).  
 
Much debate exists around the appropriate terminology for and the exact 
differentiative abilities of cells of bone marrow origin. They have been 
referred to as “bone marrow stem cells” as small proportions have stem cell 
like abilities, or as “mesenchymal stem cells” as they originate from the 
mesodermal germ layer, or “stromal cells / bone marrow stromal cells” 
(BMSCs) as they reside in the stroma of the bone marrow. This confusing 
terminology has made it hard to be certain of the true identity of the cells 
used by different research groups. Uncertainty also exists as to the true ability 
of these cells to differentiate and or transdifferentiate; this is largely due to 
the different purification and induction techniques used. For example, 
estimates of the percentage of BMSCs which are capable of being induced into 
the neural lineage vary considerably with different induction protocols; one 
group has estimated this to be around 1% for mice BMSCs (Sanchez-Ramos et 
al., 2000), whilst another group using a different induction protocol estimates 
that figure to be around 80% for human and rat BMSCs (Woodbury et al., 2000). 
Whilst we cannot ignore the species differences in the above observation, it 
remains a distinct possibility that the induction protocol plays a large part in 
the ability of BMSCs to differentiate into neural cells. It is therefore hard to 
gain a clear understanding of the abilities of BMSCs and their potential as 
therapeutic interventions for the treatment of SCI. 
 
When transplanted into the injured spinal cord some researchers have 
reported that MSCs promote functional recovery (Hofstetter et al., 2002; 
Zurita and Vaquero, 2006; Quertainmont et al., 2012), although others have 
failed to confirm this observation (Lu et al., 2005; Parr et al., 2007). It has 
been shown that axonal regeneration is promoted within but not beyond the 
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transplant (Lu et al., 2005). Whilst some investigations have revealed that 
MCSs promote Schwann cell myelination of demyelinated axons (Lu et al., 
2007), others have reported myelination by the MSCs themselves (Akiyama et 
al., 2002) although later studies have been unable to confirm this (Hunt et al., 
2008). As reviewed by Uccelli et al., 2008, MSCs have been shown to play 
numerous other roles in SCI repair processes, including a role in modulating 
the release of trophic and anti-apoptotic molecules through interacting with 
cells involved in both the innate and adaptive immune system and by 
stimulating the release of anti-inflammatory cytokines (Uccelli et al., 2008). 
 
A major complication associated with the use of MSCs is the lack of specific 
markers for their identification. In an attempt to address this problem, the 
Mesenchymal and Tissue Stem Cell Committee of the International Society for 
Cellular Therapy (ISCT) released guidelines to help identify human MSCs. The 
guidelines state that MSCs should maintain the ability to adhere to plastic 
when cultured under standard conditions; they should express CD73, CD90 and 
CD105, and lack expression of CD11b, CD14, CD19, CD34, CD45, CD79a and 
HLA-DR cell surface markers; lastly, they should have the ability to 
differentiate into adipocytes, osteoblasts and chondroblasts (Dominici et al., 
2006). Whilst this has aided greatly in cell identification, there still remains a 
great deal of variation in the levels of marker expression seen between 
laboratories. 
 
It remains a possibility that MSCs extracted from different tissues may have 
different properties that make them more or less able to combat the effects of 
spinal injury.  
 
 
1.10.6.6 Mesenchymal stem cell co-transplantation studies 
Recent studies have investigated the capacity for MSCs co-transplanted with 
OECs to improve functional outcomes following SCI. One group has reported 
improvements in behavioural scores and electrophysiological function with co-
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transplantation (Deng et al., 2008), whilst others saw improvements in 
behavioural scores and improved electrophysiological function with transplants 
of either cell type alone, no synergistic benefits were seen with co-
transplantation (Amemori et al., 2010).  
Other investigators performing co-transplantation studies have found that 
allogenic MSCs and activated Schwann cells are capable of eliciting functional 
recovery, reducing the formation of the glial scar and promoting remyelination 
to a greater degree than either cell type alone (Ban et al., 2011).  
 
 
1.11 Anatomy of the rat spinal cord  
 
The rat spinal column contains 8 cervical, 13 thoracic and 6 lumbar segments. 
Like in humans, the rat spinal column contains a central region of grey matter 
which contains neuronal and glial cell bodies, surrounded by a region of white 
matter containing the axons of ascending sensory and descending motor 
neurons. 
 
 
1.11.1 Dorsal column medial lemniscus pathway  
 
The dorsal column medial lemniscus pathway is one of the main ascending 
pathways in the mammalian CNS and has a similar organization in rats and 
humans. It carries fine touch, vibration and conscious proprioceptive 
information from the body to the primary somatosensory cortices on the 
anterior parietal lobes. The dorsal columns contain two main groups of 
ascending fibres, the direct DC pathway and the postsynaptic DC pathway 
(Tracey and Waite, 1995). The DC pathways have been shown to be comprised 
of approximately 25% propriospinal fibres (Chung et al., 1987). 
 
The cell bodies of primary sensory axons are located in the dorsal root ganglia 
of the dorsal root. They send projections into the PNS where they innervate 
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sensory receptors in skin, muscles and visceral tissues; as well as to the spinal 
cord, via the dorsal root, where they bifurcate into ascending and descending 
projections (Willis and Coggeshall, 2004) (Figure 1.5), these projections make 
up the direct DC pathway. Primary sensory axons, often termed ‘first order’ 
sensory neurons, are large myelinated fibers which transmit signals to the 
brain. Fibres in the descending branch have typically less well topographically 
organized distributions than the ascending projections, and only a small 
number of fibres project for two segments below their point of entry (Smith 
and Bennett, 1987). The centrally projecting branches ascend in the dorsal 
columns and form part of the dorsal column medial lemniscus pathway. The 
majority of ascending somatosensory projections originating in the lumbar 
region terminate in the spinal gray matter, with only an estimated 15% 
actually ascending all the way to the nucleus gracilis. Up to 63% of ascending 
somatosensory projections originating in the cervical region actually ascend all 
the way to the nucleus cuneatus (Willis and Coggeshall, 2004). Ascending 
somatosensory axons are known to be much more highly somatotopically 
organized than descending projections, for example, axonal projections from 
the lower limbs are known to ascend in the medial portions of the DCs in a 
tract known as the fasciculus gracilis, whilst sensory axons of the upper limbs 
ascend in the lateral portion of the DCs in a tract known as the fasciculus 
cuneatus (Figure 1.6) (Willis and Coggeshall, 2004). Fibres in both fasciculi are 
known to send collateral branches which project to numerous regions within 
the cord, including the dorsal and ventral horns as well as to the intermediate 
region (Willis and Coggeshall, 2004; Smith and Bennett 1987). Proportionally 
more of the first order cells from the cervical levels make synaptic 
connections with cells in the DCN, compared to those projecting from the 
lumbar levels (Smith and Bennett, 1987; Giuffrida and Rustioni, 1992). 
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Figure 1.5 Schematic diagram showing the organization of ascending and 
descending sensory projections in the spinal cord - The somas of primary 
sensory neurons are located in the dorsal root ganglia. It has two axonal 
projections, one to the spinal cord via the dorsal root, the other to the 
periphery where it innervates sensory receptors. The central projection 
bifurcates and sends ascending and descending axonal projections which have 
collateral terminals in the dorsal horn (Adapted from Brown et al., 1981). 
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The first order neurons which reach the medulla in the brain stem make 
synaptic contacts with ‘second order’ neurons in the nucleus gracilus and 
nucleus cuneatus, respectively. On leaving the so called ‘dorsal column 
nuclei’, but whilst still in the medulla, each of these fasciculi decussates and 
continues to ascend to the thalamus in tracts known as the medial lemniscus 
fasciculi. The fibers in these tracts ascend and make synaptic contacts with 
third order neurones located in the ventral posteriolateral nucleus of the 
thalamus. The third order neurons then ascend in the posterior limbs of the 
internal capsules and synapse in layer IV of the primary somatosensory 
cortices, with the sensory information from the lower body positioned more 
medially and the sensory information from the upper body positioned more 
laterally (Figure 1.6). 
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Figure 1.6 Dorsal column medial lemniscus pathway - Schematic diagram of 
the dorsal column medial lemniscus pathway showing first order large 
myelinated ascending sensorimotor fibres from the forelimb (blue) and 
hindlimb (red) ascending in the fasciculus cuneatus and fasciculus gracilus, 
respectively. Fibres in these tracts make synaptic contacts with second order 
neurons in the nucelus gracilis and nucleus cuneatus, collectively known as 
the dorsal column nuclei (DCN), which in turn project to make synaptic 
contacts with third order neurons in the ventral posteriolateral nucleus of the 
thalamus. The tracts then decussate in the thalamus and ascend in the medial 
lemniscus pathways and make synaptic contacts with neurons in layer V of the 
ipsilateral sensorimotor cortex (from http://what-when-how.com/wp-
content/uploads/2012/04/tmp1499.jpg, 2013). 
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Studies in the rat have shown that approximately 25% of axons in the DC 
pathways are unmyelinated and contain calcitonin gene related peptide 
(CGRP), suggesting that they might be involved in transmitting signals from 
either the viscera or peripheral nociceptors to the DCN (McNeill et al., 1988; 
Tamatani et al., 1989; Patterson et al., 1990). 
 
The other DC pathway, called the postsynaptic DC pathway consists of neurons 
located in the nucleus proprius, just ventral to the substantia gelatinosa in 
laminae III, IV and V, which receive input from primary afferent collaterals and 
in turn send projections that make synaptic contacts with second order cells in 
the DCNs, which are positioned in a highly somatotopically organised fashion. 
Cells in the nucleus proprius also send projections to cells in the external 
cuneate nucleus which lies laterally to the cuneate nucleus and relays 
proprioceptive signals from the upper extremities to the cerebellum, as well as 
to lemniscal neurons which send projections to the ventrobasal thalamus and 
then outputs to the primary somatosensory cortex (Rinvik and Walberg, 1975; 
de Pommery et al., 1984; Giesler et al., 1984; Cliffer and Giesler, 1989). 
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1.12 Summary of study aims 
 
The aims of this thesis were as follows:  
 
1. The aim of chapter 2 is to use direct electrophysiological, behavioral and 
anatomical techniques to investigate and characterise the effects of contusive 
SCIs of different severity on the functional changes occurring in ascending long 
white matter pathways. This information will be used to select an injury 
severity that produces moderate functional deficits which are detectable up to 
6 months post injury, and this model will be used to characterise the time 
course of secondary damage and any spontaneous recovery of functions. 
2. The aim of chapter 3 is to combine the injury model designed in chapter 2 with 
electrophysiological, behavioral and anatomical investigations to determine 
whether the delayed transplantation of a recently characterised subset of 
mesenchymal stem cells can promote the recovery of function through 
remyelination or other mechanisms of repair. 
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Chapter 2                               
Responses of the somatosensory pathways to 
contusion injury 
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2.1 Introduction 
 
SCI disrupts both ascending and descending axonal pathways, resulting in the loss 
of motor, sensory and autonomic function. Substantial spontaneous recovery has 
been observed in both experimental animals and in humans in the days, weeks 
and months following injury (Burns et al., 1997; Weidner et al., 2001; Ballermann 
and Fouad 2006; Fawcett et al., 2007). Spontaneous recovery has been 
investigated using mainly behavioural and anatomical approaches but the 
mechanisms responsible remain largely undefined. 
 
It is known that adult CNS neurones have an intrinsic capacity for regrowth over 
long distances although anatomical evidence has shown this regrowth to be 
inhibited by the inhospitable environment that results following SCI (David and 
Aguayo 1981). Thus it is unlikely that axonal regeneration contributes 
significantly to spontaneous recovery; consequently, research has largely focused 
on mechanisms such as remyelination and plasticity. 
 
Following SCI it is known that a population of fibres in the long white matter 
pathways are partially demyelinated but remain intact (Griffiths and McCulloch, 
1983). It has been demonstrated that some segmentally demyelinated axons 
retain an ability to conduct action potentials, even where the demyelinated 
region exceeds several internodes. Predictably, conduction velocities are much 
slower and the refractory periods of transmission are much longer in 
demyelinated axons; this is partly due to the redistribution of ion channels which 
spread out into the exposed internodal regions (Black et al., 1991; Felts et al., 
1997).  
 
It has been shown that infiltrating Schwann cells and oligodendrocyte precursor 
cells act to remyelinate the exposed axons, leading to functional improvements 
which can be measured electrophysiologically (James et al., 2011). Experimental 
contusion injuries have been shown to be particularly good at recreating the 
types of demyelination seen clinically, and thus provide an excellent model for 
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studying the effect of spontaneous and induced remyelination. The time course 
of the loss and potential recovery of functional abilities has not yet been fully 
characterised following moderate thoracic contusion injury.  
 
Molecular and anatomic techniques have been employed to study several types of 
so-called ‘injury-induced plasticity’ which may play a role in spontaneous 
functional recovery following SCI. Studies looking at animals in which 
spontaneous recovery is observed have revealed that both injured and the 
remaining uninjured axons undergo conformational changes including synaptic 
plasticity and axonal sprouting. Shortly after injury, inactive synapses and 
pathways may be transformed into a functional form (Merzenich et al., 1984). At 
later time points the targets of partially disrupted projections have been shown 
to upregulate the number of receptors to bind a reduced number of 
neurotransmitter molecules (Gulino et al., 2007) and spared axons have been 
shown to have the potential to sprout to form new functional synapses, thus both 
responses have the potential to partially ameliorate the effects of the injury 
(Brus-Ramer et al. 2007; Bareyre et al., 2004; Weidner et al., 2001). Whilst 
limited plasticity has been observed in the spinal cord following injury, extensive 
cortical plasticity has also been shown to rapidly occur following SCIs of different 
types (Jain et al., 1997; Bazley et al., 2011; Aguilar et al., 2010). Injury-induced 
plasticity in supra-spinal systems has been linked with improvements in 
functional outcomes following injury in both experimental animals and humans 
(Raineteau and Schwab 2001; Edgerton and Roy 2002; Oudega and Perez, 2012).  
 
The above mechanisms have been investigated mainly using molecular, cell and 
anatomical approaches, and in some studies behavioural tests have been 
employed in order to determine their influence on functional outcome. However, 
whilst behavioural tests are capable of providing measures of an animal’s ability 
to perform certain tasks which allow us to make comparisons between 
experimental groups, they are unable to ascertain the processes which underlie 
any observed changes. Behavioural tests are unable to differentiate functional 
changes in the spinal cord from functional changes occurring supra-spinally and 
71 
 
can therefore reveal nothing about the functional changes in spinal pathways. To 
make inferences about the function of spinal tracts they must be investigated 
directly using an electrophysiological approach. 
 
To determine the functional effects of injuries on long white matter tracts and 
therapeutic interventions, direct electrophysiological investigations of injured 
and uninjured pathways are required. This allows for changes in function to be 
attributed to changes seen in the investigated spinal pathways or to other, 
potentially supraspinal mechanisms. Ideally such investigations should be 
designed so that direct functional measures can be related to anatomical and 
behavioural measures. There is a paucity of such studies in the literature, with 
researchers thus far choosing to largely focus only on anatomical and behavioural 
testing alone. 
 
The assessment of potential therapies for SCI would be aided greatly by the 
accurate characterisation of direct functional measures in both normally 
functioning pathways and pathways subjected to contusion injury. The aims of 
the experiments described in this chapter are therefore: 1) to ascertain whether 
an electrophysiological approach can be used to detect functional changes in the 
ascending long white matter tracts in the dorsal columns following a contusion 
injury; 2) to design an injury protocol which will allow for direct functional 
(electrophysiological) measures to be made; 3) to determine and characterise the 
time course of changes to long tract function that might occur following 
contusion injury. 
 
To assess functional changes in the ascending dorsal column pathways, sensory 
evoked potentials (SEPs) evoked by stimulating ipsilateral radial and sciatic 
nerves were recorded from the exposed contralateral somatosensory cortex. In 
the first part of the study SEPs were compared between groups of normal animals 
and animals 6 weeks following T9 contusion injuries of different severity. After 
selecting an appropriate injury severity, SEPs were recorded at different time 
points from the acute time point up to 6 months post-injury. 
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2.2 Materials and methods  
 
2.2.1 Animals  
 
All the experiments were approved by the Ethical Review Process Applications 
Panel of the University of Glasgow and performed in accordance with the UK 
animals (Scientific Procedures) Act 1986. 
 
Observations reported in this chapter are based on the investigation of 98 adult 
male Sprague Dawley rats (Harlan, Loughborough, UK). Of these, 30 animals were 
used to investigate the effects of injury severity on cortical SEPs and 45 animals 
were used to investigate the time course of changes that might occur to SEPs. A 
further 23 normal animals were investigated electrophysiologically and were used 
as controls for both studies. The remaining 2 animals were seen to have received 
contusion injuries in which the impactor tip glanced the bone at the edge of the 
laminectomy window and were thus excluded from the study on the grounds that 
they had not received the correct severity contusion injury based on the 
exclusion criteria described below. 
  
Of the 30 animals used to investigate the effects of injury severity, 11 received a 
150 Kdyn injury, 12 received a 175 Kdyn injury and 7 received a 200 Kdyn injury. 
All animals were allowed to recover for 6 weeks before being investigated 
electrophysiologically. 
 
In total 45 animals were used to investigate the time course of spontaneous 
recovery following contusive spinal cord injuries of 150 Kdyn force. Of these, 
electrophysiological investigations were performed on 10 animals 3-4 days 
following injury, 8 after 2 weeks, 15 after 12 weeks and 12 after 6 months 
recovery. Additionally, animals that received 150 Kdyne injuries in the survival 
study were used as a 6 week survival group here (n=11). 
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For comparison, peripheral nerve evoked SEPs were also recorded from 23 normal 
animals which were used as a control group in each study. Some on these animals 
were subsequently used to investigate the effects of injury at the acute time 
point and made a further acute group in the injury severity study (n=12). 
 
 
 
2.2.2 Contusion Injury  
 
All the contusion injuries in this study were carried out by Dr. John Riddell. 
 
 
2.2.2.1 Drugs  
 
Contused animals routinely received the following peri-operative medication as 
required: 
 
Buprenorphine (Vetergesic) - analgesic: 0.05 mg/kg, administered 
subcutaneously, once at the time of induction and once again the following 
morning. 
Carprofen (Rimadyl) - non-steroidal anti-inflammatory: 5 mg/kg, administered 
subcutaneously, once at the time of induction and subsequently if direceted by 
the vetenarian if recovery seemed slower than usual. 
Amfipen - antibiotic: 22.5 mg/kg, administered subcutaneously, once 
preoperatively. 
Enrofloxacin (Baytril) - antibiotic: 5 mg/kg, administered subcutaneously, twice 
daily from day of surgery for 7 days. 
Saline: 0.2-0.4 ml/100 gm body weight, administered subcutaneously, two or 
three times daily from day of surgery for up to three days, then as required. 
 
An ophthalmic ointment was applied as required to prevent drying of the eyes 
during surgery. 
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2.2.2.2 Contusion injury procedure  
 
The dorsal surface of the spinal cord was subjected to a midline contusion injury 
at the T9 level. This location was selected as it is easily surgically accessible and 
allows electrophysiological assessment of sensory input originating in the 
hindlimb. Contusion at this level interrupts the ascending dorsal column pathways 
which carry somatosensory signals from the hindlimbs to the brain in long white 
matter tracts. Surgical instruments and materials were sterilised and precautions 
were taken to minimise the risk of infection. 
 
Animals were anaesthetised with 5% isoflurane and oxygen at the time of 
induction, and 1-3% isoflurane and oxygen during surgery. The vertebral column 
was exposed from T8-T10 and the spinal cord was exposed by laminectomy of the 
T9 vertebra. The animal was placed in a stereotaxic frame and the vertebral 
bodies of T8 and T10 were clamped with lockable Adson forceps to stabilise the 
spine. A contusion injury was induced using the commercially available Infinite 
Horizon Impactor™ (Precision Systems and Instrumentation, LLC, Lexington, KY, 
USA; Figure 2.1).  
 
Briefly, after centring the impactor tip to the middle of the exposed spinal cord, 
a computer controlled stepper motor was activated, lowering the impactor tip at 
approximately 120 m/s to contuse the exposed spinal cord until a user-defined 
force was reached, after which the impactor tip was immediately retracted 
(Figure 2.2). Computer generated graphs of force and displacement vs. time were 
then created by the Infinite Horizons Impactor (IHI) software before being saved 
and stored offline for further analysis (Figure 2.3). 
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Figure 2.1 The Infinite Horizons Impactor. The adjustable support arms were 
positioned and locked into place so that the lockable stabilising forceps could be 
used to clamp the animal into position. The impactor tip was then moved and 
lowered into position just above the exposed spinal cord using adjustable control 
wheels. Once in position the computer-controlled stepping motor is activated, 
driving the impactor rack downwards. The force sensor and impactor tip are 
located at the lower end of the impactor rack, which is in turn connected to the 
position sensor. The position and force sensors both connect to a control unit 
which interfaces with a control computer via a serial port (Image taken from the 
PSI-IH Impactor user manual 2007). 
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Figure 2.2 Contusion injury. Photograph of the injury procedure immediately 
following contusion injury. The contusion injury procedure involved performing a 
laminectomy to remove the T9 vertebrae, and rigidly fixing the T8 and T10 
vertebrae using lockable Adson forceps, the impactor tip of the Infinite Horizons 
Impactor was then positioned over the exposed T9 spinal cord and a  computer- 
controlled contusion injury of user-defined force was performed. 
77 
 
 
Figure 2.3 The Infinite Horizons Impactor software. (A) the Infinite 
Horizons Spinal Cord Impactor software (Precision Systems and 
Instrumentation, LLC, Lexington, KY, USA) showing the data generated by a 
contusion injury of 150 Kdyn.  (B) An example of a displacement vs. time 
graph with key points labelled. (C) An example of a force vs. time graph 
with key points labelled. The impactor-tip/tissue interface is recorded at 
the point where a force of 20 Kdyn is first measured, at which point a 
vertical red line is drawn through both graphs to indicate the time at which 
the initial impact occurred. A horizontal red line is then drawn on the 
displacement vs. time graph through the tip/tissue interface, indicating the 
displacement of the tip into the tissue. The tip travels slightly beyond the 
point at which desired force is achieved before the motor is able to 
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overcome its inertia and begin retracting the tip (adapted from the PSI-IH 
Impactor user manual 2007). 
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Any anomalous graphs were indicative that we had hit or grazed the bone 
surrounding the laminectomy, causing either a blunted peak, or a 
bump/second peak on the ascending part of the force vs. time graph, usually 
resulting in a severely reduced displacement distance. Such graphs indicated 
that the animal had not received the correct injury severity and therefore 
the animal was excluded from our investigations. This procedure allowed for 
highly accurate injuries, with a high degree of consistency within and across 
groups of animals, to be included in the study. 
 
In the animals which were allowed to recover post-injury, a 10-0 nylon 
suture was placed in the dura mata at the injury level to allow the location 
to be accurately identified during electrophysiological experiments and to 
aid in confirmation of the segmental level at the end of the experiment. It 
has been seen from previous studies in this laboratory that this is the most 
dependable and accurate way of locating the injury site post-mortem. The 
wound was sutured with 3-0 vicryl and closed using wound clips. Post-
operative drugs were routinely administered as described previously. In 
total, 100 animals received a contusion injury, of which 85 animals were 
allowed to recover post-injury, and were recuperated for 24 hours in a warm 
environment with free access to food and water before being allowed to 
recover for up to 6 months in normal animal housing conditions. A further 15 
animals that had received a contusion injury underwent electrophysiological 
investigation immediately, whilst the remaining two animals were excluded 
on the grounds that they had not received the correct severity contusion 
injury based on the exclusion criteria described above. 
 
 
All injury severities that were investigated immediately produced severe 
deficits in hind limb function which severely impeded the animal’s ability to 
locomote normally for 3-4 days for some animals in the least serve and 
permanently in some of the animals in the most severe injury group. Despite 
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this, all animals were able to move around their cages and were able to eat 
and drink with the aid of their fore limbs, which remained unaffected by the 
injury procedure. To encourage eating in their recovery period the animals 
were given Heinz chocolate flavoured baby food, which was placed at ground 
level in their recovery cages.  
 
As injuries at this level are known to prevent normal bladder function, the 
animals bladders were manually expressed twice daily by gently pressing the 
abdomen until normal function resumed as assessed by three consecutive 
failed attempts at expressing the bladder, usually this was seen within 7 days 
of injury in all groups, with function in the least severely injured seen to 
recover first. 
 
 
2.2.3 Electrophysiological experiments  
 
In the injury severity study, 30 animals were allowed to survive for 6 weeks 
post-injury before being investigated electrophysiologically to ascertain the 
effects of different injury severities on cortical SEPs. In the time course 
study a further 45 animals were investigated electrophysiologically in order 
to characterise the interplay between injury progression and spontaneous 
recovery from the acute to the chronic stages; 23 normal animals were 
investigated similarly and made up a control group for each study. The 
anaesthetic regime, preparatory surgery, post injury recovery and 
electrophysiological protocol were the same for animals in each 
experimental group. 
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2.2.3.1 Anaesthesia  
 
It was found that gaseous isoflurane provided the most stable anaesthesia for 
the preparatory surgery and i.v. pentobarbital the most stable for 
electrophysiological recordings. Anaesthesia was thus induced with 5% 
isoflurane in oxygen and maintained with 1-3% isoflurane in oxygen during 
the initial surgical procedures, after which frequent doses of sodium 
pentobarbital (10mg/kg i.v.) were administered as required. During 
dissection the depth of anaesthesia was assessed by monitoring pedal 
withdrawal reflexes, corneal reflexes, arterial blood pressure and 
electrocardiogram activity. Additional doses of anaesthesia were 
administered if pedal or ocular (blink) reflexes were evoked or if blood 
pressure was abnormally high or increased on pinching. During the recording 
phase of the experiment, the animal was paralysed and artificially ventilated 
(see below). Once paralysed we were unable to use pedal withdrawal or 
ocular reflexes to monitor anaesthesia levels, so anaesthetics were routinely 
administered at a rate commensurate with that required before paralysis. 
During the recording period, the arterial blood pressure’s response to 
noxious stimuli was monitored and if any response could be elicited then 
additional anaesthetic top ups could be administered, although this was 
rarely required. 
 
 
2.2.3.2 Preparatory Surgery 
 
The animal was induced as detailed above and placed in a supine position on 
an operating table.  Core body temperature was continuously monitored and 
maintained close to 37oC using a rectal temperature probe, a heating blanket 
and a radiant heat source. Adhesive tape was used to secure each of the 
limbs in position and needle electrodes placed in the skin of both forelimbs 
and the right hindlimb to allow for the continuous monitoring of the animals 
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electrocardiogram.  Once surgical levels of anaesthesia had been achieved, 
heart rate was typically between 360-400 beats/minute. Prior to the 
commencement of surgery, atropine sulphate (0.05 mg/kg i.p.; Martindale 
Pharmaceutical, UK) and dexamethasone sodium phosphate (2-3 mg/kg i.m.; 
Faulding Pharmaceuticals Plc, UK) were injected to reduce bronchial 
constriction and salivary secretions, and to prevent swelling of the spinal 
cord and brain (as evidenced by bulging of the brain or cord at the site of 
laminectmy and/or craniotomy), respectively. Before making any skin 
incisions an animal fur clipper was used to remove fur from the relevant 
areas. All fine surgery was performed with the aid of a dissecting microscope 
with foot controller (Zeiss S5, Germany). A soldering iron or electrocautery 
(Eschmann Equipment, TDB 50, UK) was used to cauterise any areas of 
bleeding. 
 
 
2.2.3.3 Tracheal, venous and arterial cannulations 
 
Tracheal, jugular vein and carotid artery cannulations were performed to 
allow for artificial respiration, intravenous drug administration and 
monitoring blood pressure, respectively. Whilst under the gaseous 
anaesthetic regime described above, the skin overlying the trachea was 
incised and retracted, and the superficial muscle overlying the trachea was 
separated. The right carotid artery was then exposed by blunt dissection and 
an approximately 2cm length was carefully separated from the vagus nerve 
and ligated distally. The proximal end was clamped and a cannula inserted 
proximally (in the direction of the heart) and tied into place before the 
clamps removal. The cannula was filled with sterile heparinised saline (1% 
heparin in saline) to maintain patency by preventing blood clot formation. 
This allowed for the continual monitoring of arterial blood pressure which 
was maintained above 80mm Hg (typically 100-120mm Hg) throughout the 
experiment. The right jugular vein was exposed in a similar fashion and 
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cannulated to allow for the administration of intravenous drugs. The muscle 
overlying the trachea was retracted, a small length of trachea was separated 
from the surrounding tissue and a small opening was created such that a 
cannula could be inserted proximally and tied into position. Aspiration of 
lung secretions from the treachea was performed from time to time to 
ensure that the trachea remained patent. All cannulae were secured to the 
skin on the animals chin with threads to prevent them from being 
accidentally dislodged and the skin incision was closed with Michel clips. 
 
Cannulation of the carotid did not appear to have negative effects on SEPs 
through reduced cortical blood flow, and has been a standard procedure for 
some time in similar studies.  
 
 
2.2.3.4 Sciatic nerve dissection  
 
To dissect the sciatic nerve the animal was placed in a prone position and 
the skin overlying the dorsal aspect of the left hind limb was incised from 
the hip joint proximally, to the knee joint distally. The biceps femoris was 
retracted by blunt dissection and the sciatic nerve exposed. A length of 
sciatic nerve was dissected free (approximately 2 cm) and sectioned distally. 
A suture loop was tied to the distal end of the sciatic nerve and loosely tied 
in order to lift it without damage. Cotton soaked in sterile saline was used to 
cover the exposed nerve and the skin incision was held closed with a tissue 
clip to prevent the nerve from drying out. 
 
 
2.2.3.5 Radial nerve dissection 
 
In order to dissect the superficial branches of the left radial nerve, the 
animal was kept in a prone position and the skin overlying the right dorsal 
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aspect of the fore limb was incised from the shoulder joint proximally, to the 
elbow joint distally.  The tensor of the triceps brachii muscle was cut using 
an electrocautery (Eschmann Equipment, TDB 50, UK) and the superficial 
branches of the radial nerve were exposed and dissected free (approximately 
2cm) from the surrounding tissues using blunt dissection. The branches were 
sectioned distally and a suture loop tied around the end of the radial nerve 
so it could be lifted without damage. Cotton soaked in sterile saline was used 
to cover the exposed nerve and the skin incision was held closed with a 
tissue clip to prevent the nerve from drying out. 
 
 
2.2.3.6 Laminectomy  
 
A laminectomy was performed to expose the lumbar (L3-4) segments of the 
spinal cord to allow for the monitoring of CDP traces which were used to 
ensure that the sciatic nerve was both functioning properly and maximally 
activated. Briefly, a midline incision was made from the mid thoracic to mid 
lumbar regions. The skin was retracted and the thoracolumbar fasciae of the 
latissimus dorsi muscles separated (partially removed if required) from the 
vertebral column. The posterior arches of the T13-L2 vertebrae were then 
carefully removed using small bone rongeurs to expose the L3-4 spinal cord. 
If required, bone wax was used to prevent any bleeding from the cut edges 
of the vertebrae with the addition of gel foam to prevent any further 
bleeding. Throughout the laminectomy procedure, great care was taken to 
avoid damaging the spinal cord. When not recording CDPs, cotton soaked in 
sterile saline was used to cover the exposed spinal cord and the skin incision 
was held closed with tissue clips to prevent the cord from drying out. 
 
 
2.2.3.7 Transfer to recording frame  
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After the preparatory surgery was completed the animal was transferred 
from the surgical table to the recording frame and the animals head was 
secured using ear bars and an incisor bar.  
 
 
2.2.3.8 Artificial ventilation  
 
To prevent movements whilst stimulating the peripheral nerves it was 
necessary to paralyse the animal using a neuromuscular blocker, after which 
it was necessary to apply artificial ventilation. After aspirating the trachea, 
the animal was paralysed with pancuronium bromide (Sigma, induced with 
0.3 mg/kg i.v. with top up doses of 0.04mg every 30 minutes or as required). 
The animal was then immediately ventilated with air by connecting a 
respiratory pump (6025 Ventilator, UGO Basile, Italy) to the tracheal 
cannula. Carbon dioxide levels were monitored (Micro-Capnometer, 
Columbus Instruments, USA) and maintained at around 4% throughout the 
experiment by adjusting the ventilation rate and or stroke volume (typically 
75-100 strokes per minute and 10-20 ml/stroke). 
 
 
2.2.3.9 Craniotomy  
 
A unilateral craniotomy in the right hemisphere was performed using a fine 
dental drill, small bone rongeurs and watch makers forceps, extending from 
4mm rostral to 4mm caudal of Bregma and 5mm laterally, exposing the 
somatosensory cortex. Bone wax was used to prevent any bleeding from the 
cut edges of the cranium with the addition of gel foam to prevent any 
further bleeding, if required. The dura was carefully opened and removed 
from the exposed cortical surface using fine tweezers and iris scissors. Great 
care was taken so as to avoid damaging the cortex. An example of an 
exposed sensorimotor cortex is shown in Figure 2.4. 
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Figure 2.4 The cortical SEP recording grid.  A craniotomy was performed 
to expose the somatosensory cortex of the hemisphere contralateral to the 
stimulated peripheral nerves. The dura was removed and SEPs were 
recorded using a silver ball electrode in a grid pattern over the cortex, with 
1 mm spacing between the locations, all relative to Bregma (B), + indicates 
rostral, - indicates caudal (Image provided by Toft and Riddell). 
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2.2.3.10 Paraffin pools  
 
Paraffin pools were created around the posterior sides of the left forelimb, 
hindlimb and craniotomy by tying threads passing through the edge of the 
skin incisions to the frame. The pools were filled with paraffin at 
approximately 37oC so that all exposed tissues were covered. This provided 
insulation to prevent current spread to other tissues on electrical stimulation 
of the peripheral nerves, as well as to reduce heat loss and prevent tissue 
drying. 
 
 
2.2.3.11 Stimulation of the sciatic nerve  
 
The sciatic nerve was carefully mounted on bipolar silver wire electrodes 
immersed in the paraffin pool created from the skin flaps of the hindlimb 
surgical site. Care was taken to prevent the nerve coming into contact with 
any of the surrounding tissues and the electrode was secured firmly into 
place once positioned. The nerve was electrically stimulated using single 
square wave stimulation pulses of 0.2 ms duration and up to 500 μA.  
 
 
2.2.3.12 Stimulation of the radial nerve 
 
The radial nerve was carefully mounted on bipolar silver wire electrodes 
immersed in the paraffin pool created from the skin flaps of the hindlimb 
surgical site. Care was taken to prevent the nerve coming into contact with 
any of the surrounding tissues and the electrode was secured firmly into 
place once positioned. The nerve was electrically stimulated using single 
square wave stimulation pulses of 0.2 ms duration and up to 500 μA, the 
stimulation parameters were set using the protocol described in section 
2.2.3.16. 
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2.2.3.13 Monitoring the condition of the sciatic nerve 
 
To check that the sciatic nerve was both functioning normally and maximally 
activated it was stimulated and a CDP waveform was recorded from the 
exposed surface of the cord just below the level of the contusion injury at 
the L3-4 border. A normal sciatic evoked CDP is composed of a stimulus 
artifact, an afferent volley and a cord dorsum potential representing the 
summed activity of circuits local to the recording electrode.  For the purpose 
of these experiments, where we were only interested in activity in long 
tracts rather than that of local circuits, therefore we were mainly concerned 
with any changes observed in the afferent volley. An example of a normal L4 
sciatic evoked CDP trace depicting the separate components of the 
waveform is shown in Figure 2.5. 
 
 
2.2.3.14 Peripheral nerve stimulation and SEP recording setup  
 
The electrophysiological setup involved stimulating the sciatic and radial 
nerves and recording the evoked potentials from the cortical surface, as 
shown in Figure 2.6. Briefly, when stimuli were applied to the radial and 
sciatic nerves with bipolar hook electrodes, potentials were recorded across 
the surface of the contralateral somatosensory cortex. SEPs generated by 
alternately stimulating the radial and sciatic nerves were recorded at 
different positions across the cortical surface using a silver ball electrode 
(Figure 2.4). 
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Figure 2.5 Sciatic evoked CDP recorded from L4 – An example of a CDP 
recorded from the dorsal surface of the spinal cord at the L4 level, showing 
the different components of the waveform: 1 = Stimulus artifact, 2 = 
Afferent Volley, 3 = Cord dorsum potential. 
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Figure 2.6 Schematic diagram of electrophysiological setup 
Schematic diagram showing the injury level and the stimulating (S) and 
recording (R) electrodes used to assess radial and sciatic SEPs.  The 
ascending dorsal column pathways were bilaterally injured at the T9 level, 
interrupting the ascending signals from the sciatic nerve whilst leaving the 
ascending radial pathway in tact (Image provided by Toft and Riddell). 
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2.2.3.15 Components and measurements of SEPs 
 
 SEPs consist of a stimulus artifact which indicates the onset of stimulation, 
followed after a brief interval by a strong depolarisation known as the SEP 
waveform which represents a summation of the post-synaptic activity evoked 
in the cortex in response to peripheral nerve stimulation, as shown in Figure 
2.7 A; the SEP waveform reflects the number and strength of these cortical 
connections and are largest at locations which receive more inputs from the 
pathways activated by the stimulated peripheral nerve. Various 
measurements can be made from SEPs in order to provide quantitative 
measurements of the ability of the stimulated pathways to transmit the 
stimulus from the peripheral nerve to the cortex, as shown in Figure 2.7 B. 
The latency of the SEPs arrival in the cortex provides useful information 
about the maximum conduction speeds in the activated pathways, whilst the 
amplitude of the negative component is capable of providing useful 
information on the strength of the transmitted signals, and the latencies of 
the negative and positive peaks are capable of providing useful information 
about the synchronicity of the action potentials arrival in the cortex, which 
in turn is a reflection of the range of conduction speeds in the activated 
pathway. 
 
 
2.2.3.16 Method of recording SEPs 
 
To assess function in the ascending sensory pathways, SEPs from the surface 
of the contralateral somatosensory cortex were recorded. Recordings were 
made using a silver ball electrode placed on the surface of the cortex, with 
the indifferent electrodes placed on nearby scalp muscle. Recordings were 
made in a grid pattern with 1 mm spacing between recording locations. The 
electrode positioning was guided with reference to a 1 mm graduated paper 
strip which was placed alongside the exposed somatosensory cortex. The grid 
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was centred at 1 mm lateral to Bregma and extended from 4 mm rostral to 4 
mm caudal and 4 mm lateral to bregma, giving a total of 36 recording 
locations (Figure 2.4). The first recording electrode was used to locate the 
position at which the SEP elicited by electrical stimulation of the radial 
nerve was maximal; this position was fixed and the electrode remained static 
throughout the experiment. The second recording electrode was used to 
locate the position at which the SEP elicited by electrical stimulation of the 
sciatic nerve was maximal. Once found, the locations where SEPs of the 
greatest amplitude could be recorded were used to ascertain the stimulus 
intensity which evoked the maximal response. The stimulus intensity was 
then set at a value that was supramaximal for both the radial and sciatic-
evoked SEPs (typically 100-200 μA) to ensure that the peripheral nerves were 
maximally activated in a consistent manner. Stimulating with supramaximal 
intensities has been standard practice in similar studies for some time now, 
and in this preparation this was seen to consistently and maximally activate 
both radial and sciatic nerves such that recordings of cortical SEPs could 
reliably be made. 
 
The roving electrode was then moved around the exposed somatosensory 
cortex and recordings were taken from each of the recording locations in the 
grid in order to map the varying responses at different locations. Alternate 
stimulation of the sciatic and radial nerves evoked SEPs which were recorded 
from the surface of the somatosensory cortex. Amplitude attenuation is 
known to occur with rapidly repeated stimuli, to avoid this, the stimulus 
repetition rate was fixed at 2 Hz, and to reduce the background noise 
averaged recordings were made of 30 sweeps recorded from each cortical 
location (Abbruzzese et al., 1990; Fujii et al., 1994). Examples of averaged 
sciatic and radial–evoked SEPs recorded at each cortical location in 
representative normal and 6 weeks survival animals are shown in Figures 2.8 
and 2.9, respectively. 
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It was noted that the accumulation of cerebrospinal fluid tended to short 
circuit the recording electrodes, resulting in smaller potentials. Therefore, 
throughout the recording of SEPs, great care was taken to remove fluid from 
the surface of the cortex. Due to this potential source of inaccuracy, the 
fluid was removed after moving the roving electrode to each new recording 
location and also during recording if the SEPs were seen to be reducing in 
amplitude whist collecting recordings from the same location. 
 
All recordings of electrical potentials were digitised using a CED 1401+ 
interface (Cambridge Electronic Design, Cambridge, UK) before being stored 
on a computer at a sampling rate of 20 kHz, without filtering. Averaging and 
taking measurements of latencies and amplitudes of electrical potentials 
were performed using Signal software (Cambridge Electronic Design, 
Cambridge, UK). 
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Figure 2.7 Examples of radial SEP waveforms. Examples of SEPs recorded 
from the exposed somatosensory cortex of a normal (non-lesioned) animal 
following stimulation of the radial nerve. All recordings were averages of 15 
sweeps and displayed using the standard electrophysiological convention of 
having positivity downwards. (A) numbered arrows point to different 
components of the surface recordings: (1) stimulus artifact, which indicates 
the timing of the stimulation; (2) onset of the positive component; (3) peak 
positive component; and (4) peak negative component of the SEP. (B) 
numbered bars indicate the different waveform measurements that were 
made: (1) latency to onset of the positive component; (2) amplitude of the 
positive component; (3) latency to peak positive component; (4) latency to 
peak negative component (Image provided by Toft and Riddell). 
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Figure 2.8 Examples of averaged normal radial and sciatic-evoked SEP traces - recorded in three 
representative uninjured animals, showing the overlapping cortical locations from which radial and sciatic SEPs 
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were recorded, and the relatively consistent locations and amplitudes at which radial and sciatic-evoked SEPs 
of maximal amplitude were recorded (shown in red). All locations are shown in mm relative to Bregma (B). 
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Figure 2.9 Examples of averaged injured radial and sciatic-evoked SEP traces - recorded in three representative 
animals 6 weeks following 150 Kdyn contusion injuries at T9, showing the overlapping cortical locations from which 
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radial and sciatic SEPs were recorded, and the relatively consistent locations and amplitudes at which radial and 
sciatic-evoked SEPs of maximal amplitude were recorded (shown in red). All locations are shown in mm relative to 
Bregma (B). 
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2.2.3.17 Recording the acute recovery of sensory-evoked potentials 
 
Once the normal map had been completed, twelve of the animals in the 
uninjured control group were injured and used to make up the acute group. 
To allow monitoring of the acute recovery the radial recording electrode was 
left in place at the end of the normal map and the roving electrode was 
placed back where the largest sciatic SEPs had been recorded. SEP recordings 
were made starting immediately following injury and continued at 5 minute 
intervals until amplitudes had stabilised. Only once SEP amplitudes had 
stabilised were acute SEP maps made. 
 
 
2.2.4 Technical considerations with peripheral nerve stimulation 
 
To obtain a quantitative measure of the summed strength of action potentials 
in the dorsal column-medial lemniscus pathway which can be compared 
between animals, it is necessary to be able to consistently activate the same 
pathway to the same extent from animal to animal. This is achieved relatively 
simply when using peripheral nerve stimulation, where care can be taken to 
ensure that the same branches of the nerve are stimulated in each animal and 
by applying a supra-maximal stimulus intensity. 
 
Occasionally a transient drift in SEP amplitude was observed. This could be 
controlled for by monitoring the sciatic SEP amplitude throughout the 
experiment. If a drop in radial SEP amplitude was observed, stimulation of 
both sciatic and radial nerves was stopped to allow time for the radial SEP 
amplitude to return to the level observed prior to the drifting. Thus, any 
change in the radial SEP amplitude was interpreted as the system drifting, and 
once it had returned to normal levels the amplitudes of sciatic SEPs could 
once again be trusted to be genuinely maximal. 
 
As described earlier, the stability of the radial SEP allows for the 
normalisation of sciatic SEP amplitudes such that they can be made directly 
comparable between animals. This is required as SEP amplitudes vary between 
normal uninjured animals, and as such must be normalised by expressing the 
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sciatic SEP amplitude as a percentage of the maximal radial SEP amplitude 
recorded in the same animal.  
 
 
2.2.5 Method for supramaximal activation of peripheral nerves 
 
In each animal, supramaximal activation of the radial and sciatic nerves was 
achieved by finding the threshold for activation and then slowly increasing the 
stimulus intensity until the SEP amplitude was seen to be maximal. 
Supramaximal stimulus intensities were then used throughout the rest of the 
experiment. 
 
 
2.2.6 Perfusion fixation 
 
At the end of electrophysiological experiments, animals were transcardically 
perfused with mammalian Ringer’s solution followed by paraformaldehyde 
fixative at the end of the electrophysiological experiment for histology. 
Animals were perfused through the right ventricle with mammalian Ringer’s 
solution, containing 0.1% lidocaine to help dilate the blood vessels and remove 
blood from the circulatory system. This was immediately followed by 1L 4% 
paraformaldehyde in 0.1M phosphate buffered saline (PBS), pH 7.4. The injury 
site was then located and carefully removed for post fixation. Post fixation 
was achieved by placing the cord in the same fixative solution overnight in 
which 30% sucrose was added for the purpose of cryoprotection. 
 
 
2.2.7 Histological processing  
 
After washing in 0.1M PBS, the injury site was identified by locating the 
marking suture in the dura and blocks containing the whole injury site were 
prepared, it was seen that the whole injury site could usually be contained 
within a 6 mm block. A notch was made in the ventral, caudal aspect of the 
block in approximately half the blocks, the remaining blocks were left intact. 
60μm sections were cut (parasagitally in notched blocks and transversely in 
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intact blocks) at -20oC using a Leica CM1850 cryostat (Leica Microsystems 
GmbH, Wetzlar, Germany). Sometimes, where the injury was extensive, it was 
difficult to cut whole sections or the sections fell apart after cutting, this was 
particularly problematic, especially in transverse sections, and precluded the 
quantification of lesion cavity volume.  Sections were washed in 0.3M PBS 
double salt (PBSD), and then incubated for 30 min in 50% ethanol. After 
washing three times for 10 minutes each in 0.1M PBS, sections were treated 
with fluorescence histochemistry techniques. 
 
Sections were incubated in anti-NF200 (1:1000, Sigma) and anti-GFAP (1:1000, 
Dako) primary antibodies at 4oC for 72hrs, which label the axons and the 
astrocytes (contusion lesion boundaries) respectively. Sections were then 
washed in PBSD and incubated in secondary antibodies, raised in the 
appropriate species, conjugated to fluorophores (Alexa 488 1:500, Rhodamine 
1:100) for 3-4 hours at room temperature or overnight at 4oC. After which, all 
sections were washed in PBS three times for 10 minutes each, mounted on 
plane glass slides in anti-fade mounting medium (Vectashield: Vector 
Laboratories, UK), before being coverslipped and the edges of the coverslip 
sealed with nail varnish and stored at -20oC in darkness. 
 
 
2.2.8 Microscopy 
 
2.2.8.1 Verification of contusion injury  
 
Phase contrast light microscopy was used to view sections containing the 
lesion cavity in order to determine the perimeter of the cavity and the 
relationship to the boundary between grey and white matter. Epifluorescence 
microscopy was also used to observe neurofilament and GFAP immunolabelling 
in the sections. 
 
 
2.2.9 Off-line analysis of electrophysiological data  
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Averaged records were inspected offline with Signal software (Cambridge 
Electronic Design, Cambridge, UK) to measure the amplitudes and latencies of 
the SEPs recorded at each location.  Maximum amplitude and latency data 
were collected in Microsoft Excel spreadsheets before being imported into 
Prism 4 software (Graphpad Software Inc, USA) for graphing.  Data from the 
SEP maps were collected in Microsoft Excel spreadsheets and imported to 3D 
Field software (Version 3.0.9.0, Copyright 1998–2007, Vladimir Galouchko, 
Russia) to create isopotential contour plots of the cortical areas in which SEPs 
were recorded.  These data were then imported to Prism 4 software for 
graphing. 
 
 
2.2.10 Statistical analysis  
 
All electrophysiological data were statistically analysed using Prism 4 software 
(Graphpad Software Inc, USA). Analysis of variance (ANOVA) and post-hoc 
Tukey’s multiple comparison tests were employed to reveal the difference 
among different groups. 
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2.3 Results 
 
2.3.1 Electrophysiological assessment of long tract functions following 
contusion injury.  
 
Sensory evoked potentials (SEPs) evoked by stimulating ipsilateral radial and 
sciatic nerves and recorded from the contralateral somatosensory cortex were 
used to assess function in the ascending dorsal column pathways following 
contusion injury at T9. Two main studies were performed: 
 
Injury severity study 
To assess the effects of injury severity, recordings were made of peripheral 
nerve-evoked SEPs from 30 animals receiving injuries of 150 kdyne (n=11), 175 
kdyne (n=12) and 200 kdyne (n=7). All of the animals were investigated at 6 
weeks post injury. 
 
Time course study 
To assess changes in long tract function with time after injury, peripheral 
nerve-evoked SEP recordings were made from animals 45 receiving injuries of 
150 kdyne at 3-4 days (n=10), 2 weeks (n=8), 12 weeks (n=15) and 6 months 
(n=12) following injury. Animals that received 150 Kdyne injuries in the injury 
severity study were used as a 6 week survival group here (n=11). 
 
For comparison, peripheral nerve evoked SEPs were also recorded from 23 
control animals, 12 of which were made from animals subsequently used to 
investigate the effects of injury at the acute time point. 
 
In either study, if whilst mapping SEPs the experiment had to be terminated 
early due to the animal losing condition then only the data obtained from full 
maps were included. 
 
 
Comparison of body weights and injury severities 
It was necessary to limit the variable parameters in each experiment to ensure 
that any differences we observed in the electrophysiological recordings were 
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solely due to differences in injury severity or survival time. One method that 
was employed was to ensure that the animals from different experimental 
groups received injuries of as similar a severity as possible. Contusion injuries 
of similar force will produce varied injury severities when applied to spinal 
cords of different sizes due to the impactor tips ability to damage a greater or 
lesser proportion of the cord depending on its size. It was therefore necessary 
to select animals for injury that were of a similar body weight and would 
therefore have similar sized spinal columns. To ensure this was strictly 
adhered to, each animal’s weight at the time of injury and the injury 
parameters provided by the Infinite Horizons software were recorded and 
graphed for comparison. 
 
Injury severity study  
Animals from each of the different injury severity groups had similar body 
weights at the time of injury, as shown in Figure 2.10 A. At the time of 
electrophysiological assessment, individuals from each experimental group 
had maintained similar body weights, as shown in Figure 2.10 B. Data 
produced by the Infinite Horizons Impactor show that the actual injury force 
that each animal was subjected to was similar between animals within each 
experimental group (Figure 2.10 C). When comparing actual injury force 
between experimental groups it is evident that each experimental group 
received distinctly different force contusions and distinctly different cord 
displacements, both of which increased in a graded fashion with increasing 
injury severity (Figure 2.10 C-D). It should be noted that the spread of data 
points in the displacement graph shown in Figure 2.10 D is thought to result 
from the non-uniform nature of the vasculature on the dorsal surface of the 
cord. 
 
Time course study 
Animals from the different time course groups had similar body weights at the 
time of injury, with the exception of animals from the acute injured group 
which were selected to be of a weight which was more comparable to that 
seen in other groups at the time of electrophysiology, as shown in Figure 2.11 
A-B. This was a deliberate decision to make the electrophysiological 
recordings more comparable between groups, which we decided was of more 
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importance than ensuring that animals were of a similar weight at the time of 
injury. Data produced by the Infinite Horizons Impactor show that the actual 
injury force that each animal was subjected to was similar between animals 
within each experimental group. Animals from different experimental groups 
were shown to have received similar force contusions and similar cord 
displacements, which suggests that they received similar severity injuries and 
are thus directly comparable (Figure 2.11 C-D). 
  
 
2.3.2 Injury severity and its effects on SEPs 
 
Typical SEP traces showed clearly that injury severity has a graded effect on 
SEPs, with more severe injuries linked to smaller amplitude SEPs which are 
slower to arrive in the cortex and are more temporally diffuse, as shown in 
Figure 2.12. To ascertain if these observations were significant, quantitative 
measures were made; the maximum radial and normalised sciatic SEP 
amplitudes, the cortical locations within which radial and sciatic SEP 
amplitudes were 80% and 15%, respectfully, of the averaged maximal radial 
SEP amplitude, and normalised latency to radial and sciatic SEP onset were 
determined in each animal as discussed below. 
 
Maximum SEP amplitudes  
Radial and sciatic SEPs were recorded at each location on the grid shown in 
Figure 2.4. Whilst radial SEP amplitudes were kept as absolute values, sciatic 
SEP amplitudes were normalised by expressing each as 15% of the maximal 
radial SEP amplitude recorded in the same animal. The maximum radial and 
sciatic SEP amplitudes recorded from animals within each experimental group 
were then statistically analysed using ANOVA with Tukey’s multiple 
comparisons and plotted as shown in Figures 2.13 A & B. Whilst Figure 2.13 A 
shows no change in maximum radial amplitudes, Figure 2.13 B shows that 
maximum sciatic SEP amplitudes were reduced in a graded fashion with 
increasing injury severity and that the maximum SEP amplitudes recorded in 
each of the injured experimental groups were significantly different from that 
recorded in normal animals. A breakdown of the statistical analysis is shown in 
Table 2.1. 
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SEP isopotential areas 
The amplitudes of the radial and sciatic SEPs evoked at each cortical 
recording site were used to construct radial and sciatic isopotential contour; 
these represent the areas of cortex from which radial and sciatic SEPs are 80% 
or 15%, respectively of the largest radial SEP amplitude recorded in each 
animal. The radial and sciatic isopotential contour areas from animals within 
each experimental group were then averaged, statistically analysed using 
ANOVA with Tukey’s multiple comparisons, and plotted as shown in Figures 
2.14 A-B. This showed that there is no observable trend between injury 
severity and radial isopotential contour size, and statistic analysis revealed 
that no significant difference exists between the radial SEP isopotential areas 
recorded in each experimental group (Figure 2.14 A). However, as shown in 
Figure 2.14 B, the sciatic SEP isopotential areas were seen to be reduced in a 
graded fashion with increasing injury severity, and the SEP isopotential areas 
recorded in each of the injured experimental groups were significantly 
different from that recorded in normal animals. A breakdown of the statistical 
analysis is shown in Table 2.1. 
 
Latency to SEP onset 
The latencies to the onset of both radial and sciatic SEPs were measured in 
each animal and normalised to account for the differences in conduction 
distance seen from animal to animal by expressing each as the % difference 
between the actual conduction distances measured in each animal and the 
maximum radial and sciatic conduction distances found across the groups, 
respectively, as shown in Figures 2.15 A-B. It can be seen from Figure 2.15 A 
that radial latencies to SEP onset remain unaffected by injury severity, with 
ANOVA and Tukey’s multiple comparisons revealing no significant difference 
between the groups. However, as shown in Figure 2.15 B, the latency to 
sciatic SEP onset was increased in a graded fashion with increasing injury 
severity, and the latencies to the onset of sciatic SEPs in each of the injured 
groups were significantly different from that recorded in normal animals. A 
breakdown of the statistical analysis is shown in Table 2.1. 
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2.3.3.1 Injury severity and its effects on the cortical locations from which 
SEPs could be recorded 
 
To investigate the distribution of SEPs in normal and injured animals, two 
approaches were used: Firstly the locations from which maximum SEPs could 
be recorded were identified, and then complete cortical SEP maps of the 
cortex were used to construct isopotential contour plots of where SEPs could 
be recorded. 
 
SEPs evoked by peripheral nerve stimulation were investigated in normal 
animals (n=23) as well as in 150 Kdyn (n=11), 175 Kdyn (n=11) and 200 Kdyn 
(n=7) injured groups. Whilst maximum radial and sciatic SEP amplitudes were 
recorded in every animal investigated, one animal from the normal group and 
two from the 150 Kdyn and 5 of the animals in the 200 Kdyn group lost 
condition before completion of the sciatic SEP map. 
 
Locations of maximum SEP amplitudes 
After performing full radial and sciatic SEP maps of the cortex, the cortical 
locations at which SEP amplitudes were maximal could be identified. This was 
achieved by recording the cortical locations at which the maximal amplitude 
radial and sciatic SEPs were recorded in each animal in the normal and injured 
groups. Figures 2.16 A-B show grids representing the cortex relative to Bregma 
(B), with 1 mm spaced grid points representing the locations from which SEP 
recordings were made. The location at which maximum SEP amplitudes were 
recorded in each animal is shown by an asterisk coloured to represent the 
normal or different injury groups. 
 
Figure 2.16 A shows the locations at which maximum radial SEP amplitudes 
were recorded in each individual animal in each experimental group. It can be 
seen that the majority of maximum radial SEP amplitudes were recorded 
within 1 mm of Bregma -1 mm, lateral 4 mm, with normal and injured groups 
appearing to display roughly the same distribution and a focus on Bregma -1 
mm, lateral 4 mm. This shows that the location of maximum radial SEP 
amplitudes does not appear to change following T9 contusion injuries of up to 
200 Kdyn force. 
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Figure 2.16 B shows the locations at which maximum sciatic SEP amplitudes 
were recorded in each individual animal in each experimental group. It can be 
seen that the majority of maximum sciatic SEP amplitudes were recorded 
within 1 mm of Bregma -1 mm, lateral 2 and 3 mms, with normal and injured 
groups appearing to display roughly the same distribution and a focus on 
Bregma -1 mm, lateral 2 and 3 mm. This shows that the location of maximum 
sciatic SEP amplitudes does not appear to change following T9 contusion 
injuries of up to 200 Kdyn force. 
 
Locations of normalised SEP isopotential contour plots 
To investigate possible changes in the cortical regions from which SEPs can be 
recorded following different injury severities the data was normalised as 
described earlier so that the data obtained from the SEP maps was less 
affected by variations in the maximal SEP amplitudes. These normalised data 
were used to create isopotential plots: contour lines delineating the area of 
cortex from which SEP amplitudes were at or greater than specified %s of the 
maximum radial SEP amplitude recorded in each animal. 
 
Using the electrophysiological approach previously described, the radial and 
sciatic SEP amplitudes were recorded at each location and normalised by 
expressing them, respectively, as 80% and 15% of the maximum radial SEP 
amplitude recorded in the same animal. Isopotential plots were then created, 
delineating the areas of cortex from which radial SEPs were ≥80% and sciatic 
SEPs were ≥15% of the maximum radial SEP amplitude recorded in each 
animal. Figure 2.17 shows the individual 80% radial and 15% sciatic 
isopotential contour plots recorded in each animal in each of the experimental 
groups. As shown in Figures 2.17 A and B, in normal animals, despite a degree 
of variation, the radial SEP isopotential plots are clearly centred on Bregma -1 
mm, lateral 4 mm and the sciatic on Bregma -1 mm, lateral 2 and 3 mms. 
Despite some variation the overall location and apparent size of radial SEP 
isopotential contours appears to remain relatively constant following 150 
Kdyn, 175 Kdyn and 200 Kdyn injuries (Figures 2.17 C, E and G). As shown in 
Figures 2.17 D, F and H, whilst the location of sciatic SEP isopotential contours 
does not appear to change following contusion injuries of any of the severities 
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investigated, the area of cortex that each isopotential plot delineates appears 
to be reduced in a graded manner with increasing injury severity. 
 
To make it easier to compare the isopotential plots from different groups the 
radial and sciatic SEP amplitudes recorded at each cortical location in each 
animal within a group were averaged so that average isopotential contour 
plots could be created. Due to the slight variation in the individual 
isopotential contours centres of focus, once averaged, the maximum SEP 
amplitude as a % of maximum radial SEP amplitude was reduced. Therefore 
the normalization %s had to be reduced in order to display the isopotential 
plots from each experimental group on the same cortical grid. Figures 2.18 A 
and B show averaged radial and sciatic isopotential contour plots from groups 
of normal 150 Kdyn, 175 Kdyn and 200 Kdyn injured animals with radial SEPs 
normalised to 80%, and the sciatic to 10% of the maximum radial SEP 
amplitude recorded in each animal. These plots show that the size and 
location of normalised, averaged radial SEP isopotential plots is not 
substantially different when comparing normal animals or any of the injury 
severities investigated (Figure 2.18 A), however, whilst the cortical locations 
of averaged sciatic SEP isopotentials appear to remain relatively constant, the 
size is reduced in a graded fashion with injury severity (Figure 2.18 B). 
 
 
2.3.3.2 Choice of injury severity for further investigation 
 
In the selection of an injury model on which to assess the effects of 
spontaneous functional changes or functional changes brought about through 
intervention strategies, it is advantageous to select an injury severity that 
causes persistent functional deficits. As functional deficits spontaneously 
change with time following injury or with the application of therapeutic 
interventions, long lasting and fairly moderate functional deficits are required 
in order to assess the potential for improvement or worsening over time. 
 
Figure 2.13 A shows that 6 weeks following contusion injuries of 150 Kdyn the 
maximum SEP amplitudes that can be detected are reduced to approximately 
50% of that seen in normal animals. This shows that up to 6 weeks following a 
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150 Kdyn injury at T9, deficits are seen to be moderate and persistent such 
that potential future changes to radial SEP amplitude that improved or 
worsened functional ability should be detected using this model. Both 175 
Kdyn and 200 Kdyn contusion injuries were seen to result in sciatic SEP 
amplitudes of less than 50% of those seen in normal animals at 6 weeks post-
injury (Figure 2.13 B); these more severe injuries would therefore be less 
useful in assessing any potential worsening of function. 
 
As discussed in chapter one, it is also desirable to select an injury model 
which causes deficits which are severe enough to be persistent without being 
so severe that the animals cannot perform behavioural tests. After observing 
the 150 Kdyn injured animals recover in their home environments it was clear 
that whilst functional deficits were present up to six weeks post injury, the 
animals appeared capable of being behaviourally tested soon after injury. The 
deficits observed in animals from both the 175 Kdyn and 200 Kdyn injured 
groups appeared severe enough that the animals would be unable to perform 
behavioural testing. 
 
 
2.3.4 Post-injury survival time and its effects on SEPs 
 
The time course of changes to SEPs evoked by peripheral nerve stimulation 
following contusion injuries of 150 Kdyn severity was investigated using 45 
additional animals. SEP recordings were made from animals receiving injuries 
of 150 Kdyn force at different time points post injury; several time points 
were investigated, including 3-4 days (n=10), 2 weeks (n=8), 12 weeks (n=15) 
and 6 months (n=12) following injury. Data obtained from the 150 Kdyn 
injured animals in the previously described severity study were also used to as 
a 6 week survival group (n=11), and data from the normal animals used in the 
previously described injury severity study were also used as a control group in 
this study (n=23); 12 of the animals included in the normal control group 
received 150 Kdyn contusion injuries immediately after the normal 
electrophysiological investigations were complete. The animals were then 
investigated electophysiologically and the data obtained were used to 
investigate the acute injury time point (n=12). 
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The effects of acute injury on SEPs 
The data on the acute functional effects of contusion injury were obtained 
from 12 animals that first underwent normal electrophysiological investigation 
and formed part of the control group, immediately after which each animal 
received a 150 Kdyn contusion injury at T9 as described earlier. The effects 
this had on radial and sciatic evoked SEPs were investigated acutely using an 
electrophysiological approach. During the acute recovery recordings, if sciatic 
SEP amplitudes were seen to stabilize, normal SEP maps were performed and 
the data were included as an acute group in the time course study below. 
 
Initial electrophysiological examination of acutely injured animals showed that 
contusion injury completely ablates sciatic SEPs, as shown in the typical SEP 
traces in Figure 2.19 which have been coloured to indicate whether normal or 
to indicate the time post injury. It can be seen that immediately following 
injury the SEPs begin to gradually recover, with more acute time points 
associated with smaller amplitude SEPs which are characteristically slower to 
arrive in the cortex and more temporally diffuse. The recovery of SEPs was 
investigated over the acute period using the electrophysiological approach 
described below.  
 
During the pre-injury normal SEP map, the cortical location at which maximal 
amplitude sciatic SEPs could be recorded was noted. After completion of the 
map the recording electrode was returned to this location for the duration of 
the acute experiment. For comparison, radial and sciatic SEP recordings were 
made immediately prior to and immediately following the injury, and then 
again at five minute intervals until either the SEP amplitudes stabilized or the 
animal began to lose condition and the experiment had to be terminated.  
 
Figure 2.20 shows a series of graphs showing the radial and sciatic SEP 
amplitudes that were recorded before injury and then at five minute intervals 
thereafter in every acutely injured animal. It can be seen that in every animal 
investigated sciatic SEP amplitudes were completely ablated as a result of the 
injury, and radial SEP amplitudes are seen to be considerably attenuated. 
Radial SEP amplitudes are usually seen to have recovered by 5 minutes post 
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injury, and appear to stay roughly stable for the duration of the experiment. 
Despite variability in time course and completeness of each animal’s recovery, 
in most animals, sciatic SEP amplitudes took around 10-15 minutes to start 
recovering and around an hour to stabilize. A representative example can be 
seen in the R13610 recovery graph in Figure 2.20 which shows the initial 
ablation of the sciatic SEP amplitudes and a considerable reduction in radial 
SEP amplitudes with injury; despite some variation in recorded SEP 
amplitudes, it can be seen that in this animal the general trend is for radial 
SEP amplitudes to recover to around pre-injury levels within 5 minutes 
following injury and for sciatic SEP amplitudes to have stabilised by around 
one hour following injury. It can be seen in Figure 2.21 that averaged data 
confirmed that by 5 minutes post injury, radial SEP amplitudes had returned 
to normal and that roughly one hour after injury both the absolute and 
normalised sciatic SEP amplitudes had stabilised. 
 
As a consequence of the lengthy and invasive surgical procedures, some 
animals began to lose condition; consequently only 5 animals were sufficiently 
stable enough for post-injury SEP maps to be made (see below), and one of 
these animals lost condition before completion of the sciatic map.  
 
 
The time course of changes to SEPs from acute to chronic injury 
The time course of changes in long tract function from normal up to 6 months 
post injury were investigated in animals subjected to a 150 Kdyn injury at T9. 
Radial and sciatic SEPs were investigated after different survival times using 
the previously described electrophysiological approach. 
 
Figure 2.22 shows typical sciatic SEP traces which demonstrate the time 
course of changes after injury. Initially, contusion injury completely ablates 
sciatic SEPs, but over time they begin to recover. More acute time points are 
associated with SEPs which are smaller in amplitude, longer in latency to 
onset and greater in temporal dispersion. Over time maximal SEP amplitudes 
can be seen to gradually return towards normal, with longer recovery times 
linked to larger amplitude SEPs which are quicker to arrive in the cortex and 
less temporally diffuse (Figure 2.22). 
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To ascertain if data obtained from the different groups were significantly 
different, the maximum normalised radial and sciatic SEP amplitudes, the 
cortical locations within which radial and sciatic SEP amplitudes were 80% and 
15%, respectively, of the averaged maximal radial SEP amplitude, and 
normalised latency to sciatic SEP onset were determined in each animal as 
discussed below. 
 
Maximum SEP amplitudes.  
Maximum radial and sciatic SEP amplitudes were measured in each animal and 
whilst maximum radial SEP amplitudes were kept as absolute values, sciatic 
SEP amplitudes were normalised to 15% of the maximum radial SEP amplitude 
recorded in the same animal. Data from all the animals in each group were 
then graphed and analysed (Figure 2.23). Figure 2.23 A reveals that no 
significant difference was observed between the maximum radial SEP 
isopotential areas recorded in each experimental group. Surprisingly however, 
a fairly substantial increase in the radial SEP amplitude was seen at the acute 
time point, after which amplitudes return closer to normal and remain fairly 
constant up to 6 months post injury (Figure 2.23 A).  Figure 2.23 B shows that 
immediately following injury sciatic SEPs were significantly reduced, and 
remained that way with some recovery by two weeks then little change up to 
12 weeks post injury; despite this the 6 months time point shows evidence for 
a possible secondary phase of recovery with sciatic SEP amplitudes no longer 
significantly different from normal. The statistical tests employed were one-
way ANOVA with post-hoc Tukey’s multiple comparisons (Table 2.2). 
 
SEP isopotential areas 
Isopotential plots were constructed to represent the areas of cortex from 
which we recorded radial and sciatic SEPs ≥80% and ≥15%, respectively, of the 
maximal radial SEP amplitudes recorded. Data from all the animals in each 
group were then averaged, graphed and analysed (Figure 2.24). Figure 2.24 A 
reveals that no significant difference was observed between the maximum 
radial SEP isopotential areas recorded in each experimental group. Though a 
trend was observed for the radial isopotential area to increase slightly with 
time following injury, a quite substantial dip was noticed in the 6 weeks 
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survival animals. Figure 2.24 B shows that the sciatic SEP isopotential areas 
were significantly reduced following injury, again with some recovery seen by 
2 weeks and little further recovery up to 12 weeks post injury. Again, the 6 
month group showed evidence of a possible secondary phase of recovery. The 
statistical tests employed were one-way ANOVA with post-hoc Tukey’s 
multiple comparisons (Table 2.2). 
 
Latency to SEP onset 
The latencies to the onset of both radial and sciatic SEPs were measured in 
each animal and normalised by expressing each as the % difference between 
the actual conduction distances measured in each animal and the maximum 
radial and sciatic conduction distances found across the groups, respectively. 
Data from all the animals in each group were then averaged, graphed and 
analysed (Figure 2.25). Figure 2.25 A reveals a small and non-significant 
increase in radial SEP onset latency up to the 2/4 day time point, followed by 
a gradual decline at each time point up to 6 months post injury, by which 
point onset latency was shorter than in normal animals, though not 
significantly so. Figure 2.25 B shows that following injury, SEP onset latencies 
were significantly increased up to the 3-4 days time point, after which they 
were reduced at each time point investigated up to 6 months post injury. At 
every time point investigated, sciatic onset latencies were significantly 
different from normal, except from the 6 months time point. This observation 
might be indicative of an ongoing recovery process. The statistical tests 
employed were one-way ANOVA with post-hoc Tukey’s multiple comparisons 
(Table 2.2). 
 
 
2.3.4.2 Survival time and its effects on the cortical areas from which SEPs 
could be recorded 
 
To investigate the distribution of SEPs in normal and injured animals, two 
approaches were used: Firstly the locations from which maximum SEPs could 
be recorded were identified, and then complete cortical SEP maps were used 
to construct isopotential contour plots of where SEPs of predetermined sizes 
could be recorded. 
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Locations of maximum SEP amplitudes 
After performing full radial and sciatic SEP maps of the cortex, the cortical 
locations at which SEP amplitudes were maximal could be identified. Figures 
2.26 A-B show grids representing the cortex relative to Bregma (B), with 1 mm 
spaced grid points representing the locations from which SEP recordings were 
made. The location at which maximum SEP amplitudes were recorded in each 
animal is shown by an asterisk coloured to represent the normal or different 
injury groups. 
 
The locations at which maximum radial SEP amplitudes were recorded in each 
individual animal in each experimental group were recorded in Figure 2.26 A. 
It can be seen that the majority of maximum   radial SEP amplitudes were 
recorded within 1 mm of Bregma -1 mm, lateral 4 mm, with normal and 
injured groups appearing to display roughly the same distribution and a focus 
on Bregma -1 mm, lateral 4 mm. This shows that the location of maximum 
radial SEP amplitudes does not appear to change from the normal to the 6 
month post injury time points. 
 
Figure 2.26 B shows the locations at which maximum sciatic SEP amplitudes 
were recorded in each individual animal in each experimental group. It can be 
seen that the majority of maximum sciatic SEP amplitudes were recorded 
within 1 mm of Bregma -1 mm, lateral 2 and 3 mms, with normal and injured 
groups appearing to display roughly the same distribution and a focus on 
Bregma -1 mm, lateral 2 and 3 mm. This shows that the location of maximum 
sciatic SEP amplitudes does not appear to change from the normal to the 6 
month post injury time points. 
 
Locations of normalised SEP isopotential contour plots 
To investigate potential changes in the cortical regions from which SEPs can 
be recorded following different injury severities, SEP isopotential contour 
plots were created from which the cortical areas from which SEPs of certain 
chosen %s of the largest radial SEP could be investigated.  
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By normalizing the data as described below, the data obtained from the SEP 
maps was less affected by variations in the maximal SEP amplitudes. These 
normalised data were used to create isopotential plots: contour lines 
delineating the area of cortex from which SEP amplitudes were at or greater 
than specified %s of the maximum radial SEP amplitude recorded in each 
animal. 
 
Using the electrophysiological approach previously described, the radial and 
sciatic SEP amplitudes were recorded at each location and normalised by 
expressing them, respectively, as 80% and 15% of the maximum radial SEP 
amplitude recorded in the same animal. Isopotential plots were then created, 
delineating the areas of cortex from which radial SEPs were ≥80% and sciatic 
SEPs were ≥15% of the maximum radial SEP amplitude recorded in each 
animal. Figure 2.27 shows the individual 80% radial and 15% sciatic 
isopotential contour plots recorded in each animal in each of the experimental 
groups. As shown in Figures 2.27 A and B, in normal animals, despite a degree 
of variation, the radial SEP isopotential plots are clearly centred on Bregma -1 
mm, lateral 4 mm and the sciatic on Bregma -1 mm, lateral 2 and 3 mms. 
Despite some variation the overall location and apparent size of radial SEP 
isopotential contours appears to remain relatively constant following 
regardless of post-injury survival time (Figures 2.27 C, E, G, I, K and M). As 
shown in Figures 2.27 D, F, H, J, L and M, the location of sciatic SEP 
isopotential contours does not appear to change following different post-
injury survival times, though some change in isopotential area is clear, as 
quantified earlier. 
 
To make it easier to compare the isopotential plots from different groups, the 
radial and sciatic SEP amplitudes recorded at each cortical location in each 
animal within a group were averaged so that average isopotential contour 
plots could be created for each group. As with the injury severity group, due 
to the slight variation in the individual isopotential contours centres of focus, 
once averaged, the maximum sciatic SEP amplitude as a % of maximum radial 
SEP amplitude was reduced. Therefore the normalization % had to be reduced 
in order to display the isopotential plots from each experimental group on the 
same cortical grid. Figures 2.28 A and B show averaged radial and sciatic 
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isopotential contour plots from groups following different post-injury survival 
times, with radial SEPs normalised to 80%, and the sciatic SEPs normalised to 
15% of the maximum radial SEP amplitude recorded in each animal. These 
plots show that the location of normalised, averaged radial SEP isopotential 
plots does not change following injury (Figure 2.28 A). No change is seen in 
the cortical locations of averaged sciatic SEP isopotentials at any time point 
following injury, however as quantified earlier, isopotential contour size is 
seen to be reduced immediately following injury then appears to increase with 
increasing post-injury survival time. 
 
 
2.3.5 Histology 
 
The injury model employed here is designed to investigate changes in function 
in white matter tracts, specifically the ascending dorsal column system. Using 
a cryostat, attempts were made to cut the injury site in to serial sections 
which would allow us to calculate the volume of the lesion cavity, however 
despite our best attempts the injury epicenters proved too fragile to be 
sectioned in tact. Despite this, we were able to section and process tissue 
from immediately either side of the injury epicenter, which allowed us to 
perform dark field microscopy on tissue sections from within the injury site 
(Figures 2.29). This revealed that our contusion injuries cause substantial 
damage to the dorsal columns. Whilst the dorsal columns are seen to be 
severely disrupted with a cavity at the tissue core, a rim of spared white 
matter tissue can be seen surrounding the cavity. 
 
In future studies the use of paraffin embedding should be investigated as a 
method of providing greater stability when cutting sections; due to time 
constraints this was not possible in this study. 
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Figure 2.10 Weights, injury forces and cord displacements of individual 
animals in the injury severity study. A) Body weight at the time of 
contusion surgery in each injury group. B) Body weight at the time of 
electrophysiology in normal animals and in each injury group. C) Actual 
contusion injury forces recorded in animals in each injury group. D) Actual 
cord displacement during contusion injury in each injury group. Bars = means. 
 
 
 
119 
 
 
 
 
      Weight at contusion surgery
A
cu
te
 (n
=1
5)
3-
4 
da
ys
 (n
=1
0)
2 
w
ee
ks
 (n
=8
)
6 
w
ee
ks
 (n
=1
1)
12
 W
ee
ks
 (n
=1
5)
6 
m
on
th
s 
(n
=1
2)
200
250
300
350
400
450
500
550
Post injury recovery time
W
e
ig
h
t 
(g
)
           Weight at electrophysiology
N
or
m
al
 (n
=2
3)
A
cu
te
 (n
=1
5)
3-
4 
da
ys
 (n
=9
)
2 
w
ee
ks
 (n
=8
)
6 
w
ee
ks
 (n
=1
0)
12
 W
ee
ks
 (n
=1
4)
6 
m
on
th
s 
(n
=1
2)
200
250
300
350
400
450
500
550
Post injury recovery time
W
e
ig
h
t 
(g
)
   Actual injury force
A
cu
te
 (n
=1
4)
3-
4 
da
ys
 (n
=1
0)
2 
w
ee
ks
 (n
=8
)
6 
w
ee
ks
 (n
=1
1)
12
 W
ee
ks
 (n
=1
5)
6 
m
on
th
s 
(n
=1
2)
140
145
150
155
160
165
170
175
180
185
Post injury recovery time
F
o
rc
e
 (
k
d
y
n
e
s
)
  Actual cord displacement
A
cu
te
 (n
=1
4)
3-
4 
da
ys
 (n
=1
0)
2 
w
ee
ks
 (n
=7
)
6 
w
ee
ks
 (n
=9
)
12
 W
ee
ks
 (n
=1
5)
6 
m
on
th
s 
(n
=1
1)
600
700
800
900
1000
1100
1200
1300
Post injury recovery time
D
is
p
la
c
e
m
e
n
t 
(u
m
)
A B
C D
 
Figure 2.11 Weights, injury forces and cord displacements of individual 
animals in the time course study. A) Body weight at the time of contusion 
surgery in each of the different post injury recovery groups. B) Body weight 
at the time of electrophysiology in the normal group and in each of the 
different post injury recovery groups. C) Actual force of contusion injury in 
each of the different post injury recovery groups. D) Actual cord 
displacement as a result of contusion injury in each of the different post 
injury recovery groups. Bars = means. 
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 Normal 150kd 175kd 200kd
 
 
Figure 2.12 Sciatic SEPs demonstrating the effects of injury severities. 
Examples of sciatic SEPs averaged from 15 sweeps, recorded from a normal 
animal and animals 6 weeks after receiving contusion injuries of increasing 
severity (Black = Normal animal, Blue = 150 Kdyn injured animal, Green = 175 
Kdyn injured animal and Red = 200 Kdyn injured animal). 
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Figure 2.13 Effects of injury severity on maximum SEP amplitude. (A) 
Maximum amplitudes of radial SEPs in normal animals and animals 6 weeks 
following T9 contusion injuries of increasing severity. (B) Maximum sciatic 
SEPs in normal animals and animals 6 weeks following injuries of increasing 
severity, expressed as a % of the maximum radial SEP amplitude recorded in 
each animal. (*p<0.05; **p<0.01; ***p<0.001; one-way ANOVA Tukey’s test. 
Error bars = SEM). 
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Figure 2.14 Effects of injury severity on isopotential contour areas. (A) 
Cortical areas from which radial SEPs at or exceeding 80% of the maximum 
radial SEP recorded in normal animals and animals 6 weeks following injuries 
of increasing severity. (B) Cortical areas from which sciatic SEPs at or 
exceeding 15% of the maximum radial SEP recorded in normal animals and 
animals 6 weeks following injuries of increasing severity. (*p<0.05; **p<0.01; 
***p<0.001; one-way ANOVA Tukey’s test. Error bars = SEM). 
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Figure 2.15 Effects of injury severity on the latency to SEP onset. (A) 
Latency to onset of radial SEPs in normal animals and animals 6 weeks 
following injuries of increasing severity. (B) Latency to onset of sciatic SEPs in 
normal animals and animals 6 weeks following injuries of increasing severity.  
(*p<0.05; **p<0.01; ***p<0.001; one-way ANOVA Tukey’s test. Error bars = 
SEM). 
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Figure 2.16 Cortical locations of maximum radial and sciatic SEPs 
recorded 6 weeks following contusion injuries of different severity.  (A) 
Cortical locations of maximum radial SEPs recorded in individual animals. (B) 
Cortical locations of maximum sciatic SEPs recorded in individual animals. 
Asterisks represent individual animals and colours represent different 
experimental groups. (1 mm spacing between recording locations relative to 
Bregma (B); caudal = negative). 
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Figure 2.17 Individual isopotential contour plots of normal animals and 
animals receiving 150 Kdyn, 175 Kdyn and 200 Kdyn injuries. Individual 
radial and sciatic isopotential contour plots normalised to 80% and 15% of the 
maximum radial SEP amplitude, respectively. Different colours were used to 
represent isopotential plots from different animals. A) Individual normal 
radial isopotential plots (n=22), B) Individual normal sciatic isopotential plots 
(n=22), C) Individual 150 Kdyn group radial isopotential plots (n=11), D) 
Individual 150 Kdyn group sciatic isopotential plots (n=11), E) Individual 175 
Kdyn group radial isopotential plots (n=11), F) Individual 175 Kdyn group 
sciatic isopotential plots (n=11), G) Individual 200 Kdyn group radial 
isopotential plots (n=7), H) Individual 200 Kdyn group sciatic isopotential 
plots (n=2). (1 mm spacing between recording locations relative to Bregma 
(B); caudal = negative). 
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Figure 2.18 Averaged and normalised radial and sciatic SEP isopotential 
contour plots recorded in normal animals and groups receiving different 
injury severities. A) Isopotential contour plots encompassing the area of 
cortex within which radial SEP amplitudes were at least 80% of the averaged 
maximal radial SEP amplitude. B) Isopotential contour plots encompassing the 
region of cortex within which sciatic SEPs could be recorded with amplitudes 
at least 10% of the averaged maximal radial SEP amplitude. (1 mm spacing 
between recording locations relative to Bregma (B); caudal = negative). 
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Figure 2.19 Example sciatic SEPs at different time points following acute 
150 Kdyn contusion injury. Examples of averaged SEP waveforms recorded 
from the cortical surface following stimulation of the sciatic nerve in a 
representative animal. Recordings were made immediately prior to injury 
(normal) and at 5 minute intervals starting immediately following a 150 Kdyn 
contusion injury.  
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Figure 2.20 Time course of SEP recovery in individual animals following 
acute T9 150 Kdyn contusion injury. Sciatic and radial SEPs were recorded 
immediately before and immediately after injury, and then again at 5 minute 
intervals until sciatic SEP amplitudes began to stabilize or the animal began 
to lose condition and the experiment had to be terminated. Red = Radial SEP 
amplitude / Black = Sciatic SEP amplitude. 
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Figure 2.21 Averaged time course of SEP recovery following acute T9 150 
Kdyn contusion injury. Sciatic and radial SEPs were recorded immediately 
before and immediately after injury, and then again at 5 minute intervals 
until sciatic SEP amplitudes began to stabilize or the animal began to lose 
condition and the experiment had to be terminated. A) Sciatic and radial-
evoked SEP amplitude recovery, expressed as an averaged amplitude (error 
bars = SEM, Red = Radial SEP amplitude / Black = Sciatic SEP amplitude; 
N=12), B) Averaged sciatic SEP amplitude recovery, expressed as a percentage 
of radial the SEP amplitude recorded at each time point (error bars = SEM; 
N=12). 
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Normal        Acute 3-4 days 2 weeks
6 weeks 12 weeks
10 ms
200µV
  
Figure 2.22 Example sciatic SEPs at different time points following 150 
Kdyn contusion injury. Sciatic SEPs recorded from a normal animal and at 
different time points following a 150 Kdyn contusion injury. SEP amplitudes 
are reduced and latencies increased following injury, but slowly return 
towards normal in the 6 months following injury. 
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Figure 2.23 Maximum SEP amplitudes recorded in 150 Kdyn injured 
animals. Maximum radial (A) and sciatic (B) SEP amplitudes, expressed as 80% 
and 15% of the maximum radial SEP amplitudes recorded in animals up to 6 
months following 150 Kdyn contusion injury, respectively. Groups of normal 
animals (n=22) were investigated, as well as animals following acute injury 
(n=8) and following 3-4 days (n=10), 2 weeks (n=9), 6 weeks (n=11), 12 weeks 
(n=14) and 6 months (n=12) survival (**p<0.01; ***p<0.001; one-way ANOVA 
Tukey’s test. Error bars = SEM). 
134 
 
 
Radial SEP isopotential area
at 80% of max. radial
N
or
m
al
 (n
=2
2)
A
cu
te
 (n
=5
)
3-
4 
da
ys
 (n
=9
)
2 
w
ee
ks
 (n
=8
)
6 
w
ee
ks
 (n
=9
)
12
 w
ee
ks
 (n
=1
1)
6 
m
on
th
s 
(n
=1
0)
0.0
0.5
1.0
1.5
2.0
Time post-injury
A
re
a
 (
m
m
2
)
Sciatic SEP ispotential area
at 15% of max. radial
N
or
m
al
 (n
=2
2)
A
cu
te
 (n
=5
)
3-
4 
da
ys
 (n
=9
)
2 
w
ee
ks
 (n
=8
)
6 
w
ee
ks
 (n
=9
)
12
 w
ee
ks
 (n
=1
1)
6 
m
on
th
s 
(n
=1
0)
0
1
2
3
4
5
6
7
8
9
10
11
*
*
** **
***
***
Time post-injury
A
re
a
 (
m
m
2
)
A
B
 
Figure 2.24 SEP isopotential contour areas recorded in 150 Kdyn injured 
animals. Radial (A) and sciatic (B) SEP isopotential areas, expressed as 80% 
and 15% of the maximum radial SEP amplitudes recorded in animals up to 6 
months following 150 Kdyn contusion injury, respectively. Groups of normal 
animals (n=22) were investigated, as well as animals following acute injury 
(n=5) and following 3-4 days (n=9), 2 weeks (n=8), 6 weeks (n=9), 12 weeks 
(n=11) and 6 months (n=10) survival (*p<0.05; **p<0.01; ***p<0.001; one-way 
ANOVA Tukey’s test. Error bars = SEM). 
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Figure 2.25 Latency to SEP onset recorded in 150 Kdyn injured animals. 
Radial (A) and sciatic (B) SEP onset latencies, recorded in animals up to 6 
months following 150 Kdyn contusion injury. Groups of normal animals (n=23) 
were investigated, as well as animals following acute injury (n=8) and 
following 3-4 days (n=10), 2 weeks (n=9), 6 weeks (n=11), 12 weeks (n=15) and 
6 months (n=12) survival (*p<0.05; **p<0.01; ***p<0.001; one-way ANOVA 
Tukey’s test. Error bars = SEM). 
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Figure 2.26 Cortical locations of maximum radial and sciatic SEPs 
recorded at different post-injury time points (A) Cortical locations of 
maximum radial SEPs recorded in individual animals, (B) Cortical locations of 
maximum sciatic SEPs recorded in individual animals. Asterisks represent 
individual animals and colours represent different experimental groups. 
137 
 
 
138 
 
 
 
Figure 2.27 Individual isopotential contour plots of normal animals and 
animals receiving 150 Kdyn injuries at T9. Radial and sciatic contours were 
normalised to 80% and 15% of the maximum radial SEP amplitude measured in 
each animal, respectively. Different colours have been used to represent data 
from different individual animals. Individual normalised radial isopotential 
contours from A) normal animals (n=22), and animals C) acutely (n=5), E) 3-4 
days (n=9), G) 2 weeks (n=8), I) 6 weeks (n=9), K) 12 weeks (n=12) and M) 6 
months (n=10) following 150 Kdyn contusion injury. Individual normalised 
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sciatic isopotential contours from B) normal animals (n=22), and animals D) 
acutely (n=4), F) 3-4 days (n=5), H) 2 weeks (n=8), J) 6 weeks (n=10), L) 12 
weeks (n=12) and N) 6 months (n=10) following 150 Kdyn contusion injury. 
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Figure 2.28 Averaged radial and sciatic isopotential contour plots of 
groups of animals recorded at different post-injury time points A) 
Isopotential contour plots encompassing the area of cortex within which 
radial SEP amplitudes were at least 80% of the averaged maximal radial SEP 
amplitude. B) Isopotential contour plots encompassing the region of cortex 
within which sciatic SEPs could be recorded with amplitudes at least 15% of 
the averaged maximal radial SEP amplitude. All distances are in mm relative 
to Bregma (B). 
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Figure 2.29 Dark field histology of contusion injury site. Transverse section 
from an animal that received a 150 Kdyn force injury. T9 contusion injuries 
cause substantial damage to dorsal white matter tracts. Whilst the dorsal 
columns (DC) are severely disrupted, a cavity forms at the tissue core but a 
rim of spared white matter tissue encloses the cavity. Scale bar = 1 mm. 
Notch = Ventral and caudal. 
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Table 2.1 Statistic analysis of electrophysiological data obtained from injury severity groups. Results of ANOVA and Tukey’s 
post-hoc multiple comparison tests performed on each experimental group included in the injury severity study. 
 
 
Sciatic 
Isopotential 
Area 15% 
Max Radial 
Radial Isopotential 
Area 80% Max 
Radial 
Sciatic SEP Max. 
Amplitude as % Max. 
Radial 
Radial Max. 
SEP Amplitude  
Sciatic Latency 
to SEP Onset 
Radial Latency to 
SEP Onset 
One-way ANOVA P<0.0001**** P > 0.05 (ns) P<0.0001**** P > 0.05 (ns) P<0.0001**** P > 0.05 (ns) 
Tukey's Multiple 
Comparison Test - - - - - - 
  Normal vs 150 Kdyn  P < 0.01** P > 0.05 P < 0.001*** P > 0.05 P < 0.01*** P > 0.05 
  Normal vs 175 kdyn P < 0.001*** P > 0.05 P < 0.001*** P > 0.05 P < 0.001*** P > 0.05 
  Normal vs 200 kdyn P < 0.001*** P > 0.05 P < 0.001*** P > 0.05 P < 0.001*** P > 0.05 
  150 Kdyn vs 175 kdyn P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
  150 Kdyn vs 200 Kdyn   P < 0.001*** P > 0.05 P < 0.05* P > 0.05 P < 0.05* P > 0.05 
  175 Kdyn vs 200 Kdyn  P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
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Table 2.2 Statistic analysis of electrophysiological data obtained from time course groups. Results of ANOVA and Tukey’s 
post-hoc multiple comparison tests performed on each experimental group included in the time course study. 
 
 
Sciatic Isopotential 
Area 15% Max 
Radial 
Radial Isopotential 
Area 80% Max 
Radial 
Sciatic SEP Max. 
Amplitude as % Max. 
Radial 
Radial Max. SEP 
Amplitude  
Sciatic 
Latency to SEP 
Onset 
Radial Latency 
to SEP Onset 
One-way ANOVA P<0.0001**** P > 0.5 (ns) P<0.0001**** P > 0.5 (ns) P<0.0001**** P<0.0001**** 
Tukey's Multiple 
Comparison Test - - - - - - 
  Normal vs Acute  P < 0.01** P > 0.5 P < 0.01** P > 0.5 P < 0.001*** P > 0.05 
  Normal vs 3-4 days  P < 0.001*** P > 0.5 P < 0.001*** P > 0.5 P < 0.001*** P < 0.05 
  Normal vs 2 weeks  P < 0.05* P > 0.5 P < 0.01** P > 0.5 P < 0.01** P > 0.05 
  Normal vs 6 weeks  P < 0.05* P > 0.5 P < 0.01** P > 0.5 P < 0.01** P > 0.05 
  Normal vs 12 weeks  P < 0.001*** P > 0.5 P < 0.001*** P > 0.5 P < 0.01** P > 0.05 
  Normal vs 6 months  P > 0.05 P > 0.5 P > 0.05 P > 0.5 P > 0.05 P > 0.05 
  Acute vs 3-4 days  P > 0.05 P > 0.5 P > 0.05 P > 0.5 P > 0.05 P > 0.05 
  Acute vs 2 weeks  P > 0.05 P > 0.5 P > 0.05 P > 0.5 P > 0.05 P > 0.05 
  Acute vs 6 weeks  P > 0.05 P > 0.5 P > 0.05 P > 0.5 P > 0.05 P > 0.05 
  Acute vs 12 weeks  P > 0.05 P > 0.5 P > 0.05 P > 0.5 P > 0.05 P > 0.05 
  Acute vs 6 months  P > 0.05 P > 0.5 P > 0.05 P > 0.5 P > 0.05 P > 0.05 
  3-4 days vs 2 weeks  P > 0.05 P > 0.5 P > 0.05 P > 0.5 P > 0.05 P > 0.05 
  3-4 days vs 6 weeks  P > 0.05 P > 0.5 P > 0.05 P > 0.5 P < 0.05* P > 0.05 
  3-4 days vs 12 weeks  P > 0.05 P > 0.5 P > 0.05 P > 0.5 P < 0.05* P < 0.001 
  3-4 days vs 6 months  P < 0.01** P > 0.5 P > 0.05 P > 0.5 P < 0.001*** P < 0.001 
  2 weeks vs 6 weeks  P > 0.05 P > 0.5 P > 0.05 P > 0.5 P > 0.05 P > 0.05 
  2 weeks vs 12 weeks  P > 0.05 P > 0.5 P > 0.05 P > 0.5 P > 0.05 P > 0.05 
  2 weeks vs 6 months P > 0.05 P > 0.5 P > 0.05 P > 0.5 P > 0.05 P > 0.05 
  6 weeks vs 12 weeks  P > 0.05 P > 0.5 P > 0.05 P > 0.5 P > 0.05 P > 0.05 
  6 weeks vs 6 months  P > 0.05 P > 0.5 P > 0.05 P > 0.5 P > 0.05 P > 0.05 
  12 weeks vs 6 months  P > 0.05 P > 0.5 P > 0.05 P > 0.5 P > 0.05 P > 0.05 
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2.4 Discussion  
 
In this chapter it has been shown that SEPs recorded across the surface of the 
sensorimotor cortex which are due to impulses conveyed from hindlimb sensory 
afferents along the dorsal column system of the spinal cord, provide a sensitive 
measure of the severity of contusion injury of the thoracic spinal cord. It was 
also shown that such recordings can be used to investigate the time course of 
functional changes in the dorsal column system following injury. 
 
 
Rationale for the use of SEPs as an indicator of long white matter tract 
function 
 
One of the major mechanisms underlying loss of function following spinal cord 
injury is damage to white matter tracts, which compromises their ability to 
transmit impulses properly. One of the major ascending long white matter 
pathways responsible for transmitting sensory information from the skin to the 
sensory cortex is the dorsal column medial lemniscal pathway. The first order 
neurones in this pathway are sensory neurones with somas in the dorsal root 
ganglia, each of which has a central axon projecting into the dorsal columns. A 
proportion of these axons ascend in the dorsal column pathways and project to 
the dorsal column nuclei in the brainstem. Here signals are relayed to the 
thalamus via the medial lemniscus pathway and subsequently the sensory 
cortex. SEPs represent the activity of synapses and neurons in the sensorimotor 
cortex and, although other pathways converge on the cortex, the early 
negative component of the SEP is mediated entirely by impulses transmitted 
along nerve fibres ascending in the dorsal columns of the spinal cord (Angel and 
Berridge, 1974). 
 
The axons that make up the dorsal columns are topographically organised so that 
those entering the cord more caudally occupy a more medial position than those 
that enter more rostrally – for example, in the rat the sciatic nerve afferents 
enter the cord primarily through the 4th, 5th and 6th lumbar dorsal roots. 
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Although in rats the sciatic nerve is a mixed nerve, containing muscular and 
cutaneous afferents and fibres of proprioceptive origin, it is the large diameter 
cutaneous afferents that can be found in this medial location within the 
fasciculus gracilis in the dorsal white matter (Angel and Berridge 1974, Fern et 
al., 1988), whereas the radial nerve afferents enters the cord almost exclusively 
through the C6 dorsal roots and ascend in the fasciculus cuneatus, which is 
located lateral to the fasciculus gracilis. Thus by centring our impactor tip in the 
middle of the dorsal columns we are able to focus our injury on the tracts being 
investigated. 
 
Following electrical stimulation of afferents in hindlimb nerves, the dorsal 
column pathway conveys this activity along the spinal cord to the dorsal column 
nuclei in the brain stem and then via the thalamus to layer iV of the sensory 
cortex. Since the primary afferent fibres forming this pathway enter the spinal 
cord below the level at which the contusion injury was made their function is 
affected by damage to the dorsal column fibres. This is the rationale for using 
the SEPs evoked by electrical stimulation of the sciatic nerve in the hindlimb as a 
measure of how the transmission of impulses along this pathway are affected by 
injury.  
 
Three measures of the effectiveness of transmission along the dorsal column 
pathway were recorded. These were the maximal amplitude of the SEP, the area 
within which SEPs of a given amplitude were evoked and the shortest latency of 
the SEPs.   
 
SEPs provide a measure of the severity of an experimental contusion injury 
By measuring SEPs from groups of animals subjected to contusion injuries of 
graded severities we were able to show that each of the parameters of the SEPs 
we chose to measure were correlated with injury severity. Results show that 
there is a clear correlation between injury severity groups and SEPs and that 
each of the SEP parameters measured shows a change that follows this 
relationship. 
 
The observed reduction in sciatic maximum amplitude and reduced isopotential 
area suggests that fewer dorsal column fibres are contributing to the SEPs 
146 
 
evoked after injury and that more of these fibres are damaged the greater the 
force used to produce the injury. The increased latency to onset of sciatic SEPs 
after injury also correlates with injury severity, and could be due to two main 
mechanisms: increased latency at supraspinal relays or reduced conduction 
velocities in the dorsal columns: 
 
Increased latency at supraspinal relays 
The loss of dorsal column fibres contributing to the evoked potentials could 
increase the time taken for the relay of impulses in the dorsal column nuclei, 
thalamus and layer iV of the cortex. Transmission of impulses through these 
relays depends on convergence of inputs and temporal summation which leads to 
action potentials being generated in the postsynaptic neurons. Increased 
latencies can lead to reduced synchronicity which means actions arriving at 
target neurons at different times so reduced temporal summation. This happens 
more quickly the more synchronous and powerful the input, however if the input 
is reduced due to loss of fibres or the input is less synchronous because of a 
reduced conduction velocity in spared fibres then both of these effects would 
lead to longer delays at each of the relays and a longer overall latency.  
 
Reduced conduction velocities in the dorsal columns 
Increased latencies to the onset of SEPs could be due to reduced conduction 
velocities in the spared fibres as a result of damage to the fibres produced by 
the injury. It could also potentially occur if the contusion preferentially damaged 
larger diameter fibres, if for example they were more susceptible to injury than 
medium diameter fibres. 
 
As the increased latency to SEP onset could be due to an effect directly on 
conduction along the dorsal column fibre or on the delay in the relays of the 
dorsal column pathway it is not possible to directly deduce the change in 
conduction velocity of the dorsal column fibres as a result of the injury and 
damage such as demyelination. 
 
 
Time course data 
 
SEPs are abolished immediately on injury 
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This thesis represents the first time that SEP recovery has been investigated at 
such an acute time point using an electrophysiological approach. Here we show 
for the first time the immediate abolition of SEPs with spinal contusion injury, as 
well as their re-emergence and partial recovery over the minutes to hours post-
injury. 
 
Most SCI research has thus far focussed on what happens in secondary injury i.e. 
how injury to axon progresses to eventual axonal death over longer time periods. 
Much less research has focused on acute changes in function after axonal injury, 
especially transient changes. However, the early effects of CNS injury have been 
investigated in the guinea pig optic nerve, where soon after injury damage to the 
nodes of ranvier, leading to ‘nodal blebs’ leading to loss of conduction that 
recovers over time (Maxwell et al., 1991). Others have reported that 
dysregulation of ionic concentration gradients caused by leaking from damaged 
cell membranes prevents signal transduction, this is seen to recover to an extent 
over time in axons that have not been axotomised (Borgens, 1988) 
 
Another possible explanation for this observation is that the acute loss of 
function results from the initial mechanical damage caused by the contusion. 
McCulloch and Griffiths reported disruption of myelin sheaths and partial 
demyelination within 1½ hrs of impact injuries (Griffiths and McCulloch, 1983). 
 
 
Use of radial SEPs for normalising sciatic SEP data 
Although the transmission of sensory input entering the spinal cord below the 
injury will be affected by the injury, the radial nerve enters the spinal cord 
through cervical dorsal roots, well above the injury level, and is not therefore 
directly affected by it. As a result the maximum radial SEP amplitudes, latencies 
to SEP onset and isopotential areas remain fairly constant in animals regardless 
of different batches, injury severities or survival times. Despite others reporting 
the expansion of the forelimb cortical representations following thoracic 
transection injury (Aguilar et al., 2010; Ghosh et al., 2009 and 2010), here we 
found no such expansion or movement in the centre of focus, though this may 
result from the different injury models used. 
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In these experiments the only time we observed any substantial change in radial 
SEPs was immediately following acute injury, with amplitudes dropping 
substantially before rapidly recovering, usually within 5 minutes. Whilst the 
poorly defined phenomena of ‘spinal shock’ may play a role, it is more likely a 
result of the more general shock e.g. neurogenic shock that leads to changes in 
autonomic function which are transient. i.e. the injury could have resulted in a 
short term change in general physiology that was manifest in a change in the 
radial SEP acutely because SEPs are so sensitive in general (Dumont et al., 2001) 
 
Despite this, the maximum radial SEP appears to be constant and stable in both 
amplitude and location of cortical focus, which makes it ideally suited to 
normalising data obtained from sciatic SEPs and thus validates the normalisation 
protocol used here. 
 
 
How do the electrophysiologically detected changes in function correlate 
with behavioural changes in function. 
A major difficulty when attempting to correlate electrophysiological observations 
with behavioural measures is the absence of behavioural tests that specifically 
depend on the integrity of the dorsal column pathway. In preliminary 
experiments we found that complete dorsal column lesions made with a wire 
knife device did not abolish withdrawal reflexes from the hindlimbs. 
 
Implications of observations for understanding spinal cord injury and 
developing therapies  
These findings suggest that most of the damage to long white matter tracts 
results directly from the injury and occurs at the time of the injury, and that 
secondary mechanisms do not appear to lead to much additional damage if 
recovery seen in acute experiments is compared to 3-4day survival animals. This 
implies that there may be limited opportunities for a neuroprotective strategy 
since there may not be much to protect against. However, it is possible that 
neuroprotective strategies could speed the recovery of function. 
 
Despite seeing considerable repair and recovery with time, others have reported 
that the repair and optimisation of function in fibres that are spared may not be 
complete (James et al., 2011); this was demonstrated experimentally by cooling 
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exposed rat cords following injury and recording from single fibres which were 
more responsive with cooling than without, thus offering a therapeutic target 
which could be effectively utilized even in the chronic stages of injury. 
Combined these findings suggest that strategies for enhancing repair or 
restoring/optimising function could be beneficial. Other potential therapeutic 
strategies include optimising myelination, improving the quality of endogenous 
remyelination and compensating for the lack of myelin or suboptimal 
remyelination. 
 
 
Technical issues 
 
Injury severity 
The infinite horizons impactor with its force feedback controller optimises the 
consistency with which injuries with regards to mechanical properties. However, 
some variation is inevitable because of differences in the degree of stretch of the 
cord, the amount of bone removed by the laminectomy, the precise alignment of 
the impactor tip with spinal cord midline and the effect this will have on the 
injury properties; there will also be biological variability, for example in the 
pattern of blood supply. 
 
Variation was minimised via several strategies, including having the same operator 
carry out all of the injuries, by removing any animals in which bone strikes were 
indicated by the graphical output of the impactor and using animals with as similar 
weight as possible, though acute animals were a compromise between weights at 
injury and weights at electrophysiology. 
 
Another potential source of variation is the anaesthetic used during the 
electrophysiological recordings; unpublished observations from this laboratory 
show changes in SEPs amplitude between sodium pentobarbatal, ketamine or 
urethane anaestheasia. We therefore selected the anaesthetic known to have least 
effect on SEPs, sodium pentobarbital, for use in all SEP recordings 
 
 
Electrophysiology 
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Efforts were made to reduce the degree of variability in the collection of 
electrophysiological data, including the monitoring of and removal of fluids to 
avoid shorting the electrodes and ensuring that the level of anaestheasia was 
maintained as level as possible. Fluctuations in cortical excitability are well 
known and may be due to changes in anaesthetic level or changes in 
physiological conditions. These changes in excitability affect transmission 
through each of the relays of the dorsal column system – the dorsal column 
nuclei, the thalamus and the cortex- and can therefore result in significant 
changes in SEP amplitude. Physiology was maintained within close limits by 
monitoring and controlling core temperature, blood pressure and end tidal 
CO2. Supramaximal stimulation was used to avoid any drifting in stimulation 
parameters; this was determined as described earlier, by raising the stimulus 
intensity incrementally until maximum maplitude SEPs were observed, and 
then stimulating with a supramaximal intensity. 
 
As discussed previously, recordings of radial evoked SEPs were used to 
normalize the recordings of sciatic evoked potentials by expressing the 
maximal sciatic SEP amplitudes as a percentage of the maximal radial SEP 
amplitudes recorded in each animal. The sciatic evoked SEPs could be 
normalised in each animal on the grounds that the forelimb SEPs will not be 
affected by the injury, and by using this as a reference, the effects of drifts in 
the conditions of recording of the sciatic SEPs could be reduced. 
This approach assumes no change in radial SEP as a consequence of injury or 
with time following injury, and was thus validated by the observations made 
here. Additionally, several different SEP parameters were quantified in order 
to increase the possibility of detecting changes. 
 
Advantaged of using SEPs to measure white matter function 
SEPs recorded from the cortical surface have greater sensitivity than other 
methods such as single fibres recordings or recording of SEPs by less invasive 
methods. This is because recording SEPs does not rely on sampling enough fibres 
to find those that are still conducting, but instead activates all fibres and 
detects the summed actions of all spared fibres; it is thus a more sensitive 
method of detecting and measuring residual function after injury. Consequently, 
SEP recordings have therefore detected recovery of function at much earlier 
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time points (within minutes of the injury) than has previously been reported. For 
the same reasoning the absence of any detectable activity immediately following 
the contusion in the acute injury experiments can be considered a reliable 
observation and is not attributable to insufficient sensitivity of the assessment 
method. The failure of James et al, 2011 to observe early recovery is probably 
explained by the sampling issue referred to above. 
 
The invasive approach adopted here provides maximal control over the 
stimulation and recording conditions. This is important in obtaining consistent 
and reliable results. The use of skull screws for recording or the use of needle or 
cuff electrodes to activate primary afferents does not provide the same level of 
control due to the slight variability of the cortical location from which maximal 
SEPs can be recorded and the possibility of not maximally activating peripheral 
nerves due to movement of cuff electrodes. This may explain the failure of these 
approaches, despite involving the use of SEP recording, to detect functional 
recovery at early time points. Invasive approaches such as that used here which 
are capable of accurately characterising the effects of injuries on the cortical 
locations from which maximal amplitude SEPs can be recorded will assist in more 
accurately locating skull screws and thus aid the refinement of such non-invasive 
approaches.   
 
 
Disadvantages of using SEPs to monitor long white matter tract function 
That there are two disadvantages of using the full dorsal column lemniscal 
pathway. Firstly, we cannot rule out compensatory changes in synaptic efficacy 
within the relays – but this does not appear to interfere with the utility of the 
SEPs as an indicator of injury severity because the different SEP parameters were 
correlated with injury severity even at 6 weeks, by which time plastic changes 
can be expected to be established; secondly, the conduction velocity of 
afferents cannot be directly determined only an indirect indication of changes 
obtained. This is because the summation of post-synaptic potentials at synapses 
onto neurons in the relay nuclei of the pathway also contributes to determining 
the latency between stimulation and onset of the SEPs generated. Thus it is not 
possible to directly determine changes in the conduction velocity of dorsal 
column fibres using SEPs because changes in latency do not directly relate to 
changes in conduction velocity but may also reflect longer delays for 
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transmission in the relays of the pathway.  The approach used here measures 
function in the population of damaged fibres as a whole rather than individual 
fibres so that the latency information applies only to the fastest conducting 
fibres contributing to the SEP, conduction delays in the fibre population as a 
whole cannot be determined. Stimulation of the ascending dorsal column 
pathways results in the generation of both anterograde and retrograde action 
potentials. Retrograde compound action potentials (CAPs) have been used to 
provide an accurate measure of the conduction properties in long white matter 
tracts as they allow for recordings to be made directly from the stimulated nerve 
without the added complication of synaptic relays distorting the properties of 
the recorded CAP. In this respect, stimulating the spinal cord and recording 
retrograde action potentials from the dorsal roots provides a method of providing 
much more accurate information on the conduction properties of tracts or 
individual single fibres that make up the ascending dorsal column system. Such 
recordings are of great utility when assessing the effects of therapies on the 
conduction properties of fibres in the dorsal column pathways, which can provide 
accurate information on the integrity of nerve fibres, allowing for inferences to 
be made about the integrity of their myelination (James et al., 2011; Bei and 
Smith, 2012). Despite this, here we elected to use anterogradely conducting 
action potentials to assess the summed functional capabilities in the tracts under 
investigation, taking in to account the effects of signal amplification at each of 
the cortical relays; this provides a method of quantitatively assessing the direct 
inputs to the cortex and hence allows for a more accurate measure of an injury’s 
effects at the cortical level.   
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Chapter 3                        
Investigation of human lamina propria 
mesenchymal stem cells as a potential 
therapy for spinal cord injury 
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3.1 Introduction 
 
Mesenchymal stem cells (MSCs) are multipotent stromal cells with the ability 
to self replicate, proliferate and differentiate into numerous mesenchymal 
tissues. It has been shown that MSCs can be isolated from virtually all post-
natal organs and tissues (da Silver Meirelles et al., 2006).  
 
In studies looking at neuronal regeneration, MSCs derived from bone marrow 
(BMSCs) have been studied the most intensively (Dezawa et al., 2001; 
Hofstetter et al., 2002; Keilhoff et al., 2006; Krampera et al., 2007), though 
several other sources have also been investigated, including the umbilical 
cord, (Cao et al., 2009) and adipose tissue (Gimble et al., 2007). Whilst it has 
been shown that BMSCs from humans and rats can be induced to differentiate 
in to neural cells (Woodbury et al., 2000), when compared with neural tissue 
derived stem cells BMSCs have been shown to have a lower neurogenic 
potential (Song et al., 2007). Some investigators have even observed improved 
neurological function with BMSC transplantation following compression injury 
despite no cells being observable as early as 7 days post transplantation 
(Quertainmont et al., 2012). It is thus likely that the reparative capabilities of 
BMSCs come from their ability to modulate the environment in to which they 
are transplanted, rather then their differentiative capabilities (van Poll et al., 
2008). Numerous studies have reported that BMSCs release anti-inflammatory 
and anti-apoptotic molecules as well as several trophic factors known to play 
active roles in supporting axonal growth, immunomodulation, angiogenesis, 
remyelination and protecting against apoptotic cell death (Caplan and Dennis, 
2006; de Silva Meirelles et al., 2006; Uccelli et al., 2011). 
 
When transplanted into the injured spinal cord, BMSCs have been shown to 
migrate to the site of injury where they reduce the degree of neuro-
degeneration (Quertainmont et al., 2012) whilst concomitantly enhancing 
neuro-regeneration (Lu et al., 2004), although in many instances it has been 
shown that the transplanted cells and their effects appear to be limited to the 
transplant site (Hofstetter et al., 2002; Lu et al., 2005, 2006; Boido et al., 
2012). Whilst several investigators have reported improved function after SCI 
with BMSC transplants (Chopp et al., 2000; Hofstetter et al., 2002; Wu et al., 
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2003; Zurita et al., 2004; Ohta et al., 2004; Quertainmont et al., 2012), others 
have not seen such improvements (Ankeny et al., 2004; Lu et al., 2005). 
 
A recent study utilizing in vitro MSC cultures suggested that human MSCs 
isolated from the lamina propria of the nasal mucosa (hLP-MSCs) might have 
greater therapeutic potential for the treatment of SCI than those isolated 
from bone marrow (Lindsay et al., 2013). It was reported that when compared 
to BMSCs, hLP-MSCs have significantly greater clonogenic capabilities, have a 
higher level of mitotic activity and are able to induce significantly greater 
degrees of myelination in vitro (Lindsay et al., 2013). Isolating MSCs from the 
nasal lamina propria also provides a more easily accessible and less invasive 
source of cells for autologous transplantation. 
It has been shown that hLP-MSCs secrete a factor or factors which enhance 
myelination in vitro. Adding conditioned medium from cultures of hLP-MSCs 
increases the myelination of neurites in dissociated embryonic spinal cord 
cultures grown on an astrocyte monolayer (Figure 3.1). Interestingly, human 
bone marrow derived MSCs tend to inhibit myelination in these same cultures. 
The increased myelination promoted by the hLP-MSCs involved central type 
myelination by oligodendrocytes in the culture system. These observations 
suggested that hLP-MSCs might provide a means of enhancing the remyelination 
of spared fibres if transplanted into the site of a spinal cord injury. The aim of 
this chapter was therefore to combine electrophysiological and behavioral 
approaches to determine whether hLP-MSCs, when transplanted into an animal 
model of contusive SCI, would by promoting remyelination and possibly other 
mechanisms in addition, improve functional outcome following injury.  
 
 
3.2 Methods  
 
3.2.1 Experimental Design 
 
Figure 3.2 summarises the experimental design. As the in vitro investigation of 
hLP-MSCs suggested that remyelination was a potential mechanism, we elected 
to use a contusion injury model which is known to result in demyelination of 
spared fibres. The focus was on the assessment of long white matter tracts and 
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the injuries were therefore made at a T9 level. Transplants of cells (or 
injections of medium in control animals) were made 3 weeks after injury – a 
time point at which we have shown that conduction along the dorsal column 
pathway has stabilized following injury (see chapter 2). Immunosuppression 
(cyclosporine, 20 mg/kg s.c.) was begun two days before transplantation and 
continued daily throughout the study. Functional outcomes were assessed by 
behavioural testing performed throughout the study period and extending for 7 
weeks after the transplantation of cells or medium injections. At the end of 
the testing period, long tract function (ascending dorsal column somatosensory 
pathway) was assessed in electrophysiological experiments under terminal 
anaesthesia. At the end of this each animal was perfusion fixed and 
histological processing of the injury sites performed to assess the survival of 
transplanted cells as well as to investigate aspects of repair using 
immunohistochemistry and confocal microscopy. 
 
 
3.2.2 Animals  
 
Observations reported in this chapter are based on the investigation of adult 
male Sprague Dawley rats (Harlan, Loughborough, UK). Sprague Dawley rats 
were chosen as they are known to perform behavioural tests more readily than 
other strains. Before beginning the investigation, animals were screened for 
the ability to run on the Digigait™ treadmill. In total 60 animals were screened 
and 29 animals were excluded from the study due to not being able to run on 
the Digigait™ treadmill, with 31 capable of running sufficiently well to be 
included in the study. Each of these animals was subjected to a 150 Kdyn 
contusion injury at the T9 level, of which 16 later received hLP-MSC 
transplants into the lesion cavity at three weeks post injury, and 15 later 
received injections of medium and acted as controls. Two of the hLP-MSC 
transplanted animals were used to assess cell survival and distribution at 
different time points post-injury (10 days and 6 weeks post transplantation); 
the remaining 14 transplanted animals, and the 15 control animals were 
allowed to survive for 7 weeks post transplantation, throughout which time 
their functional abilities were investigated using various behavioural tests; at 
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the end of the study, all animals were investigated using electrophysiological 
techniques as described in chapter 2. 
 
A summary of the testing protocol timeline is given in the schematic diagram 
shown in Figure 3.2, and the number of animals used at each point are shown 
in Figure 3.3, and described in detail below. 
 
At the start of the experiment, animals were randomly assigned to one of two 
groups and each group was assigned to receive either cellular transplants or 
medium injections, to avoid bias this was performed by a member of the 
animal house staff who was blind to the experimental procedure. All 
subsequent surgeries and behavioural tests were performed with the 
researchers blind to the experimental groups, unless where practically 
impossible, for example the surgeon was able to see if cells or medium were 
being injected into the injury site. 
 
 
3.2.3 Extraction, purification and culture of hLP-MSCs 
 
3.2.3.1 Preparation of human lamina propria mesenchymal stem cells  
 
All cell culture was performed by Dr. Susan Lindsey in Professor Sue Barnett’s 
laboratory in the Beatson Institute, University of Glasgow.  
 
The cells used for transplantation came from three middle aged donors 
undergoing nasal septoplasty operations from which nasal biopsies were 
obtained with informed consent. The cells were grown in culture and 
conditioned media obtained from each of the cultures was confirmed to 
enhance myelination when assessed using the myelinating cultures (Figure. 
3.1). The cells were transduced to express green fluorescent protein (GFP) 
prior to transplantation. Similar numbers of animals were transplanted with 
cells from each of the three donors and these were matched by control 
animals which were injured in the same way but were injected with medium 
instead of cells (Figure 3.5). Here we elected to use the same media as the 
hLP-MSCs were cultured in as a control so we could attribute any differences 
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to the cells or the media provides the only way of differentiating the effects of 
the cells from that of the media they were cultured in. Whilst is may be 
advantageous to fill the injury cavity with any cell type, which could act as a 
beneficial substrate, no cell line has been sufficiently characterised as to fully 
understand its effect in the injured cord and thus make for an accurate 
control. Also, due to potential differences in cell size it would make accurate 
comparisons difficult to make as transplanted cell counts would either differ 
or fill the cavity to a greater or lesser degree. 
 
Briefly, biopsies were kept on ice in Hanks balanced salt solution (HBSS) 
containing penicillin (100 units/ml), streptomycin (100 μg/ml) and fungizone 
(Amphotericin B, 1.25 μg/ml) (all, Invitrogen, UK). After mincing with a 
scalpel the tissue was digested using 1.33 % collagenase (Sigma-Aldrich, UK) 
for 20 min followed by incubation with soya bean trypsin inhibitor and DNAse 
to reduce clumping (0.04 mg/ml bovine pancreas DNAse, 3.0 mg/ml bovine 
serum albumin-fraction A in L15; Sigma-Aldrich). Cells were mechanically 
dissociated by pipetting, then triturating through a 23G needle. The digested 
tissue was then grown in minimum essential medium alpha (MEM, Invitrogen) 
containing 10 % foetal bovine HyClone© serum (MEM: 10%) (Thermo 
Scientific, UK) and incubated at 37 °C and 7 % CO2, changing half of the 
medium every 2-3 days. After 5 days a heterogeneous monolayer of spindle 
shaped cells would develop. Purification of human MSCs was performed using 
an EasySep® Human CD271 positive selection kit (StemCell Technologies Inc, 
Grenoble, France). After purification, the cells, now termed hLP-MSCs, were 
only used up to passage 6. 
 
 
3.2.4 Contusion Injury  
 
All the contusion injuries and cell transplants in this study were carried out by 
Dr. John Riddell. 
 
The T9 spinal cord was subjected to a 150 Kdyn contusion injury using the 
same procedure as described in chapter 2. A suture was placed in the dura 
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over the injury site at a known location so that it could be identified in the 
later cell transplantation procedure, and a piece of latex was used to cover 
the exposed cord and held in place with 6-0 Vicryl (Ethicon Inc, Johnson and 
Johnson, USA), which reduced the adhesion of scar tissue to the dura, and 
aided in re-exposure of the injury site at the time of transplantation. Animals 
routinely received the same peri-operative medication as described in chapter 
2. 
 
 
3.2.5 Immunosuppression  
 
To reduce the chances of cellular transplants being immunologically rejected, 
animals received daily subcutaneous injections of cyclosporine (20 mg/kg 
subcutaneously) starting 48 hours prior to transplantation and continuing for 
the duration of the experiment. In order to ensure that any observed changes 
were solely down to the presence of transplanted hLP-MSCs, the control 
animals were also immunosupressed throughout in a similar fashion. All the 
animals used in this study were immunosupressed with daily injections of 
cyclosporine. 
 
 
3.2.6 Delayed cell transplantation  
 
Transplantation surgery was performed 3 weeks after injury to ensure that the 
protocol could be replicated using autologous transplants in humans following 
SCI. This delay also helped to minimize the chances of transplant rejection 
due to the elevated immune response that is known to occur immediately 
following injury (Dumont et al., 2001a). 
 
 
3.2.6.1 Transplantation of hLP-MSCs into the injury site  
 
In order to ascertain if hLP-MSCs transplants are able to improve function in 
the ascending dorsal column pathway we aimed to transplant cells directly 
into the lesion cavity that forms following the contusion injury. Briefly, a glass 
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micropipette with an internal tip caliber of between 40-70μm was loaded with 
cells (concentrated into a slurry containing ~100,000-200,000 cells per 
microlitre), mounted on a stereotaxtic manipulator and inserted into the 
lesion cavity through a slit in the dura to a depth of 1200μm. Between 10-50μl 
of the cell suspension was then injected, by applying brief (40ms) pressure 
pulses (Picoinjector, WPI, Srasota FL, USA), as the pipette was slowly raised to 
a depth of around 200μm or until the cells overflowed. Animals were then 
sutured and clipped closed before being allowed to recover in a warm 
environment with free access to food and water. 
 
 
3.2.6.2 Media injections into the injury site  
 
As a control for the animals which received cell transplants, a group of 
animals received injections of the same media as was used to suspend the 
cells: minimum essential medium alpha (aMEM, Invitrogen, UK) containing 10 % 
foetal bovine HyClone© serum (Thermo Scientific, UK), supplemented with 2 
mM EDTA (Sigma-Aldrich, UK). Injections were made using the same procedure 
and volumes as were used for cellular transplants. 
 
The wound was closed and analgesia, antibiotics and subcutaneous saline 
routinely administered, as described earlier. Animals were placed in a warm 
environment with free access to food and water and allowed to recuperate. 
Animals were allowed to survive for 7 weeks before electrophysiological 
assessment. 
 
 
3.2.7 Cell survival 
 
Two animals received 150 Kdyn injuries and hLP-MSC transplants at 3 weeks 
post injury and were allowed to survive for 10 days and 6 weeks each, after 
before being perfused and the injury sites removed to assess cell survival. The 
remaining 14 transplanted animals were allowed to recover for 7 weeks post-
transplantation. At the end of the study all animals were sacrificed via 
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perfusion fixation, as described in chapter 2, and the injury sites removed and 
processed with the immunohistological techniques described in detail below. 
 
 
3.2.8 Behavioural testing  
 
All 15 control animals and 14 cell transplanted animals that were due to 
undergo electrophysiological assessment were assessed using numerous 
behavioural tests, as described in detail in the next section.  
 
 
3.2.8.1 The DigiGait™ Imaging System 
Initially animals were selected for this study via a rigorous acclimatisation 
process in which animals were slowly introduced to the Digigait™ apparatus for 
2-5 minutes each day for a week. In order to test compliance, once 
acclimatised each animal was tested on the Digigait™ system pre-operatively 
and its ability or inability to run on the treadmill was noted. It was seen that 
around half of the animals tested were able to run on the Digigait™. Batches 
were then made up entirely from animals that had shown a pre-operative 
ability to run on the treadmill. 
 
All 14 animals that received hLP-MSCs transplants and all 15 animals that 
received medium injections were tested using the Digigait™ Imaging System, in 
total 8 cell-transplanted and 10 medium injected animals were able to run on 
the treadmill. 
 
Animals that could run without problem were tested with the DigiGait™ 
Imaging System (Mouse Specifics, Boston, MA, USA) on a weekly based, 
starting 1 week before injury and continued weekly for the duration of the 
experiment (Figure 3.2). The Digigait™ System utilises treadmill running and 
ventral plane videography to provide a non-invasive method for quantitatively 
and semi-autonomously comparing numerous spatial and temporal indices of 
gait dynamics and posture, including stride length, stance width, stance 
duration, braking duration, swing duration, propulsion duration, paw angle 
and stride frequency as previously described (Li et al., 2005). 
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Animals were trained to run at 22 cm/s on a transparent treadmill and 
recorded from below with an 80 Hz high speed video camera. All 14 animals 
that received hLP-MSCs transplants and all 15 animals that received medium 
injections were tested using the Digigait™ Imaging System, of these 8 cell-
transplanted and 10 medium injected animals were able to run at the desired 
speed for the duration of the study, the 10 animals which were unable to run 
at the desired speed were excluded from this part of the study. 
 
Using the DigiGait™ imaging software, sections of video in which the animal 
was moving at a relatively constant speed and in a straight line were selected 
and saved for offline analysis. The aim was to record a minimum of four 2-3 
second long clips for each animal at each time point. Animals were initially 
acclimatized on the treadmill with the motor speed set to zero. The treadmill 
was started at 12 cm/s at the start of the first testing session, and then raised 
to 22 cm/s; thereafter the treadmill was started at 22 cm/s. Previous work in 
this laboratory has shown that this method produces higher levels of 
compliance than if treadmill speed is increased incrementally. To reduce 
stress and fatigue, animals were only ever kept inside the Digigait™ machine 
for a maximum of 10 minutes in any one testing session, and if they fatigued 
before sufficient runs had been collected they were given several hours to 
recover before trying again. 
It was observed early on that most animals were unable to run sufficiently 
well on the treadmill in the first week post-injury, so it was decided to miss 
this time point so as not to stress the animals, and instead we started testing 
at two weeks post-injury. 
 
Analysis of DigiGait™ videos  
Videos were backed up and processed using the Digigait™ analysis software. 
The snout was blocked to prevent it falsely being identified as a paw. This was 
achieved by telling the software which direction the animal was running in 
and the snout blocker manually adjusted to be as small as possible whilst still 
blocking the snout to ensure that fore paw placements were not blocked. 
Colour filters were adjusted such that paw placements were detected but tail, 
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genitals and the area around the snout were not. Stance and swings were 
manually corrected if required by comparing the plotted temporal history of 
paw placements with the actual video. The software then allowed for the 
deletion of any false stances and the merging of stances on either side of any 
false swings. Once videos were manually corrected the DigiGait™ analysis 
software analysed them frame by frame and automatically calculated 
numerous different spatial and temporal indices of gait dynamics and posture 
which was output to a Microsoft Excel spreadsheet. 
 
 
3.2.8.2 BBB locomotor assessment scale  
 
In order to assess voluntary locomotor abilities, each animal was assessed 
using the standardized Basso, Beattie and Bresnahan (BBB) locomotor 
assessment scale (Basso et al., 1995), which as discussed in greater detail in 
chapter 1, provides a simple, quick, cheap and non-invasive method of 
assessing open field locomotion. The BBB test is a commonly used behavioral 
test used by researchers investigating the effects of spinal cord injury, and 
thus it provides an invaluable way for researches to understand the true 
severity of injuries performed by other researchers.  
 
Animals were placed one at a time into a shallow circular pen of ~1.5m 
diameter and allowed to locomote freely for a minimum of 3 minutes whilst 2 
assessors scored the animal’s locomotor abilities on a 21 point ordinal scale 
(Basso et al., 1995). All animals intended for electrophysiological investigation 
were assessed using the BBB scale at 5 days post-injury and then once weekly 
for the duration of the study. Animals which scored above 11 on the BBB scale 
by day 5 post-injury were considered to have not been injured properly and 
were removed from the study; fortunately, only one of the animals that 
received transplants and none of the animals in the control group fell into this 
category. If the assessor’s scores differed then extra time was allowed until a 
consensus could be reached. If an animal was scored on the border between 
two points, or if the assessors failed to reach consensus, then the lower of the 
two scores was assigned. 
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Animals were also scored using the BBB subscore (Lankhorst et al., 1999) by 
allowing them to locomote freely in the open field whilst two trained 
assessors scored them on a 7 point scale, in a similar fashion to BBB scoring. 
Again, if the animal was scored on the border between two points, or if the 
assessors failed to reach consensus, then the lower of the two scores was 
assigned. 
 
 
 
Analysis of open field locomotion 
 
 
3.2.8.3 BBB subscore  
 
To increase the accuracy of open field locomotor assessment, all animals were 
also assessed using the BBB subscore on the same days as they were tested 
using the BBB. As discussed in greater detail in chapter 1, the BBB subscore 
utilises a non-ordinal 7 point scale which requires 2 assessors to observe the 
animal freely locomoting in the same circular pen as is used for the BBB scale 
and score each animal’s locomotor abilities. The BBB subscore was designed to 
allow for a more accurate assessment of functional deficits than the BBB 
scale, especially once higher motor functions return; this greater degree of 
accuracy was achieved due to the BBB subscore scale being non-ordinal and as 
such points could be awarded for behavioural measures occurring in any order 
(Lankhorst et al., 1999). 
 
 
3.2.8.4 Sensory testing  
 
Animals were assessed for changes in sensation or the development of 
mechanical allodynia using von Frey hairs, a series of 20 monofilaments in a 
linear scale of physical force which can be used to assess changes in touch 
sensitivity in response to mechanical stimulation which have been shown to 
occur following spinal contusion injury (Hulsebosch et al., 2000).  
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Von Frey filaments are made from hygroscopic materials and their bending 
forces are significantly affected by humidity and temperature (Andrews, 
1993). Consequently, care was taken to ensure that the temperature and 
humidity levels in the testing room were maintained at a constant level, 
typically between 50-80% humidity and 20-25°C. 
Animals were assessed for increased pain sensitivity using a von Frey hair 
applied to the plantar surface of the forepaws. The testing protocol relied on 
the up and down method (Dixon, 1980) to determine the 50% withdrawal 
threshold. According to Dixon, this method requires 6 responses in the 
immediate vicinity of the 50% threshold. Response counting was 
retrospectively started from the response elicited immediately prior to 
crossing the threshold for eliciting a response.  
 
 
3.2.8.4.1 Forepaw plantar von Frey hair testing  
 
Each animal was tested using von Frey hairs applied to the plantar surface of 
each forepaw. Hindpaw testing was not performed as the relationship of this 
to pain is uncertain (Baastrup, et al., 2010). Animals were tested using the up-
down technique described by Dixon et al., 1980, by placing them one at a 
time into an enclosure with a grated floor which permitted access to the 
plantar surface of the paws and given 5-10 minutes to acclimatize to the new 
environment before testing began. In order of increasing force, different von 
Frey hairs were then applied to the plantar surface of the forepaws with 
enough force for the filament to bend slightly. Each filament was held in this 
position for 2 seconds or until the animal initiated an avoidance response. If 
no response was observed after 2 seconds the filament was removed and the 
animal was given 3 minutes recovery time before the filament with next 
higher force was applied similarly, this process was repeated until a response 
was initiated. Avoidance responses were usually restricted to the animal 
lifting and repositioning the paw being tested, however on occasion animals 
were observed vocalizing, trying to bite or jumping away from the filament.  
Animals were tested once pre-operatively and once again at 10 weeks post-
injury. The levels of mechanical sensitivity were quantified using the up and 
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down method of Dixon et al., 1980 to determine the 50% withdrawal 
threshold. All tests were performed by an experimenter who was blind to each 
animal’s condition, in order to avoid conscious or unconscious bias which may 
have invalidated the results. 
 
3.2.8.4.2 Girdle von Frey hair testing  
 
To assess the development of at level pain in response to mechanical 
stimulation, each animal was tested using von Frey hairs applied to the girdle 
at 2cm caudal and 2cm lateral to the injury site, bilaterally. To aid in the 
location of these sites the animals were marked using permanent marker at 
the time of injury, the marks were checked weekly throughout the experiment 
and reapplied if they began to fade. Animals were placed one at a time into a 
normal cage without any bedding or lid and given 5-10 minutes to acclimatize 
to the new environment before testing began. A single von Frey filament of 
(2.44g force) was applied to each location and held against the skin so that 
the filament bent. This was held in place for 2-3 seconds or until it evoked an 
avoidance response. This was repeated 10 times in each location, giving the 
animal at least 30 seconds to recover in between, and the number of 
avoidance responses recorded in each location was averaged. Avoidance 
responses were varied and included head turning, biting, running away or 
jumping. Care was taken to not confuse normal movement, such as relocating 
within the pen, with an avoidance response, if such movements were observed 
then the animal was given 3 minutes to recover before testing was resumed. 
 
Analysis of girdle von Frey test  
Animals were tested by applying a 2.44 g forced von Frey filament at 2 
locations on each animal’s girdle, set at 2 cm below and 2 cm lateral to 
midline, bilaterally. The filament was applied with enough force to slightly 
bend it, this was performed ten times on each side and one point was awarded 
for each avoidance response observed, as discussed in detail earlier. The 
scores from each side were then averaged and graphed, as shown below. 
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3.2.8.4.3 Dynamic weight bearing test  
 
Animals were assessed for the development of allodynia using a newly 
developed dynamic weight bearing (DWB) device (Bioseb, Boulogne, France), 
capable of assessing postural equilibrium in animals in the open field.  
 
Animals were placed one at a time into a Plexiglass enclosure measuring 22 x 
22 x 30 cm with a floor sensor consisting of an array of 1936 captors arranged 
in a 44 x 44 grid (10.89 mm2 per captor), and allowed to locomote freely for 4 
minutes whilst the weights borne by each limb in each paw placement were 
recorded and stored for offline analysis (Figure 3.5A). Testing sessions were 
also videoed from the lateral plane to allow the raw data from each paw 
placement to be synchronised with the video using Bioseb’s DWB v1.3 software 
to aid in offline analysis (Figure 3.5B). Recorded paw placements were 
considered valid when >4 g was detected on a single captor, with a minimum 
of 2 adjacent captors detecting >1 g.  When these parameters were detected 
and weight distribution was stable for more than 0.5 s, the validated paw 
placements were assigned as either left or right hind paw or fore paw by a 
trained assessor after reviewing the video and a scaled map of the activated 
captors. Mean values for the weights borne by each limb were calculated by 
dividing the average weight borne by each limb by the average length of time 
of each limbs validated paw placements.  
 
In preliminary tests performed in our laboratory by Dr. Ahmed Emraja, it was 
discovered that in normal animals, during periods when all four paws are in 
contact with the floor, animals consistently bear significantly more weight on 
their hind paws than their forepaws (Figure 3.5C). Sham surgery at the T9 
level had no effect on this (Figure 3.5D), but following a contusion injury at 
the T9 level there was a redistribution of weight such that some of the weight 
normally borne by the hindpaws is shifted to the forepaws (Figure 3.5E). There 
was no spontaneous recovery of this for at least 6 weeks after the injury 
(Figures 3.5F-G), making this an ideal assessment of posture on which to test 
therapies for SCI. 
 
168 
 
The DWB test was performed on all the animals tested prior to injury in order 
to create a set of baseline data for comparison. Each of the 15 medium 
injected control animals and the 13 hLP-MSC transplanted animals (that 
achieved normal BBB scores at 5 days post injury) were tested again at 10 
weeks post-injury. 
 
Analysis of dynamic weight bearing test  
As discussed earlier, each animal was placed in the DWB enclosure and 
allowed to locomote freely for 4 minutes as the software automatically 
recorded the timing and weight borne by each paw placement. Each video was 
reviewed alongside the recordings made by the pressure transducers and each 
paw placement was manually validated. The mean values for the weights 
borne by each limb were calculated by dividing the average weight borne by 
each limb by the average length of time of each limbs validated paw 
placements and expressed as a percentage of each animal’s body weight. 
 
 
 
 
3.2.9 Electrophysiology  
 
3.2.9.1 Anaesthesia  
 
All animals were anaesthetised as described in Chapter 2 during the 
preparatory surgery and electrophysiological assessment. 
 
 
3.2.9.2 Preparatory surgery  
 
All preparatory surgery and the protocols for electrophysiological assessment 
were exactly the same as described in Chapter 2, (including the use of CDPs to 
monitor function in the sciatic nerve and dorsal columns below the injury 
level). 
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3.2.9.3 Recordings of sensory evoked potentials  
 
To assess function in the ascending dorsal column pathways of the spinal cord 
and the effect of hLP-MSC transplants, SEPs evoked by electrical stimulation 
of the radial and sciatic nerve were recorded from the contralateral 
sensorimotor cortex. Recordings of SEPs were made whilst stimulating the 
radial and sciatic nerve with supramaximal stimulus intensity. Stimulating and 
recording protocols were the same as described in Chapter 2. Whilst recording 
SEPs, great care was taken to remove fluid from the surface of the cortex to 
avoid inaccuracy of recordings. 
 
Recordings of electrical potentials were digitised (Cambridge Electronic Design 
1401+ interface, Cambridge, UK) and stored on a computer at a sampling rate 
of 20 kHz, without filtering. Averaging and measurements of the amplitudes 
and latencies of electrical potentials were performed using Signal software 
(Cambridge Electronic Design, Cambridge, UK). 
 
 
3.2.9.4 Perfusion fixation  
 
All animals were transcardically perfused at the end of their 
electrophysiological assessment so that the injury site could be preserved and 
removed for histological processing, as described in Chapter 2. 
 
 
3.2.10 Histological processing  
 
3.2.10.1 Histological processing of spinal cord for contusion site and cell 
distribution  
 
Approximately 3 cm of spinal cord centered on the middle of the injury site 
was dissected out of each animal and cut in to three 8mm blocks, one 
centered on the middle of the injury site and one each from immediately 
rostral and immediately caudal to the injury block. Most animals had their 
cords cut in the parasaggital plane to preserve information about the 
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distribution of hLP-MSCs in the rostro-caudal axis. When cut parasaggitally, 
rostro-ventral and caudo-ventral notches were made on the rostral and caudal 
blocks, respectively, and either a rostro-ventral or caudo-ventral notch was 
made on each of the injury blocks, favoring the end that seemed firmest. 
Some animals were cut in the transverse plane, for which no notch was made 
so that the injury site could be optimally preserved. Blocks were cut into 60 
μm sections at -20oC using a Leica CM1850 cryostat (Leica Microsystems GmbH, 
Wetzlar, Germany). Sometimes, where the injury was extensive, it was 
difficult to cut whole sections or the sections fell apart after cutting, this was 
particularly problematic, especially in transverse sections, and precluded the 
quantification of lesion cavity volume. Sections were washed in 0.3M 
phosphate buffered saline (PBS double salt), and then incubated for 30 min in 
50% ethanol.  After washing three times for 10 minutes each in PBS, sections 
were treated with fluorescence histochemistry techniques. 
 
Sections were incubated in combinations of anti-NF200 (1:1000, Sigma), anti-
GFAP (1:1000, Dako), anti-P0 (1:100, Santa Cruz), anti-laminin (1:100, Sigma) 
and anti-GFP (1:1000, Serotec) primary antibodies at 4oC for 72hrs, which 
were used to label the axons, reactive astrocytes, peripheral type myelin, the 
basement membrane of the basal lamina and green fluorescent protein, 
respectively.  Sections were then washed in PBSD and incubated in secondary 
antibodies, raised in the appropriate species, conjugated to appropriate 
fluorophores (Alexa 488 1:500, Rhodamine 1:100 and DL649 1:500; Jackson 
Immunoresearch, USA) for 3-4 hours at room temperature or overnight at 4oC. 
All sections were then washed in PBS three times for 10 minutes each, 
mounted on plane glass slides in anti-fade mounting medium (Vectashield: 
Vector Laboratories, UK), before being coverslipped and the edges of the 
coverslip sealed with nailvarnish and stored at -20oC in darkness.  
 
 
3.2.11 Microscopy 
3.2.11.1 Verification of contusion injury 
Phase contrast light microscopy was used to view sections containing the 
lesion cavity in order to determine the perimeter of the cavity and the 
relationship to the boundary between grey and white matter.  Epifluorescence 
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microscopy was also used to observe NF200, GFAP, P0, laminin and GFP 
immunolabelling in the sections. 
 
 
3.2.11.2 Distribution of hLP-MSCs  
Sections taken from animals that had received hLPs-MSC transplants were 
examined with epifluorescence microscopy (Nikon Eclipse E600) in order to 
confirm transplanted cell survival and to document their distribution. Two 
animals were used to assess cell survival in injured animals at 10 days and 6 
weeks following injury. Confocal microscopy was used to illustrate the 
distribution of the transplanted hLP-MSCs, see below. 
 
 
3.2.12 Off-line analysis of SEPs  
 
As described in Chapter 2, averaged SEP records were created from which 
measurements were taken offline using Signal software (Cambridge Electronic 
Design, Cambridge, UK). Data were collated in Microsoft Excel spreadsheets 
and imported to Prism 4 software (GraphPad Software Inc, USA) for graphing. 
Data from the SEP maps were collected in Microsoft Excel spreadsheets and 
imported to 3D Field software (Version 3.0.9.0, Copyright 1998–2007, Vladimir 
Galouchko, Russia) to create isopotential contour plots of the cortical areas in 
which SEPs were recorded. Contour measurements were made in the 3D field 
software and the data were averaged and imported to Prism 4 software for 
graphing. 
 
 
3.2.12.1 Conduction latency of SEPs in the dorsal column-medial lemniscus 
pathway  
 
SEP traces were analysed in order to calculate the conduction latencies in the 
dorsal column-medial lemniscus pathway. This was performed in 13 hLP-MSC 
transplanted and 15 medium injected control animals by measuring the time 
delay between stimulus application and the arrival of potentials in the cortex 
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using Signal software (Cambridge Electronic Design, Cambridge, UK). Latencies 
were normalised with respect to the different conduction distances by 
measuring each animal’s conduction distance and correcting conduction 
latencies by the percentage difference between the conduction distance 
recorded in each animal and the maximum conduction distance recorded in 
any animal. 
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3.3 Results  
 
3.3.1 Assessment of long tract function after contusion injury with delayed 
hLP-MSC transplants  
 
In order to assess the effects of delayed hLP-MSC transplants on long tract 
function, 14 animals received 150 kdyn contusion injuries at T9; three weeks 
later they received injections of GFP labeled hLP-MSCs directly into the injury 
epicenter. Each animal’s functional capabilities were monitored by 
behavioural testing and long tract function was assessed directly using an 
electrophysiological approach, as described below. 
 
For comparison 15 animals received similar injections of medium and were 
assessed thereafter by researchers blind to their experimental group. 
 
GFP labeling allowed the transplanted cells to be easily identified in the 
histological analysis detailed below. 
 
 
3.3.2 Comparison of body weights and injury severities 
 
To ensure that any differences we observed in the electrophysiological 
recordings were solely due to the presence or absence of hLP-MSCs, it was 
necessary to limit the variable parameters in each experiment. Firstly, 
animals were randomly assigned to experimental groups by a member of the 
animal house staff blind to the experimental protocol. For this same reason it 
was necessary to ensure that the animals from different experimental groups 
received injuries of as similar a severity as possible. Contusion injuries of 
similar force will produce varied injury severities when applied to spinal cords 
of different sizes due to the impactor tips ability to damage a greater or lesser 
proportion of the cord depending on its size. It was therefore necessary to 
select animals for injury that were of a similar body weight and would 
therefore have similar sized spinal columns. To ensure this was strictly 
adhered to, each animal’s weight at the time of injury and the injury 
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parameters provided by the Infinite Horizons software were recorded and 
graphed for comparison, so that any anomalous animals could be considered 
for exclusion. 
 
As shown in Figure 3.6, individuals included in the both experimental groups 
had similar body weights throughout the study. Whilst body weight did 
increase through the 10 weeks of testing, animals from both the medium 
injected and hLP-MSC transplanted groups were of a similar weight at the time 
of contusion injury surgery, medium injection/cell transplantation surgery and 
terminal electrophysiology. We can therefore be sure that the animal’s cords 
were damaged in as equally a proportional manner as possible, that each 
transplant or injection was made into as similar an injury site as possible and 
that the electrophysiological data was obtained in as similarly sized animals as 
possible.  
 
The Infinite Horizons Impactor is able to record the actual force pushing back 
against the impactor tip and the displacement of the cord; these data can be 
used to ensure that all the animals received as similar an injury as possible. 
Figures 3.7A-B show that the animals from each group received injuries of 
similar force and cord displacements. 
 
By monitoring and where possible reducing variables such as these as much as 
is feasibly possible, we can increase confidence that any changes seen 
between the groups result from the hLP-MSCs vs. control differences. 
 
 
3.3.3 Behavioural testing  
 
3.3.3.1 Assessment of function using Digigait™  
 
Animals were tested using the Digigait™ system at weekly intervals from pre-
injury to 9 weeks post-injury. In total 9 of the 14 animals that received hLP-
MSCs transplants and 10 of the 15 animals that received medium injections 
were able to run on the Digigait™ treadmill throughout the testing period, and 
so were included in this part of the study – the animals that were either 
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unable or stopped running were kept for BBB testing, BBB subscore testing, 
DWB testing, sensory testing, electrophysiological testing and histological 
investigation.  
 
Whilst many of the gait indices recorded by the Digigait™ Imaging System 
showed no differences between the groups, there were three which did 
appear to display differences between hLP-MSC transplanted and medium 
injected groups: 
 
Gait symmetry 
Figure 3.8A shows the observed changes in gait symmetry; that is, a ratio of 
the frequency of forelimb steps divided by the frequency of hindlimb steps. In 
normal animals, because forelimb and hindlimb stepping is fully coordinated 
i.e. the frequency of forelimb and hindlimb stepping is the same, this ratio is 
one. After injury there is a loss of this coordination reflected in an increase in 
this ratio. This loss of forelimb-hindlimb co-ordination is seen in both the 
transplanted and medium injected animals since both received the same 
injury. Both groups of animals also show a recovery of this co-ordination with 
time after injury. That is to say, the ratio of forelimb to hindlimb steps 
returns towards one. It can be seen in Figure 3.8A that the recovery of gait 
symmetry in the hLP-MSC transplanted animals occurs faster and at the end of 
the experiment is slightly more complete than that seen in the medium 
injected animals. This suggests that hLP-MSCs helped enhance the recovery of 
gait symmetry. Figure 3.8B shows the absolute gait symmetry values obtained 
in normal animals and animals from both experimental groups at the time 
points which appeared to have the greatest difference, namely 7, 8 and 9 
weeks post injury. A two way ANOVA test was performed on these data, 
revealing that there is no statistically significant difference between the 
groups at any of the time points investigated (P>0.05). The size of the 
standard error bars in Figure 3.8B indicates that the variation seen within 
each group was high enough to prevent the observed trend for hLP-MSC 
transplanted animals to recover gait symmetry faster, from being significantly 
different. 
 
Stride Frequency 
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Using the Digigait™ system it was possible to record changes in stride 
frequency, a measure of the average number of forelimb or hindlimb steps 
taken per second, in medium injected and hLP-MSC transplanted animals from 
pre-injury to 9 weeks post-injury (Figure 3.9A); this provides an interesting 
insight into the mechanisms underlying recovery of co-ordinated stepping. It 
might be expected that the loss of co-ordination following a T9 contusion 
injury would be because the hindlimbs slow down after injury; however, the 
data in Figure 3.9A show that this is not the case. Surprisingly, the loss of gait 
symmetry shown in Figure 3.8A-B is actually explained by the forelimbs 
increasing their stepping frequency after injury, while that of the hindlimbs 
initially changes very little (Figure 3.9A). This is confirmed in Figure 3.9B 
which shows the difference in forelimb-hindlimb stride frequency recorded in 
normal animals and animals from both experimental groups at the time points 
which appeared to have the greatest difference, namely 7, 8 and 9 weeks post 
injury. It can be seen that the injury initially caused the difference between 
forelimb and hindlimb stepping frequency to increase, though by 7-9 weeks the 
difference in stride frequency can be seen to be recovering in hLP-MSC 
transplanted animals faster than in medium injected animals. Figure 3.9A 
shows that from around 2 weeks following injury, the forelimbs begin to slow a 
little and the hindlimbs speed up a little. Thus, a more similar stride frequency 
i.e. closer co-ordination of forelimb and hindlimb stride frequency is achieved 
by adaptations of both the forelimbs and hindlimbs to a new common stride 
frequency rather than by normalisation of the stride frequency to that before 
the injury; thus it can be seen that animals employ compensatory mechanisms 
which, combined with limited functional recovery act to return stride 
frequency towards normal levels. Two way ANOVA tests were performed on 
these data, revealing that although there is a trend, no statistically significant 
difference exists between the forelimb and hindlimb data from each of the 
groups at any of the time points investigated (P>0.05). 
 
Alternate stepping 
The coordination of all four limbs is important in quadrupeds and can be used 
to measure function in the spinal cord. In normal animals the predominant 
pattern of stepping is an alternate pattern which follows the sequence 
illustrated in Figure 3.10Bi of left HL followed by left FL followed by right HL 
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followed by right FL and so on. Before injury this sequence occurs for about 
90% of the steps. However, after injury this sequence is known to break down 
and becomes uncoordinated, instead following one of several non-alternate 
step sequence patterns such as the example shown in Figure 3.10Bii. Animals 
stepping sequence patterns were recorded by Digigait™; Figure 3.10Biii shows 
a representative example of a partially coordinated animal as shown in the 
Digigait™ software.  
 
Figure 3.10A shows the step sequence data recorded in transplanted vs. 
control animals as a % of normal alternative stepping sequence. It can be seen 
that a greater recovery of co-ordinated stepping occurs in transplanted 
compared to medium injected animals. Whilst the % alternate steps do not 
recover fully in either group, the transplanted animals tend to show some 
improvement which is not matched by the control animals (Figure 3.10A). 
Despite this trend, a two way ANOVA test performed on these data revealed no 
statistically significant difference between the groups at any of the time 
points investigated (P>0.05). 
 
 
3.3.3.2 Assessment of locomotor function using the BBB locomotor 
assessment scale and the BBB subscore  
 
As discussed earlier, locomotion in the open field can be assessed by two 
trained testers observing each animal as it was allowed to freely locomote in a 
shallow pen for 4 minutes. Each animal is then scored out of 21 on the BBB 
locomotor assessment scale and out of 7 for the BBB subscore using the 
respective scoring scales. 
 
In total, 13 animals which received hLP-MSC transplants and 15 medium 
injected animals were assessed using the BBB locomotor assessment scale and 
the BBB subscore. The time course of recovery of locomotion in hLP-MSC 
transplanted and medium injected groups, as measured by the BBB locomotor 
assessment scale and BBB subscores, is shown in the graphs shown in Figures 
3.10 A-B. It can be seen that the contusion procedure resulted in substantial 
reductions in the BBB and BBB sub-scores assigned to both cell-transplanted 
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and medium injected animals by 5 days post-operatively. However, both 
experimental groups were then seen to begin to recover their locomotor 
abilities at similar rates, though whilst substantial recovery was observed, the 
locomotor abilities of both the hLP-MSC transplanted and the medium injected 
groups were seen to plateau without returning to pre-operative levels. Two-
way ANOVA statistical tests were performed to ascertain if there were any 
significant differences between the data obtained from each group at each 
time point; it was seen that there were no significant differences observed 
between groups at any of the experimental time points for the duration of the 
study, as measured via both tests (Figure 3.11A-B).  
 
 
3.3.4 Sensory testing 
 
3.3.4.1 Forepaw plantar von Frey testing 
 
The 50% withdrawal thresholds of the forepaws were determined using the up 
and down method described by Dixon, 1980, as described earlier. Results 
obtained in normal uninjured animals were compared with those obtained in 
injured animals that had received either medium injections or hLP-MSC 
transplants. As shown in Figure 3.12, after performing one-way ANOVA with 
Tukey’s post-hoc analysis, it was seen that the force required to cross the 50% 
withdrawal thresholds of uninjured animals was significantly higher than 
either the medium injected or cell transplanted groups. Although no 
significant difference was observed, a trend can be seen in which medium 
injected animals tend to have a lower 50% withdrawal threshold than cell 
transplanted animals, suggesting that hLP-MSC transplants might play a role in 
reducing forepaw sensitivity up to 7 weeks post-transplantation (Figure 3.12). 
 
 
3.3.4.2 Girdle von Frey testing 
 
To assess the development of tactile allodynia in response to mechanical 
stimulation, a single calibrated von Frey filament (2.44 hair / 0.04 g) was 
applied to two regions located on each animal’s back, at 2 cm lateral and 2 
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cm caudal to the injury level, bilaterally, as described earlier and shown in 
Figure 3.13A.  
 
Previous work performed in this laboratory by Dr. Ahmed Emraja using T9 
contusion injuries of 200 Kdyn force showed that injury can lead to an 
increased number of avoidance responses to girdle von Frey stimuli for up to 6 
weeks following injury, whilst sham operations produced no such increases to 
pain sensitivity (Figure 3.13B). It is therefore not unreasonable to assume that 
contusion injuries of 150 Kdyn force should evoke increases in tactile allodynia 
recorded across the girdle.  
 
In order to assess if the application of hLP-MSCs had any effect on tactile 
allodynia, the number of avoidance responses that girdle von Frey testing 
produced in uninjured animals was compared with that produced in the same 
animals after they had received 150 Kdyn contusion injuries at T9, followed by 
either medium injections (n=15) or hLP-MSC transplants (n=14) at 3, 4, 8 and 
10 weeks post-injury. As shown in Figure 3.13C, when compared to the 
number of responses made by animals preoperatively, the number of 
avoidance responses produced in uninjured animals was significantly increased 
in both medium injected and cell transplanted groups by 3 weeks post 
operatively (one way ANOVA – Tukey’s post-hoc test). At every post-operative 
time point tested, no significant difference in the number of avoidance 
responses was observed between medium injected and cell transplanted 
groups (2 way ANOVA, P>0.05), though a trend was seen for reduced pain 
sensitivity in the cell transplanted group (Figure 3.13C).  
 
 
3.3.5 Dynamic weight bearing testing  
 
Each animal was therefore assessed using the DWB apparatus as described 
previously. As mentioned previously, normal baseline data was obtained from 
all the animals prior to injury (n=29), which showed that in normal animals 
approximately 35% and 65% of their total body weight is placed on the 
forepaws and hindpaws, respectively, as shown by the dashed red line on the 
graphs in Figure 3.14. 
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By 7 weeks following either hLP-MSC transplantation or medium injection, 
animals from both medium control (n=15) and cell transplanted (n=14) groups 
were tested again, revealing a clear trend whereby the percentage of total 
body weight placed on the forepaws had increased to around 40% and the 
total body weight placed on the hindpaws had decreased to around 60% 
(Figure 3.14). A student’s T-test was performed on the data, which revealed 
that there was no significant difference between the % body weights placed on 
either the fore paws or hind paws of the medium injected vs. hLP-MSC 
transplanted groups. This could result from a number of mechanisms, 
including the development of allodynia in the hind paws which causes animals 
to transfer a greater proportion of their weight to the fore paws; 
alternatively, this may result from a compensatory mechanism adopted by the 
animals to compensate for the deficits caused by the injury. 
 
 
3.3.6 Electrophysiological assessment of long tract function in hLP-MSC 
transplanted SCI animals 
 
In order to assess the effects of hLP-MSC transplants on function in the 
ascending dorsal column white matter pathways following SCI, groups of hLP-
MSC transplanted (n=14) and control animals (n=15) were investigated using 
the electrophysiological approach described earlier. 
 
As described in greater detail below, SEPs evoked by stimulating ipsilateral 
radial and sciatic nerves were recorded from the contralateral somatosensory 
cortex at ten weeks post-injury in animals receiving either 3 weeks delayed 
hLP-MSC transplants or for comparison, similar injections of medium. 
 
 
hLP-MSC transplants and their effects on SEPs 
As before, SEPs were recorded in order to quantify any differences that may 
exist between the groups. Maximum SEP amplitudes, the cortical areas from 
SEPs could be recorded and the latency to SEP onset, were recorded in each 
animal as discussed below. 
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Maximum SEP amplitudes 
Maximum radial and sciatic SEPs were measured in each animal, as described 
earlier. Whilst radial SEP amplitudes were kept as absolute values, sciatic SEP 
amplitudes were normalised by expressing each as 15% of the maximal radial 
SEP amplitude recorded in the same animal; the results are shown in Figures 
3.14 A-B. A student’s T-test was performed on the data, revealing no 
significant difference between the maximum amplitude radial or sciatic SEPs 
recorded in each of the groups (Figures 3.14 A-B).  
 
SEP isopotential areas 
Maximal radial and sciatic SEP amplitudes were measured in each animal and 
normalised to 80% and 15% respectively, of the maximal radial SEP amplitude 
recorded in the same animal. These data were used to construct isopotential 
contour plots which delineate the area of cortex from which radial and sciatic 
SEPs could be recorded which were ≥80% or ≥15%, respectively of the largest 
radial SEP amplitude recorded in each animal; the results are shown in Figures 
3.15 A-B. A student’s T-test was performed on the data, again revealing no 
significant difference between the groups (Figures 3.16A-B). 
 
Latency to SEP onset 
Latencies to radial and sciatic SEP onset were recorded from individual 
animals in each group and normalised to account for the different conduction 
distances as described earlier; the results are shown in Figures 3.17A-B. A 
student’s T-test was performed on the data, which again revealed no 
significant difference between the groups (Figure 3.17B).  
 
Together these data reveal that hLP-MSCs appear to have no significant effect 
on long tract function, following 150 Kdyn contusion injury at T9. 
  
 
3.3.6.1 The effects of hLP-MSCs transplants on the cortical locations from 
which SEPs could be recorded 
 
Medium injected control group 
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Peripheral nerve-evoked SEP recordings were made in 15 medium injected 
control animals at 10 weeks post-injury. In each animal, clear surface 
potentials were evoked by stimulation of both the radial and sciatic nerves. 
SEP amplitudes were normalised by expressing the radial and sciatic SEP 
amplitudes recorded at each location as 80% and 15% respectively, of the 
maximum radial amplitude recorded in each individual. Normalised radial SEPs 
from each animal were relatively consistent and could be recorded from 
Bregma 0 mm to -2 mm at 4 mm lateral to Bregma (Figure 3.18A), and 
normalised sciatic SEPs could be recorded from Bregma 0 mm to -3 mm from 
2-4 mm lateral to Bregma (Figure 3.18B). Normalised radial and sciatic SEP 
amplitudes from all animals were then averaged and plotted as isopotential 
contour lines which encompass the area of cortex within which SEP amplitudes 
were 80% and 15%, respectively, of the averaged maximal radial SEP 
amplitude. As shown in Figure 3.19A, this revealed that the centre of focus for 
averaged radial SEPs was located from Bregma -1 mm to -2 mm at 4 mm 
lateral to Bregma, and the centre of focus for sciatic SEPs was located around 
Bregma -1 to -2 mm rostrocaudally at 2-4 mm lateral to Bregma (Figure 
3.19B). 
 
The centres of focus seen here are the same as were recorded in normal 
animals in chapter 2 (eg. Figures 2.17 A-B and Figures 2.18 A-B), which 
indicates that medium injections have no effect on the cortical locations from 
which SEPs can be recorded. 
 
hLP-MSC injected group 
Peripheral nerve-evoked SEP recordings were made in 14 hLP-MSC 
transplanted animals at 10 weeks post-injury. In each animal, clear surface 
potentials were evoked by stimulation of both the radial and sciatic nerves; 
amplitudes were normalised as before. Normalised radial SEPs from each 
animal were relatively consistent and could be recorded from Bregma 0 mm to 
-2 mm at 4 mm lateral to Bregma (Figure 3.18C), and normalised sciatic SEPs 
could be recorded from Bregma 0 mm to -3 mm from 2-4 mm lateral to 
Bregma (Figure 3.18D). Normalised radial and sciatic SEP amplitudes from all 
animals were then averaged and plotted as isopotential contour lines, as 
described earlier. As shown in Figure 3.19A, this revealed that the centre of 
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focus for averaged radial SEPs was the same as was seen in the control group, 
located from Bregma -1 mm to -2 mm at 4 mm lateral to Bregma. The centre 
of focus for sciatic SEPs was also the same as was seen in the control group, 
located around Bregma -1 to -2 mm rostrocaudally at 2-4 mm lateral to 
Bregma (Figure 3.19B). 
 
Together these results indicate that hLP-MSCs have no significant effect on 
the cortical locations from which SEPs can be recorded. 
 
 
3.3.7 Histology 
 
Survival of transplanted cells 
Sections of spinal cord from the injury sites of all animals were processed for 
anatomical observations. Sections from all transplanted animals were 
inspected for the presence of GFP labeled transplanted hLP-MSCs. Figure 3.20A 
shows an example of a transplant site from an animal used in a pilot study 
which shows many surviving cells 10 days after transplantation into a T9 150 
Kdyn contusion injury. Figure 3.20B shows an equivalent section from one of 
the animals from the main study perfused 7 weeks after transplantation which 
has fewer labeled cells. Both of these animals received daily injections of 
Cyclosporin which was essential for survival of the cells. Evidence of labeled 
cells was observed in all 13 of the transplanted animals used in the main study 
but in some animals the numbers of surviving cells were low and in all animals 
the numbers of cells were less than are typically seen in our experience when 
performing syngeneic transplants of primary cells such as OECs or Schwann 
cells. For comparison, Figure 3.20C shows GFP labeled OECs 4 weeks after 
being transplanted into a cervical contusion injury. This syngeneic transplant 
(F344 donor and recipient animals) did not require Cyclosporin treatment.  
 
Injury cavities 
Sections from the injury site were investigated to determine the degree to 
which transplanted cells and/or extracellular matrix had filled the cavities 
that typically form in the weeks following injury. The injury sites were 
classified as completely filled, partially filled or cavitated (Figures 3.21A-C). 
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The frequency with which injury sites of these types were observed in the 
transplanted and medium control groups is shown in Table 3.1. In more than 
half the transplanted animals (8 of 14) the injury site was completely filled 
with cells or extracellular matrix rich in laminin, whereas only 3 of the 15 
medium injected animals had injury sites completely filled with matrix. 
Concomitantly, the non-transplanted group showed a higher proportion of 
partially matrix filled or cavitated injury sites. 
 
 
Assessment of myelination  
The standard method of assessing demyelination and remyelination is to use 
electron microscopy to assess the axonal diameter to myelin thickness ratio, 
known as the G-ratio. Remyelinated axons have smaller G-ratios than normally 
myelinated cells, which in the absence of a remyelination specific antibody is 
the only way of differentiating remyelinated cells from cells that survived the 
injury with their myelin sheath intact. 
 
As we prioritised investigating the fate of transplanted cells, the opportunity 
for investigating myelination using an anatomical approach was limited due to 
the limited tissue and fact that we could not use the same tissue for both 
immunohistochemistry and electron microscopy due to the need for different 
perfusion and tissue processing protocols.  
 
Sections from both medium injected and transplanted animals were processed 
using antibodies for axons (neurofilament) and a constituent of peripheral type 
myelin (P0). P0 immunolabelling was seen in both medium injected and 
transplanted animals (see Figures 3.22A-B), but preliminary analysis suggested 
that there was a wider distribution of P0 in transplanted animals and that this 
was specifically in areas where transplanted cells were located. P0 
immunolabelling frequently showed a close association with neurofilament 
labelled nerve fibres and was present both within and out with the 
transplanted injury site (Figure 3.22C). The labelling within the injury site 
most likely represents myelination of regenerating nerve fibres while that out 
with might reflect remyelination of spared fibres.   
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Figure 3.1 hLP-MSCs enhance oligodendrocyte myelination in dissociated 
spinal cord cultures. The rational for using hLP-MSCs came from preliminary 
in vitro myelination studies. A) Spontaneous oligodendrocyte myelination was 
observed in dissociated spinal cord culture. B) The presence of hLP-MSC 
conditioned media enhances the degree of oligodendrocyte myelination. C) 
The presence of hBM-MSC conditioned media reduces the degree of 
oligodendrocyte myelination. D) Quantitative analysis reveals that when 
compared to control cultures (n=9), hLP-MSC conditioned media (n=5) 
promotes a highly significant increase in oligodendrocyte myelination, 
whereas hBM-MSC conditioned media (n=9) produces a highly significant 
reduction in the amount of oligodendrocyte myelination (Error bars = SEM). 
PLP = Myelin proteolipid protein – marker for oligodendrocyte myelin, SMI-31 
= Neurofilament protein – marker for axons and dendrites; **p<0.01; 
***p<0.001; one-way ANOVA Tukey’s test. Scale bar = 100 μm. (Adapted from 
Lindsay et al., 2013). 
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 Figure 3.2 Experimental design - Schematic diagram summarizing the 
experimental design. 
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Figure 3.3 Flow diagram of animal use- Flow diagram detailing the n 
numbers used at each point in the experimental design. 
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Figure 3.4 Source of transplanted hLP-MSCs and myelination in culture 
promoted by conditioned medium. Right: hLP-MSCs were obtained from three 
individuals; after culturing, cells from each individual were transplanted into 
several injured rats with similar numbers of rats concommittantly receiving 
injections of unconditioned media. Left: Conditioned medium taken from the 
cells from each donor promoted myelination in culture. (Unpublished work 
performed by Dr. Susan Lindsay). 
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Figure 3.5 - Dynamic Weight Bearing (DWB) test. A) DWB apparatus and B) 
DWB software analysis of paw pressures. C) In Naïve animals more weight is 
distributed to the hindpaws than the forepaws. D) After sham surgery there 
is no change in the distribution of body weight. E) T9 150 Kdyn contusions 
lead to a redistribution of body weight from the hindpaws to the forepaws. F) 
There is no change in this redistribution at up to 6 weeks post-operatively 
(All = SEM; FPBL = Forepaw Baseline; HPBL = Hindpaw Baseline; unpublished 
observations by Dr. Ahmed Enraja, 2013). 
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Figure 3.6 Individual body weights at different points throughout the 
study. The body weights of individual animals in both the medium injected 
control group and the hLP-MSC transplanted group were recorded at the time 
of contusion surgery, media injection/cell transplantation surgery and 
terminal electrophysiological surgery. Student’s T-test’s were performed on 
data sets from each time point, revealing no significant differences between 
the groups at any of the time points (all p>0.05; Bars = means). 
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Figure 3.7 Contusion injury impact force and tissue displacement. Both 
experimental groups received similar contusion injuries. All animals received 
similar force injuries resulting in similar degrees of tissue displacement. 
Student’s T-test’s revealed no significant differences between injury force or 
displacement between the groups (all p>0.05; Bars = means). 
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Figure 3.8 Gait symmetry. Digigait™ data revealed a trend for earlier 
recovery of gait symmetry in hLP-MSC transplanted animals compared to 
control animals. A) Gait symmetry ratio of FL-HL steps in hLP-MSC 
transplanted and medium injected groups over time. B) Gait symmetry 
absolute values at pre-injury and three of the most chronic post-injury time 
points studied (Error bars = SEM; hLP-MSC group – N=9 / Medium group – N=10. 
All = 2 way ANOVA, P>0.05). 
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Figure 3.9 Stride Frequency. Digigait™ data revealed a trend for earlier 
recovery of stride frequency in hLP-MSC transplanted animals compared to 
control animals. A) Stride frequency in hLP-MSC transplanted and medium 
injected groups over time. B) Differences in stride frequency absolute values 
at pre-injury and three of the most chronic post-injury time points studied 
(Error bars = SEM; hLP-MSC group – N=9 / Medium group – N=10. All = 2 way 
ANOVA, P>0.05). 
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Figure 3.10 Alternate stepping. Digigait™ revealed a trend for earlier 
recovery in hLP-MSC transplanted animals compared to control animals. A) % 
alternate stepping over time B) Digigait™ method of recording alternate 
steps, with i) Showing normal alternate stepping sequence, ii) showing 
dyscoordination and iii) Schematic diagram showing Digigait™ method of 
recording step sequence. (L = left, R = right, F = forelimb, H = Hindlimb). hLP-
MSC group – N=9 / Medium group – N=10. All = 2 way ANOVA, P>0.05. 
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Figure 3.11 Assessment of locomotor abilities in the open field. A) The BBB locomotor assessment scale and B) The BBB subscore 
were used to assess locomotor abilities in hLP-MSC transplanted and medium injected animals, at 5 days post-operatively and then 
once weekly for the duration of the study (both = 2 way ANOVA, P>0.05. Plotted as the median and interquartile range). 
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Figure 3.12 Forepaw 50% withdrawal thresholds. Von Frey filaments were 
applied to the forepaws of normal, uninjured animals (n=9) and in groups of 
animals that received contusion injuries of 150 Kdyn force followed by 3 week 
delayed medium injections (n=15) or hLP-MSC transplants (n=13). In injured 
groups, testing was performed once, at 10 weeks following the injury (One 
way ANOVA, Tukey’s post-hoc test. Error bars = SEM; *=p<0.05 / **=p<0.01). 
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Figure 3.13 Pain sensitivity testing. A) A von 
Frey hair (2.44 hair / 0.04g) was applied to skin 
2cm caudal and 2cm lateral to the injury location 
to assess the development of tactile allodynia. B) 
Previous studies have shown that allodynia 
develops at this level by 2 weeks following a 200 
Kdyn or 150 Kdyn contusion injury, C) 
Transplanted and control groups developed 
allodynia similarly by 3 weeks following 150 Kdyn 
contusion injury and sensitivity remained elevated 
for up to 10 weeks post injury (2 way ANOVA – 
P>0.05. Error bars = SEM. Figures A and B provided 
by Dr. Ahmed Emraja). 
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Figure 3.14 Dynamic weight bearing (DWB) tests.  The distribution of 
weight applied to forelimbs vs. hindlimbs was recorded using the DWB test in 
hLP-MSC transplanted animals and medium injected controls (NBL = Normal 
base line levels for uninjured animals; both = Student’s T-test – P>0.05. Error 
bars = SEM). 
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Figure 3.15 Maximum SEP amplitudes. Maximum SEP amplitudes  recorded 
in hLP-MSC transplanted and medium injected controls A) Maximum radial 
SEP amplitude expressed as a % of the maximum radial SEP amplitude 
recorded in each animal, B) Maximum sciatic SEP amplitude expressed as a % 
of the maximum radial SEP amplitude recorded in each animal, (Student’s T-
tests – all = P>0.05. Error bars = SEM). 
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Figure 3.16 SEP isopotential areas. SEP isopotential contour plots recorded 
in hLP-MSC transplanted and medium injected controls. A) Maximum 80% 
radial SEP isopotential area, B) Maximum 15% sciatic isopotential areacorded 
in each animal, (Student’s T-tests – all = P>0.05. Error bars = SEM). 
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Figure 3.17 Latency to SEP onset. Latency to SEP onset recorded in  hLP-MSC 
transplanted and medium injected controls. A) Latency to radial SEP onset, B) 
Latency to sciatic SEP onset (Student’s T-tests – all = P>0.05. Error bars = 
SEM).  
 
 
 
 
 
 
203 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.18 Individual SEP isopotential contour plots of medium injected 
and hLP-MSC transplanted animals. Individual isopotential contour plots 
encompassing the areas of cortex within which radial and sciatic SEP 
amplitudes were at least 80% and 15% of the maximal radial SEP amplitudes 
recorded in each animal, respectively. A) Individual radial isopotential 
contour plots from medium injected animals (n=15), B) Individual sciatic 
isopotential contour plots from medium injected animals (n=15), C) Individual 
radial isopotential contour plots from hLP-MSC transplanted animals (n=14), 
D) Individual sciatic isopotential contour plots from hLP-MSC transplanted 
animals (n=14). All distances are in mm relative to Bregma (B). 
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Figure 3.19 Averaged radial and sciatic SEP isopotential contour plots 
recorded in medium injected and hLP-MSC transplanted groups. A) 
Isopotential contour plots encompassing the area of cortex within which 
radial SEP amplitudes were at least 80% of the averaged maximal radial SEP 
amplitude. B) Isopotential contour plots encompassing the region of cortex 
within which sciatic SEPs could be recorded with amplitudes at least 15% of 
the averaged maximal radial SEP amplitude. All distances are in mm relative 
to Bregma (B) Red = Medium injected group (n=15); Green = hLP-MSC 
transplanted group (n=14). 
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Figure 3.20 Cell survival following delayed transplantation into the 
contused spinal cord. Confocal microscope images showing the survival of 
transplanted cells at and around the injury epicenter of spinal cords subjected 
to contusion injuries of 150 Kdyne force at T9. A) hLP-MSC transplants at 10 
days post transplantation. B) hLP-MSC transplants at 6 weeks post 
transplantation. C) Syngeneic F344 rat OEC transplants at 4 weeks post 
transplantation into a cervical level contusion injury, for comparison. (GFAP = 
blue, GFP-transplanted cells = green (in A&B), olfactory ensheathing cells = 
green (in C)). 
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Figure 3.21 Assessment of injury cavity filling. Confocal 
microscope images showing the different degrees of 
cavitation infilling at the injury site 10 weeks following 
injury and 7 weeks following hLP-MSC transplants or 
medium injections.  A) An example of filled cavities in a 
control animal. B) An example of a partially filled cavity in 
a transplanted animal. C) An example of an empty cavities 
in a medium injected animal (GFAP = blue, Laminin = red, 
GFP-hLP-MSCs = green). 
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Figure 3.22 Assessment of myelination and remyelination with peripheral 
type myelin. P0 labelled cells in T9 150 Kdyn injury sites 10 weeks following 
injury and 7 weeks following media injection or hLP-MSC transplantation. A) 
Parasagittal sections from A) medium injected and B) hLP-MSC transplanted 
animals showing immunolabelling for P0, a component of peripheral type myelin. 
a and b show boxed areas in A and B at higher power. C) High power confocal 
image of P0 immunolabelling associated with neurofilament labelled axons. 
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Table 3.1 Cavity Infilling in hLP-MSC transplanted and medium injected 
animals.  Incidence of matrix infilling of cavities at the injury sites in 
transplanted and medium injected animals, 7 weeks post 
transplantation/injection. hLP-MSC group - n=14 / Medium group – n=15. 
 
 
 hLP-MSCs Medium 
Filled      57%   (8)     20%   (3) 
Part filled      36%   (5)     66%   (10) 
Cavity      7%     (1)     14%   (2) 
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3.3.8 Discussion 
 
The electrophysiological recordings reported here suggest some recovery of 
function with time after injury. hLP-MSC transplants appeared to have little or no 
effect on the functional integrity of the dorsal column pathway. BBB open field 
locomotor testing did not reveal any difference between the recoveries of cell 
transplanted and control groups. Gait analysis, performed using the Digigait™ 
imaging system revealing a trend for earlier recovery of co-ordination between 
forelimbs and hindlimbs in hLP-MSC transplanted animals compared to control 
animals. Moreover the step sequence data also suggested a better recovery of co-
ordinated stepping in transplanted compared to medium injected animals. DWB 
testing was used to measure the percentage of body weights borne by each of the 
forepaws and hindpaws, demonstrating no effect of transplanted cells on postural 
changes. hLP-MSC transplants did not increase indicators of neuropathic pain 
suggesting they are unlikely to exacerbate neuropathic pain following spinal cord 
injury. Immunohistological analysis suggested that there was a wider distribution 
of P0 (mature peripheral-type myelin immunoreactivity) in transplanted animals 
and that this was specifically in areas where transplanted cells were located. 
 
 
Potential reasons for absence of electrophysiologically detectable 
improvements in dorsal column transmission 
Researchers using similar injuries have shown persistent demyelination (James et 
al., 2011; Totoiu and Keirstead, 2005) so it is reasonable to assume that the model 
used here should produce similar demyelination which offers a therapeutic target 
for improving function. 
 
Since there should be a therapeutic target for the cells to act on i.e. to improve the 
completeness of myelination, several explanations exist which could explain the 
current findings. One possibility is that the cells do not survive in sufficient 
numbers to result in a robust enhancement of remyelination – although this 
argument is confounded by the fact that we have demonstrated the cells surviving 
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for up to 6 weeks post transplantation, and arguably this is when they should be 
having an effect on the ongoing process of endogenous myelination. When 
interpreting this observation we must remain cognisant of the fact that cell 
transplants designed to promote processes such as repair of myelination need not 
be an intrinsic part of the structure of repair, and need not necessarily form the 
myelin sheath themselves; it should be possible and might be desirable for the 
transplanted cells to die once their job is done. Other explanations include the 
possibility that the cells are not distributed optimally for secreted factors to reach 
OPCs close to demyelinated dorsal column fibres, or that the cells simply do not do 
in vivo what they do in an in vitro system. 
 
It also remains a possibility that the electrophysiological assessment is not sensitive 
enough to detect improved remyelination and/or functionally superior myelination, 
for example, with better internodal distance and nodal structure and distribution of 
ion channels. Also, there remains a possibility that endogenous remyelination is as 
complete as possible, and that there remains other reasons which could explain why 
demyelination is persistent and the factors produced by the transplanted cells 
cannot overcome these.  
 
Enhanced recovery speeds shown by the longitudinal behavioural tests may reflect 
an increased speed of remyelination encouraged by the cells but that this benefit 
does not lead to a long term advantage because in the absence of cells, endogenous 
mechanisms eventually lead to the same degree of myelination, this raises the 
possibility that in injuries where there is more persistent demyelination that the 
factors produced by the hLP-MSCs may provide a more significant advantage.   
 
As discussed earlier, without the use of electron microscopy to assess the G-ratios 
of myelinated axons, we are unable to assess the degree of remyelination and as 
such are reliant on IHC techniques. With no specific marker for central 
remyelination, we are only able to assess the degree of peripheral type 
myelination. Whilst this technique cannot measure remyelination by 
oligodendrocytes, it does provide some indication of the injured cords ability to 
support remyelination of demyelinated axons. 
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Mechanisms underlying promotion of improved gait 
It has been shown that locomotion and gait are controlled primarily by pathways in 
deeper or more ventral parts of the spinal cord (Raineteau et al., 2002). 
As a result, studies in which the effect of lesions in different areas of the spinal 
cord have been investigated suggest that a large proportion of the dorsal white 
matter, including the dorsal columns, can be damaged before any obvious changes 
in locomotion can be detected. Thus, the electrophysiology of the dorsal columns 
and the gait analysis are therefore complementary measures of functional outcome 
which assess different pathways in the spinal cord. Gait analysis showed that 
whereas transplants have no obvious effect on dorsal column transmission, the 
recovery of co-ordinated stepping showed a trend for more rapid and more 
complete in transplanted animals compared to non-transplanted controls. 
Compensatory mechanisms may account for the discrepancy between functional 
improvements recorded by electrophysiological testing and behavioural testing. For 
example, here we report that reinstating co-ordination of forelimb and hindlimb 
stride frequency is achieved by adaptations of both the forelimbs and hindlimbs to 
a new common stride frequency rather than by normalisation of the stride 
frequency to that before the injury; thus it can be seen that animals employ 
compensatory mechanisms which, combined with limited functional recovery act to 
return stride frequency towards normal levels. It remains to be determined whether 
the mechanisms by which gait has been shown to be improved in this study during 
treadmill based locomotion would be the same in overland locomotion where 
animals have the possibility of reducing the speed of locomotion. A recent 
investigation into the effects of intraspinal OEC transplantation on gait and long 
tract function in spinal-cord-injured companion dogs showed similar improvements 
in forelimb-hindlimb coordination with no improvement in long tract function 
measured via a non-invasive transcranial magnetic SEP and MEP stimulation and 
recording protocols (Granger et al., 2012). However in this study the scores for 
individual forelimb and hindlimb scores were not given, so it is unknown whether or 
not similar compensatory adaptions to gait were made. 
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Another potential mechanism by which cell transplants might improve functional 
outcome is via a neuroprotective effect. However, this is unlikely to be involved in 
the functional recovery in gait seen in this study as the transplants were made 
three weeks after the injury, by which time point we consider it to be a chronic 
injury as previous studies have shown that the function of the dorsal column system 
has stabilized by this time point. Plus, since it is unlikely that an autologous 
transplant strategy would allow for transplants earlier than a few weeks after 
injury, a neuroprotective mechanism is unlikely to be relevant in this scenario. 
Whilst there is no direct evidence that cell transplants promote plasticity, it 
remains a possibility. Because the study design was optimised to assess long tract 
function it provides less information about mechanisms such as plasticity but 
plasticity at the low thoracic level (the level of the transplant) is unlikely to 
significantly affect gait co-ordination and promotion of plasticity remote from the 
transplant site.   
 
P0 immunolabelling 
Since P0 is a marker for peripheral type myelin, its presence in the injury cavity 
shows that there is Schwann cell myelination occurring. There were some 
indications that P0 immunolabelling might be greater in transplanted animals. For 
one of the transplanted animals this was seen to be concentrated in areas where 
transplanted cells were located, and this appeared to be located deeper within the 
cord than was typical for non-transplanted animals. James et al., 2011 did not 
report such ventral P0 labeling, but rather reported P0 labeled cells present more 
dorsally in the dorsal columns after 4 wks post-injury; thus suggesting that the more 
ventrally located labeling reported here could be related to the transplanted cells. 
One explanation for the peripheral type myelin seen here is that Schwann cells are 
attracted to the injury site and are encouraged to migrate more ventrally. Another 
viable explanation is that the factors produced by transplanted hLP-MSCs are 
capable of inducing OPCs to differentiate into Schwann cells (Zawadzka et al., 
2010) which then form peripheral type myelin in the injury site. 
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Further work is required to validate these findings but if they can be confirmed 
then more efficient remyelination of more ventral locomotor tracts may explain the 
trend for more rapid recovery of coordinated locomotion seen in the transplanted 
animals in this study.  
 
Axonal ingrowth 
Ingrowth of neurofilament immunolabelled axons was seen within the transplanted 
injury sites and also within the matrix filling the injury site of non-transplanted 
animals. Although the extent of this axonal ingrowth was not quantified, the 
density of axons appeared greater in the transplanted animals. Axons could be seen 
at the centre of what was clearly an infilled injury cavity which was devoid of any 
spared tissue. Because of this and the tortuous morphology of these axons there is 
no doubt that these represent regenerating rather than spared fibres (Steward et 
al., 2003).  As we had no reason to suspect these axons to show bridging axonal 
regeneration no tract tracing was carried out in these experiments. Since these 
axons form blind endings within the transplant or matrix infill, the regeneration is 
likely to be of no functional importance. It is possible that the regeneration that 
occurs in the axon within the injury site stimulates sprouting of additional axon 
collaterals from more distal portions of the fibres. This might conceivably lead to 
improved function locally but there is no evidence for this at present and it would 
require a different electrophysiological approach in which local circuit activity 
could be recorded from around the injury area. Investigating cord dorsum potentials 
provides an excellent way of achieving this (Toft et al., 2007). 
 
 
Reasons for limited cell survival 
Although transplanted cells could be detected in all of the transplanted animals, 
their numbers were relatively low and less than in previous cell transplantation 
studies we have carried out in our laboratory using, for example, syngeneic animal 
cells. 
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The immune response immediately following injury is one of the largest barriers to 
transplant survival, though by simply delaying transplantation until the immune 
response begins to subside, as in this study, researchers are able to increase the 
likelihood that cells will survive after transplantation. Xenotransplants invariably 
require hosts to be immunosupressed in order to ensure cell survival. 
As well as delaying transplants until the immunological response had started to 
subside, we also provided immunosuppression with daily injections of cyclosporin 
beginning 24hrs prior to transplantation and maintained daily throughout the 
experimental period. Despite this, it remains possible that the immunosuppressive 
regime may be inadequate to ensure long term transplant survival and that the 
immunological response which occurred prior to immunosuppression has effects 
which last beyond the commencement of immunosuppression. Whilst these factors 
are likely involved in contributing to the loss of transplanted cells, numerous other 
factors will also play a significant role in the loss of cells, including a lack of trophic 
support and their introduction to an environment with extreme electrochemical 
imbalances as a result of the secondary injury sequale. 
The gross structure of the injured cord might also play a role in limiting cell 
survival. For example, this injury model produces large cavities which transplanted 
cells would find it hard to survive in the centre of, due to the lack of metabolic 
support and the ongoing effects of the secondary injury. Additionally, our histology 
showed that in some animals the cavities were septated and that while one cavity 
showed evidence of transplanted cells the adjacent cavity did not. This is 
presumably because the injection, which was made at the injury epicentre filled 
one cavity but that the septae prevented cells spreading throughout the injury site. 
This could be improved in future by making multiple injections. 
 
 
Immunosuppression – problem of testing autologous transplant strategy with 
human cells in animals 
A problem that occurs when studying human cells in animal models is that it is 
necessary to suppress the immune system using immunosuppressive drugs or to 
conduct experiments in animals in which the immune system is compromised by a 
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genetic mutation (nude animals). In studies where it is envisaged that grafts would 
in any case be allogeneic, this is less of a problem because it can be argued that 
immunosuppression would have to be a part of the therapy. In this case, however, 
it is envisaged that the grafts would come from the patient themselves i.e. the 
patient would act as their own donor, and that this would avoid the need for 
immunosuppression. This is seen as the big advantage of using cells from this 
source. However, this means that immunosuppression in the animal model is not a 
realistic feature but is a necessary condition. Although nude rats might be an 
alternative to an immunosuppressive treatment and could offer an advantage in 
terms of promoting better graft survival, they have the disadvantage that the injury 
occurs in an animal lacking an immune response. Giving immunosuppression a few 
days before the transplant has the advantage over nude rats that the injury at least 
develops with the usual immunoreactive response. In nude rats it is possible that 
the injury environment is not a good model of the clinical situation since the 
immune response to traumatic injury is considered an important component of the 
response to injury and the secondary sequallae, without which the nude rats will 
respond to the injury in a significantly different manner to that seen with 
functional immunological systems, ie. clinically.  
 
Preclinical and clinical trials 
This investigation was designed to assess the beneficial potential of hLP-MSCs with 
a view to one day developing an autologous transplantation strategy. Whilst this is 
the first time that hLP-MSC have been assessed in vivo for the treatment of SCI, 
many other pre-clinical investigations have used MSCs from different sources and 
used different purification protocols, routes and timings of transplantation; whilst 
these studies have resulted in vastly different outcomes, all have demonstrated 
that MSCs are safe to transplant into the CNS, and the majority have 
demonstrated that transplanting MSCs into the injured cord has a positive effect 
on recovery (reviewed by Forostyak et al., 2013). Despite the variability in 
protocols and efficacies seen in pre-clinical studies, many labs have already 
entered into clinical trials, with to date several hindered people having been 
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made the recipients of MSCs for the treatment of SCI (reviewed by Kwon et al., 
2013). Whilst it is clear that the different protocols and cell sources investigated 
are capable of eliciting different effects on the sequalea that follows SCI – this, 
combined with the findings reported in this study raise questions as to why clinical 
trials are already underway before any firm consensus has been reached on the 
optimal protocols for extraction, purification, culturing and transplantation of 
MSCs. 
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General discussion and future directions 
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Electrophysiological approaches for investigating function after spinal cord 
injury 
 
How it has been used and what it has shown in this project 
In this project we have demonstrated that SEP recording can provide an indicator of 
the severity of injury to the dorsal columns. We have then used this approach to 
provide the first accurate and complete information on the time course of changes 
in function of white matter pathways of the spinal cord after a traumatic injury.   
 
Electrophysiological testing is the only way of providing direct information on what 
is happening to local circuits and pathways in the spinal cord after injury and 
treatments. This project has demonstrated that this approach is possible for 
recordings of long white matter pathways. 
 
 
Advantages over other electrophysiological approaches/previous studies 
This in vivo and invasive approach under terminal anaesthesia is the first time this 
protocol has been used to provide an accurate picture of changes occurring directly 
within the spinal cord at the level of long tract function. Other approaches have 
been used in an attempt to obtain this important information. However, single fibre 
sampling has a more limited resolution as only a subset of the injured fibres can be 
assessed and as such may not allow investigation of severe injuries or at time points 
soon after injury. Whilst investigation of retrograde compound action potentials is 
capable of providing detailed information about the integrity of the tracts and 
individual fibres investigated, this approach remains limited in resolution as it is not 
capable of selectively measuring the function in the whole tract. Unfortunately, 
non-invasive methods of recording SEPs appear to have not yet reached a sufficient 
point of refinement to be able to provide an alternative means of obtaining this 
information; again there appears to be a lack sensitivity in the early stages after 
injury and they are also subject to a great deal of variability. 
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General disadvantages / limitations of an electrophysiological approach 
Although there are some clear and valuable advantages in using an 
electrophysiological approach to obtain information on the function of pathways 
and circuits directly at the spinal cord level, there are a number of difficulties and 
limitations to this approach.  
 
Anatomical restrictions mean that only certain pathways can be studied because 
only some are conveniently arranged such that they can be maximally activated in a 
selective way to allow for quantitative comparisons between animals and treatment 
groups. Similarly, only certain pathways are accessible and convenient for recording 
from in a manner that allows for recording and assessing total or massed activity in 
the pathway i.e. summed activity – this is usually in the form of surface potentials 
that can be recorded in a consistent manner. In practice this means the dorsal 
column pathway and corticospinal pathway. 
 
Electrophysiological tests are unable to differentiate positive and negative changes 
in an animal’s condition. Changes in function can be good or bad, for example, an 
increase in the strength of a pathway might be due to regeneration or plasticity and 
the new connections might be functionally useful and provide an improved 
functional outcome or they may be inappropriate and of no functional benefit. It is 
even possible that they may be maladaptive and lead to problems with pain or 
spasticity, or autonomic problems. As a result it is desirable to perform behavioural 
testing along-side electrophysiology, though as behaviour depends on integrated 
functions and is rarely critically affected by a single pathway, there is no behaviour 
that directly depends on the function of one single pathway. Correlating 
electrophysiological changes in function with behaviour is less of an issue if the 
underlying mechanisms for change are neuroprotective mechanisms or mechanisms 
such as remyelination which should not alter connectivity but preserve more of the 
previous fibres and their existing connections.  
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Stem cell therapies 
 
Stem cell therapies for the treatment of SCI have received a great deal of focus due 
to the numerous reports that they can positively influence recovery following SCI; 
including the reported involvement of various cell lines in the regulation of trophic 
factors and cytokines in vivo, the ability to positively influence neighbouring cells 
via paracrine secretions, extracellular matrix molecules and the secretion of 
neurotrophic factors as well as their ability to transdifferentiate into cell types 
which are known to play important roles in recovery following SCI. 
 
Recently a great deal of focus has been placed in MSCs of various origins for the 
treatment of SCI. Most focus has been placed on MSCs of bone marrow origin, whilst 
the reported effects of MSCs have been varied many authors have reported 
improvements in functional recovery recorded both electrophysiologically and 
behaviourally. Recent in vitro studies have shown that MSCs isolated from the 
human nasal lamina propria have greater myelinating abilities than BMSCs, though 
as reported here, hLP-MSCs did not produce the same level of functional recovery in 
vivo as has been reported with BMSCs. Thus whilst here we report modest trends 
suggesting improved functional outcomes with hLP-MSCs, the differences between 
the in vitro and in vivo preparations appear to be enough to curb the hLP-MSCs 
beneficial effects on functional recovery to such an extent that are exceeded in 
vivo by those reported following MSC of alternate origin, including BMSCs. 
 
Despite the variability in the reported pre-clinical efficacies of stem cells at 
ameliorating the effects of SCI, several clinical trials are currently underway. As 
there is currently no consensus on the optimal source, isolation, purification or 
culturing or transplantation protocols used in pre-clinical trials, it would seem that 
clinical trials may have been started prematurely. In order to maximise the efficacy 
of clinical studies, it would seem logical to wait until consensus is reached in the 
aforementioned protocols in pre-clinical studies. These same problems also exist in 
the development of stem cell therapies for other CNS diseases; this is perhaps a 
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product of the extremely high potential seen for such therapies combined with the 
massive incentive to prevent further damage and ameliorate functional deficits.     
Future directions 
 
Extending the approach to obtain information on local circuit (grey matter) 
function 
The current work demonstrates the usefulness of an invasive in vivo 
electrophysiological approach for obtaining information on the function of white 
mater tracts after traumatic injury. A similar approach would be valuable in 
providing information about local circuit function. Local circuit functioning can be 
investigated most simply and straight forwardly using cord dorsum potential 
recording. This approach has been used to investigate the effect of OEC transplants 
on CDPs evoked by sensory afferents in the dorsal roots in a wire knife injury model 
(Toft et al., 2007). It provided evidence that OEC transplants have a 
neuroprotective effect if transplanted acutely. However, so far there has been no 
investigation of how contusion injuries affect local circuits in the grey matter 
around the injury or how function in the grey matter changes with time after 
injury. This information would be potentially valuable in indicating how much 
damage occurs at the initial injury and how much additional damage occurs as a 
result of secondary injury mechanisms. By investigating the time course of changes 
in function after the injury, the time over which the secondary mechanisms 
continue to cause deterioration in local circuit function could be determined. This 
approach could also indicate whether there is any recovery in this function and over 
what period this occurs and when a stable situation indicative of the chronic stage 
of the injury is reached. Such information would be valuable in indicating how much 
potential there is for reducing the impact of traumatic spinal cord injury by using 
neuroprotective strategies. It would also indicate the time window within which 
such treatments would need to be administered to be effective. This information 
does not exist either for animal models or in humans despite its obvious importance 
in the development of neuroprotective strategies for treating spinal cord injury. 
Investigation of other treatments based on other strategies would also benefit from 
knowledge of what represents a chronic time point in an animal model since it is 
necessary to know before considering transplantation whether a treatment is likely 
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to be of benefit to newly injured (acute injury) patients or could benefit existing 
patients with long term (chronic) injuries. 
 
Potential for developing a chronic recording approach in the future 
The present study obtained valuable information on the time course of changes in 
function of long white matter pathways over time. However, to obtain this 
information, large numbers of animals had to be used in acute experiments 
conducted at different time points. This has a cost implication in terms of the 
expense of the experiments and is very time consuming to perform. It would also be 
desirable to minimise the numbers of animals used in future studies. Although, 
chronic recording approaches adopted so far do not seem to have the appropriate 
sensitivity of accuracy it is possible that they could be improved and used to obtain 
longitudinal information from the same animal over a period of time after the 
injury. For example it may be possible to use the information generated in this 
study on the location of maximal SEPs to guide the best placement of electrodes for 
chronic implantation. These locations were fairly consistent and injury did not 
significantly shift the distribution of these maximal recording locations. Similarly, it 
may be possible to implant cuff electrodes around peripheral nerve such as the 
sciatic nerve or forelimbs nerves in order to provide better control over stimulation 
parameters. 
 
Thus chronic recording of SEPs, if carefully approached – for example using 
appropriate types of electrodes appropriately sited so as to have good control over 
stimulation of the nerve, might offer an adequate way of assessing dorsal column 
function and might provide a means of following changes due to treatments in a 
longitudinal fashion. 
 
As discussed above, one of the disadvantages of using SEPs as a way of monitoring 
function in long white matter tracts is that it is a pathway which involves relays. 
Although these relays are probably an advantage in terms of increasing the 
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sensitivity of the approach, they have the disadvantage that they complicate 
interpretation of latency changes in the pathway. Recordings directly from the 
dorsal column fibres represent an advantage in this respect. However, this may be 
difficult to achieve as a recovery procedure as stimulation of the dorsal columns 
strong enough to activate the majority of primary afferents usually causes muscle 
contractions and temporary paralysis and artificial ventilation would therefore 
probably be required. Preliminary experiments in our lab have suggested that the 
alternative possibility of recording directly at the site of termination of the 
ascending dorsal column fibres in the dorsal column nuclei is not very promising 
because the resulting potentials that can be recorded from the surface of the brain 
stem are relatively small but also rather spread out and complex in form (i.e. 
consisting of several peaks). This would make quantification difficult although the 
earliest latency response could probably be determined. Also the cerebellum has to 
be retracted slightly to provide adequate access for these recordings. 
 
 
Cell transplantation and the future of therapies for spinal cord injury 
The most definitive answer to whether myelination is enhanced in transplanted 
animals would be to investigate this by using electron microscopy and quantifying 
the proportions of axons that are demyelinated, normally myelinated and 
remyelinated with peripheral versus central type myelin. Given that the survival of 
cells shown in this study was poor in comparison to when transplants have been 
made into syngeneic animals, experiments using different immunosuppressive 
regime would have to be considered. Another alternative would be to use animal 
cells, which have yet to be investigated. This would remove the need for 
immunosuppression since the study could be carried out in an inbred rat strain using 
syngeneic cells. The survival of the cells in this model should be good and the 
immune response would not be compromised in any way. The down side of this 
approach is that there may be differences between animal cells and human cells. 
Another approach could be to use nude or athymic rats system. The in vitro 
evidence for enhanced myelination was obtained using conditioned media obtained 
from cultures of human cells but tested on neural cells from animals grown in 
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culture. Whilst there are some immune cells present in the culture but this clearly 
does not represent a normal immune system. It is therefore not clear whether 
immune responses are necessary or contribute to the mechanism of enhanced 
myelination. 
 
A further possible approach would be to investigate the factor or factors that is 
produced by the LP-MSCs and is within the conditioned media secreted by them and 
added to the myelinating cultures. If the important factor(s) could be identified 
then it might be possible to deliver these in some way to the injury site. This might 
be possible by engineering cells to over-secrete the factors and therefore produce 
them in a higher concentration with the potential for greater effectiveness. It 
might also be possible having identified the factor(s) that are important to isolate 
these and to deliver them to the injury site using an intrathecal cannula with its tip 
placed close to the injury and an implanted osmotic pump. This could be used to 
deliver the factors over a prolonged period. However, the factors would need to be 
stable at body temperature and they would need to penetrate the spinal cord tissue 
readily. Intravenous delivery might be an alternative but would be less targeted and 
may not reach the spinal cord as readily as direct delivery, although disruption of 
the blood brain barrier as a result of the injury may facilitate this.   
 
This thesis provides valuable insights into long tract function in the dorsal columns 
following moderate contusion injury at T9, as well as providing a well characterised 
model on which to test therapeutic interventions. Using this model we have 
investigated the effects of hLP-MSC transplants on function in long tracts and have 
provided promising directions for future investigations. 
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